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I have characterized chaperone requirements for the biogenesis, maturation, and degradation of a 
cytosolic substrate, firefly luciferase (FFLux), in yeast, and of an integral membrane protein, 
cystic fibrosis transmembrane conductance regulator (CFTR), in yeast and in mammals.  
 
It was previously demonstrated that the cytoplasmic Hsp40, Ydj1p, is required for efficient 
expression of FFLux in yeast. This raised the question whether two Ydj1p-interacting molecular 
chaperones, the yeast Hsp70, Ssa1p, and the yeast Hsp90, Hsp82, also impact FFLux expression. 
The possible influence of a nucleotide exchange factor for Ssa1p, Fes1p, was also investigated. I 
found that the chaperone requirements for FFLux biogenesis are distinct but overlapping. 
Whereas Ssa1p and Fes1p likely collaborate to fold FFLux, Ssa1p, independent of its nucleotide 
exchange factor, was necessary for stabilizing FFLux protein and message, and for efficient 
induction of FFLux mRNA. Therefore, Fes1p impacts only a subset of Ssa1p’s actions. Although 
FFLux folding progresses independent of Hsp82, efficient expression of FFLux depends on 
Hsp82, mainly due to Hsp82’s contribution to FFLux translation.  
 iii
To identify the complete spectrum of chaperones that affect ER associated degradation (ERAD) 
of CFTR, I took a genomic approach in yeast. Transcriptional profiles between yeast expressing 
CFTR and control strains were examined by microarray analysis. Among the genes up-regulated 
in strains expressing CFTR was one encoding a small heat shock protein (sHsp), HSP26. 
Therefore, I investigated CFTR degradation in yeast strains lacking HSP26 and found that the 
protein was stabilized; stabilization was enhanced in a strain lacking both HSP26 and another 
sHsp-encoding gene, HSP42. In contrast, degradation of a soluble ERAD substrate and of 
another transmembrane protein proceeded with equal efficiency in wild type and in hsp26hsp42 
mutant yeast. Next, I examined whether sHsps regulate CFTR biogenesis in mammalian cells. I 
found that ∆F508-CFTR degradation was enhanced when αA-crystallin was over-expressed in 
HEK293 cells, although wild type CFTR biogenesis was unaffected. To examine why this sHsp 
accelerated degradation of ∆F508-CFTR, αA-crystallin was purified and I found that it was able 
to suppress aggregation of CFTR’s first nucleotide binding domain. Together, these results 
suggest that sHsps increase ∆F508-CFTR’s accessibility during proteasome-mediated 
degradation. 
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 1. INTRODUCTION 
 
 
 
 
1.1. SECRETORY PATHWAY 
 
 
Based on sequence analyses of eukaryotic genomes an estimated ~20% of all proteins reside in 
or traverse the secretory pathway (Lander et   al., 2001). The first committed step in this pathway 
is the translocation of newly synthesized polypeptides into the endoplasmic reticulum (ER). 
Protein import proceeds mainly co-translationally in mammals, but in yeast, it may occur co- or 
post-translationally. During co-translational translocation, the signal recognition particle (SRP) 
interacts with the signal peptide once it emerges from the ribosome. This process attenuates 
translation and the ribosome-polypeptide-SRP complex interacts with the SRP receptor at the 
ER-membrane. GTP-binding and hydrolysis liberate SRP, translation resumes and the 
polypeptide is released to the translocation machinery at the ER membrane (Johnson and van 
Waes, 1999; Keenan et al., 2001; Luirink and Sinning, 2004). During post-translational 
translocation, the polypeptide is completely synthesized and discharged from the ribosome 
before associating with the translocation machinery at the ER (Rapoport et al., 1999) and a key 
component of this machinery is the Sec61p translocation channel (Romisch, 1999). In both cases, 
Hsp70s and their co-factors are required for successful protein import in yeast (Chirico et al., 
1 
 1988; Deshaies et al., 1988; Caplan et al., 1992; Sanders et al., 1992; Brodsky et al., 1995; 
McClellan et al., 1998; McClellan and Brodsky, 2000; Fewell et al., 2001). 
 
After folding in the ER and passing ER quality control (see below), secreted proteins are 
selectively incorporated into budding transport vesicles. These vesicles, which are coated with 
the COPII protein complex, collect the selected cargo from the ER and migrate to the ER-Golgi 
intermediate compartment or the Golgi complex (Barlowe et al., 1994; Bonifacino and Glick, 
2004). In contrast, retrograde transport back to the ER, which may be required to retain proteins 
in the ER, occurs via COPI coated vesicles (Letourneur et al., 1994; Bonifacino and Glick, 
2004). Further trafficking of protein substrates to the plasma membrane, the trans-Golgi network, 
and the endosome is supported by yet another pathway that utilizes clathrin coated vesicles 
(Bonifacino and Lippincott-Schwartz, 2003; Bonifacino and Traub, 2003). 
 
Regardless of the acceptor organelle to which the vesicles are targeted, the coats must be shed 
and the vesicles must fuse with the acceptor membrane in order to deliver their cargo. Membrane 
fusion relies on complex formation between specific v-SNARE proteins of the transport vesicle 
with specific partner t-SNARE proteins on the target membrane (Chen and Scheller, 2001; 
Bonifacino and Glick, 2004). While different v-/t-SNARE complexes are able to convey some 
level of specificity to the process of membrane fusion, tethering factors provide additional target 
specificity prior to SNARE complex formation (Barr and Short, 2003; Bonifacino and Glick, 
2004). Various steps of the vesicle budding, targeting, and fusion process are regulated and 
timed by different Rab proteins via GTP hydrolysis (Bonifacino and Glick, 2004). Therefore, the 
biogenesis of secretory proteins followed by their shuttling to the right destination within the cell 
2 
 is highly regulated and complex; quality control check points at different steps along this journey 
prevent the cell from the fatal consequences that may arise from mistakes. One check point in the 
early secretory pathway is ER protein quality control. 
 
 
 
 
1.2. ER PROTEIN QUALITY CONTROL 
 
 
Protein maturation and folding in the ER are pre-requisites for subsequent transport through the 
secretory pathway because soluble and integral membrane proteins are subject to ER protein 
quality control (ERQC) (Ellgaard and Helenius, 2003). Proteins that are unable to fold or 
assemble into multi-protein complexes fail to pass the ERQC check-point and may be degraded, 
which unburdens the ER from housing aberrant proteins and eliminates the potential formation 
of toxic protein aggregates.  ER proteins that are targeted for degradation are destroyed by the 
cytoplasmic proteasome.  As a result, soluble proteins within this compartment must be re-
exported, or “retro-translocated” to the cytoplasm, and the selection, targeting, and proteolysis of 
proteins residing in the ER or at the ER membrane has been referred to as ER associated protein 
degradation (ERAD) (Tsai et al., 2002; Kostova and Wolf, 2003; McCracken and Brodsky, 
2003). By definition, then, ERAD can be sub-divided into three stages: substrate recognition in 
or at the ER, targeting to the proteasome, and proteasome-mediated degradation. 
   
3 
 1.2.1. The ubiquitin –proteasome pathway 
 
 
Many ERAD substrates are ubiquitinated prior to their degradation via the 26S-proteasome. 
Conjugation of ubiquitin to the candidate protein requires three distinct steps (see Figure 1). 
First, the ubiquitin activating enzyme (E1) activates ubiquitin in an ATP-dependent manner 
through the formation of a high energy intermediate. Second, the activated ubiquitin is now 
passed on to a ubiquitin conjugating enzyme (E2). Finally, the ubiquitin moiety is transferred 
from the E2 to a lysine residue of the substrate that is bound to an ubiquitin ligase (E3), which 
catalyzes this reaction. Depending on the class of E3 involved, the attachment of the ubiquitin to 
the substrate proceeds either directly or indirectly (Glickman and Ciechanover, 2002; Pickart, 
2004). While in most organisms only one E1 activates ubiquitin to transfer it to a range of E2s, 
many E3s exist. For example, the human genome encodes for more than 40 putative E2s and 
over 500 predicted E3s (Wong et al., 2003). Sequentially appending ubiquitin onto substrates 
already containing ubiquitin creates a polyubiquitin chain. Once a minimum of 4 ubiquitins is in 
place, the ubiquitinated protein might then be identified by the 26S proteasome which degrades 
the substrate after deubiquitination by deubiquitinating enzymes (Thrower et al., 2000; Glickman 
and Ciechanover, 2002). The 26S proteasome consists of 1 or 2 19S regulatory particles, also 
called the “cap” or PA 700, and a 20S catalytic core (see Figure 2). The 19S regulatory particle 
prevents proteins from aggregating, remodels polypeptide conformation, binds to ubiquitinated 
proteins, catalyzes retro-translocation of ERAD substrates out of the ER, and drives  
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 Figure 1: Ubiquitin-proteasome pathway. 
Ubiquitin is activated and covalently linked to an E1 in an ATP-dependent process. Activated 
ubiquitin is then transferred to an E2.  An E3 facilitates the conjugation of ubiquitin via its C-
terminal glycine to a lysine or a primary amine in the substrate. The polyubiquitinated substrate 
is recognized by the proteasome, deubiquitinated by Dubs and degraded. E1=ubiquitin activating 
enzyme, E2=ubiquitin conjugating enzyme, E3=ubiquitin ligase, Ubi=ubiquitin, 
Dub=deubiquitinating enzyme, G=glycine, K=lysine, magenta line=ERAD-substrate. 
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                                                 Figure 1: Ubiquitin-proteasome pathway. 
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 Figure 2: Structure of the 26S proteasome. 
ased on electron microscopy from Drosophila 26S 
                 
       
 
The three-dimensional structure model is b
proteasome and the crystal structure of Thermoplasma 20S proteasome. The 19S regulatory 
particles are represented in blue, the proteolytic 20S core particle is depicted in yellow.  
(Adapted from Voges et al., 1999). 
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              Figure 2: Structure of the 26S proteasome. 
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deubiquitinated substrates into the 20S core (Glickman et al., 1998; Braun et al., 1999; 
.2.2. Distinct requirements for the degradation of ER-lumenal and transmembrane 
 
fter they are selected for degradation in the ER, evidence suggests that soluble lumenal ERAD 
Strickland et al., 2000; Verma et al., 2000; Dai and Li, 2001; Lee et al., 2001; Lam et al., 2002; 
Liu et al., 2002; Lee et al., 2004). The 20S core harbors three distinct proteolytic activities that 
degrade substrates. The importance of the ubiquitin-proteasome pathway is emphasized by the 
plethora of substrates degraded and its implication in human diseases. 
 
 
1
proteins 
 
A
substrates, and at least some integral membrane substrates, are retro-translocated through the 
Sec61p translocation channel (Romisch, 1999); however, Sec61p function may be dispensable 
for the degradation of other membrane substrates (Walter et al., 2001; Huyer et al., 2004).  In 
this case, the endopeptidase activity of the proteasome, or other proteases might clip cytoplasmic 
loops and directly extract the substrate (Walter et al., 2001; Liu et al., 2003), or a recently 
defined protein complex in the ER membrane might form a specific retro-translocation channel 
(Lilley and Ploegh, 2004; Ye et al., 2004). In any event, many studies indicate that ERAD 
substrate retro-translocation from the ER and delivery to the proteasome is catalyzed by a multi-
protein complex containing Cdc48p (also known as p97, or “Valosin-containing protein”, VCP), 
Ufd1p, a factor isolated in a screen for ubiquitin fusion degradation mutants, and Npl4p, which is  
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 encoded by a gene that, when mutated, leads to defects in nuclear protein localization (Bays and 
the polypeptide backbone and then to the polyubiquitin conjugate on ERAD substrates that is 
chaperones—such as the ER lumenal Hsp70, BiP—which facilitate folding but can then “decide” 
section 1.3. below). Lectins recognize glycans on secreted proteins. Specifically, calnexin and 
1 9 2, 
glucosidase. Removal of the remaining glucose frees the glycoprotein from the lectins so they 
as EDEM, has been proposed to bind the Man8-containing glycan and to target these 
in hydrophobic amino acids, and cycles of ATP binding, hydrolysis and ADP release are coupled 
Hampton, 2002) (also see Table 1 for definitions).  The Cdc48p-Ufd1p-Npl4p complex binds to 
appended through the action of E2s and E3s (see above); ATP hydrolysis by Cdc48p is required 
to complete retro-translocation (Ye et al., 2003). In addition, the 19S “cap” (PA700) of the 
proteasome itself might facilitate the retro-translocation of some ERAD substrates (Lee et al., 
2004). Key mediators of ERAD substrate selection are ER resident lectins and molecular 
to target proteins for degradation (Fewell et al., 2001; Ellgaard and Helenius, 2003); also see 
calreticulin bind and retain immature monoglucosylated glycoproteins (Glc Man GlcNAc Glc is 
glucose, Man is mannose, GlcNAc is N-acetyl glucosamine) that have been trimmed by 
can exit the ER.  Prolonged ER retention results in mannose-trimming, and another lectin, known 
glycoproteins for ERAD (Molinari et al., 2003; Oda et al., 2003). Although the calnexin and 
calreticulin cycles are absent in the yeast S. cerevisiae, the EDEM homologue known variably as 
Mnl1p or Htm1p also facilitates the proteolysis of glycosylated ERAD substrates (Jakob et al., 
2001; Nakatsukasa et al., 2001).  In contrast, Hsp70s, such as BiP, recognize peptides enriched 
with the association and dissociation of peptide substrates. Hsp40 co-chaperones enhance the 
ATPase activity of Hsp70s, and thus impact Hsp70-peptide capture.  Together, Hsp70-Hsp40 
chaperone pairs can retain aggregation-prone, misfolded proteins in solution (Fewell et al.,  
10 
 Table 1: Partial list of factors required for ERAD, ERAD substrates, and description of constructs tested. 
 
 
 Subcellular 
localization 
Description 
Hsp104 Cytosol Yeast heat shock protein, 104 kD 
Involved in stress response, protein folding 
Ssa1p Cytosol Yeast heat shock protein, 70 kD 
involved in protein translation, translocation, 
degradation, folding 
Kar2p (mBiP 
homolog) 
ER Yeast heat shock protein, 78 kD 
involved in protein translocation, retro-
translocation, folding degradation 
Cwc23p Cytosol Yeast heat shock protein, 40 kD 
Hlj1p Cytosol, ER 
membrane anchored 
Yeast heat shock protein, 40 kD 
Involved in protein folding 
Jid1p Transmembrane, ER Yeast heat shock protein, 40 kD 
Jem1p ER Yeast heat shock protein, 40 kD 
involved in protein folding 
Scj1p ER Yeast heat shock protein, 40 kD 
involved in protein folding 
Mnl1p = Htm1p ER Yeast lectin, man8 binding, involved in ERQC  
EDEM ER Mammalian lectin, man8 binding, involved in 
ERQC  
Sec61p ER membrane Yeast translocon 
Cdc48p = p97 = 
Vcp 
Cytosol Yeast AAA-ATPase, involved in apoptosis, cell 
cycle, ER associated protein metabolism, vesicle 
fusion, ubiquitin dependent protein catabolism 
Ufd1p Cytosol Yeast Cdc48p cofactor 
Npl4p Cytosol Yeast Cdc48p cofactor 
Der3p = Hrd1p ER membrane Ubiquitin ligase 
Der1p (mDerlin-
1 homolog) 
ER membrane Protein degradation (mDerlin, 
 proposed  component of dislocon machinery) 
Hrd3p ER membrane Ubiquitin ligase 
Doa10p ER membrane Ubiquitin ligase 
Ubc1p Cytosol Ubiquitin conjugating enzyme 
Ubc7p Cytosol, ER 
membrane anchored 
Ubiquitin conjugating enzyme 
Wsc1p Transmembrane, ER Cell wall integrity and stress response component 1 
KHN ER lumen yeast Kar2p signal sequence fused to simian virus 5 
HA-Neuraminidase ectodomain 
Ste6p Transmembrane, 
plasmamembrane 
Yeast plasma membrane mating factor transporter 
Ste6p* Transmembrane, ER Mutated form of Ste6p 
11 
  
 
Subcellular  
Localization 
Description 
KWW Transmembrane, ER KHN luminal domain/Wsc1p transmembrane 
domain/Wsc1p cytosolic domain 
KSS Transmembrane, ER KHN luminal domain/Ste6p transmembrane 
domains/ Ste6-166p mutant cytosolic domain 
KWS Transmembrane, ER KHN luminal domain/Wsc1p transmembrane 
domain/ Ste6-166p mutant cytosolic domain 
CPY Vacuole Yeast carboxypeptidase Y 
CPY* Retained in ER Mutated form of CPY 
CT* Transmembrane, ER Membrane-bound CPY* lacking a cytosolic 
domain 
CTG* Transmembrane, ER CT* with GFP as cytosolic domain 
GFP Cytosol Green fluorescent protein 
Vph1p Transmembrane, 
plasmamembrane 
Yeast vacuolar ATPase 
CFTR Transmembrane, 
plasmamembrane 
Mammalian, cystic fibrosis transmembrane 
conductance regulator 
A1PiZ Retained in ER Variant of mammalian α1-protease inhibitor, 
ERAD substrate 
∆GpαF Retained in ER Mutant form of yeast mating factor, 
unglycosylated, ERAD substrate 
ERAD  ER associated degradation 
ERAD-L ER lumen ERAD upon checkpoint in the ER lumen 
ERAD-C Cytosol ERAD upon checkpoint in the cytosol 
 
(Table 1 continued) 
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 2001).  Not surprisingly, the release of BiP from ERAD substrates correlates with their 
degradation (Knittler et al., 1995), and mutations in the gene encoding yeast BiP, KAR2, and/or 
deletion of BiP’s Hsp40 partners, JEM1 and SCJ1, slow the degradation of soluble ERAD 
substrates such as a mutated form of carboxypeptidase Y (CPY), which is denoted “CPY*”, a 
nonglycosylated mating factor precursor known as pαF, and the Z variant of the human α1-
protease inhibitor, A1PiZ, in yeast (Plemper et al., 1997; Brodsky et al., 1999; Nishikawa et al., 
2001; Kabani et al., 2003). BiP is not required for the degradation of several integral membrane 
ERAD substrates in yeast, including CFTR (the cystic fibrosis transmembrane conductance 
regulator), Vph1p (a vacuolar ATPase), and a mutated form of a plasma membrane mating factor 
transporter, Ste6p, abbreviated as Ste6p*. Instead, their degradation requires a cytoplasmic 
Hsp70, Ssa1p (Hill and Cooper, 2000; Zhang et al., 2001; Huyer et al., 2004). Together, these 
data indicate the existence of at least two pathways for ERAD substrate selection—one that 
recognizes aberrant integral membrane proteins and another that recognizes ER lumenal soluble 
proteins.  In addition, the molecules that select substrates in the two classes include both lectins 
that bind to specific glycan moieties and molecular chaperones that associate directly with the 
polypeptide.  
 
Another apparent distinction between the ERAD pathways taken by soluble and membrane 
proteins is that soluble substrates can be transported to the Golgi and appear to be retrieved to the 
ER prior to degradation, whereas integral membrane ERAD substrates are retained in the ER 
(Caldwell et al., 2001; Vashist et al., 2001). Nevertheless, a discussion of “soluble” versus 
“membrane” ERAD substrate might be irrelevant: There could be varying requirements for the 
degradation of membrane proteins with different numbers of integral membrane domains or even 
13 
 for one membrane protein with topologically distinct mutations.  For example, the degradation of 
a membrane protein containing either a misfolded lumenal, transmembrane, or cytosolic domain 
might only require factors located in the same compartment as the aberrant domain.  Although it 
is clear that ERAD is comprised of many different pathways, it has been difficult to 
unequivocally establish their existence.  However, recent studies from the Ng and Wolf 
laboratories have better defined several distinctions between pathways taken by ERAD 
substrates en route to degradation (Taxis et al., 2003; Vashist and Ng, 2004).  
 
 
1.2.3. Protein sorting based on topology and localization of misfolded domains  
 
 
The integral membrane substrates employed previously contained lesions located in the cytosolic 
domains, whereas misfolded domains in the soluble substrates resided exclusively in the ER 
lumen. This raised the possibility that the location of the lesion with respect to the ER 
membrane, rather than the residence of the protein (i.e., soluble versus membrane), determined 
the substrate’s trafficking pattern. To examine this hypothesis, Vashist et al. designed protein 
chimeras with defined folded and misfolded domains and with different topologies (see Figure 3 
and Table 1 for definitions of domains and proteins utilized), and then determined the 
requirements for their degradation by pulse-chase analysis in various wild type and mutant yeast 
strains (Vashist and Ng, 2004).  The degradation of KHN, a soluble ERAD substrate consisting 
of a misfolded ER-lumenal domain was examined previously (Vashist et al., 2001), and in the 
newer study a chimera denoted KWW was designed that also contained a misfolded ER-lumenal  
14 
 Figure 3:  A schematic representation of chimera ERAD substrates. 
Three letter designations that describe the composition of the constructed ERAD substrates. The 
first, second, and third letters portray the lumenal, transmembrane, and cytosolic domains, 
respectively. KHN is depicted by blue stars, the Wsc1p transmembrane domain by red bars and 
the folded cytosolic and lumenal domains by red circles, and Ste6p* (“Ste6”) is depicted by 
black bars/loops (transmembrane domain), black circles (folded cytosolic domain), and black 
stars (misfolded cytosolic domain).  Also see the Table 1 for definitions of all proteins used to 
create these substrates. 
(Adapted from Vashist and Ng, 2004). 
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                                         Figure 3: A schematic representation of chimera ERAD substrates. 
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 domain but was anchored to the ER membrane by a single transmembrane domain (Figure 3). 
Using these substrates, the authors first re-investigated whether only soluble ERAD substrates 
appeared to be transported to the Golgi prior to their degradation (Caldwell et al., 2001; Vashist 
et al., 2001). If this were the case, KWW should be degraded independently of ER-to-Golgi 
transport, but Ng and colleagues discovered that membrane-bound KWW was degraded at a rate 
similar to soluble substrates and that a block in ER-to-Golgi transport stabilized KWW. 
Surprisingly, KWW degradation also required, Der1p, a protein so far known to facilitate only 
the degradation of lumenal substrates, and interestingly it is the yeast homologue of the putative 
retro-translocation channel (Knop et al., 1996; Vashist et al., 2001; Lilley and Ploegh, 2004; Ye 
et al., 2004). Overall, one conclusion from this study is that the site of the lesion is the major 
determinant for this aspect of the ERAD pathway, and the authors proposed two surveillance 
mechanisms: ERAD-L (ERAD-Lumenal), which monitors the folded state of lumenal domains, 
and ERAD-C (ERAD-Cytosolic), which monitors the folded state of cytosolic domains (see 
Figure 4). Consistent with this distinction, only the ERAD-L pathway required the function of 
the yeast EDEM homologues, Mnl1p/Htm1p (see above) (Vashist and Ng, 2004). 
 
To further define the relationship between ERAD-L and ERAD-C, Ng and co-workers next 
constructed a polytopic membrane protein with misfolded domains on both sides of the 
membrane (KSS; Figure 3). In principle, KSS should exhibit determinants for both the ERAD-L 
and ERAD-C pathways, but KSS instead exhibited characteristics only of an ERAD-C substrate: 
A short half-life, Der1p-independent degradation, no requirement for ER-to-Golgi transport, and 
dependence on the Doa10p ubiquitin ligase (E3; see section 1.2.1). Although it cannot be 
completely excluded that the magnitude of the folding defect in each domain differs, or that  
17 
 Figure 4: Distinct ERAD pathways lead to degradation via the proteasome. 
Black stars represent misfolded domains, and black triangles are N-linked core glycans. Whereas 
all ERAD substrates tested in vivo require the proteasome and probably the Cdc48-Ufd1p-Npl4p 
complex (A and B), there is significant variety and distinction concerning the rest of the ERAD 
machinery. For example, soluble substrates interact with lumenal chaperones to remain 
aggregation-free (A), whereas transmembrane proteins with prominent cytosolic domains require 
cytosolic chaperones (e.g. Ssa1p) for degradation (B). Misfolded ER lumenal proteins, and some 
transmembrane proteins with folding defects in the lumen, can be transported from the ER and 
appear to be retrieved from the Golgi before being degraded by the ERAD-L pathway.  Their 
degradation requires Der1p (whose function is unknown), EDEM, and specific ubiquitin 
conjugating enzymes and ligases (A).  In contrast, transmembrane proteins with misfolded 
domains in the cytosol, are retained in the ER and degraded by the ERAD-C pathway (B). 
(Ahner and Brodsky, 2004). 
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Figure 4.A: Distinct ERAD pathways lead to degradation via the proteasome. 
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Figure 4.B: Distinct ERAD pathways lead to degradation via the proteasome. 
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 domain accessibility to components of each machinery differs, these data strongly suggest that 
the ERAD-C check-point precedes the ERAD-L checkpoint. 
 
 
1.2.4. Protein sorting based on membrane association and solubility 
 
 
Taxis et al. (Taxis et al., 2003) uncovered substrate-specific requirements of the ERAD 
machinery by similarly constructing and analyzing structurally different proteins, but each 
contained the same ER-lumenal ERAD substrate, CPY*. Thus, the degradation of CPY* was 
compared to CT*, which is a fusion protein containing CPY* anchored to the ER membrane via 
a single transmembrane domain, and CTG*, which is a chimera between GFP (Green 
Fluorescent Protein) in the cytoplasm and CT* (see also Table 1). Based on data from pulse-
chase analyses in wild type and mutant yeast strains, the authors identified a core machinery 
required for the degradation of all three substrates, and that consists of the Der3p ubiquitin ligase 
(also known as Hrd1p), the ubiquitin-conjugating enzymes Ubc1p and Ubc7p, the Cdc48p-
Ufd1p-Npl4p complex, and the proteasome (see Figure 4 and Table 1). But, the Der3p ubiquitin 
ligase was dispensable for KSS and Ste6-166p degradation, which depended instead on the 
Doa10p ligase (Vashist et al., 2001).  Therefore, ubiquitin ligases seem to exhibit specificity 
rather than being part of the general ERAD machinery.   
 
According to the model by Vashist et al. (Vashist et al., 2001), one would expect CT* and CTG* 
to be targeted to the ERAD-L pathway, like CPY*, since the aberrant domain in each substrate 
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 resides in the lumen. Instead both CT* and CTG* were degraded independently of Der1p and 
ER-to-Golgi transport, suggesting that the membrane-spanning segment affects the ERAD 
pathway selection.  In accordance with a previous observation, however, Wolf and colleagues 
found that CTG*, but neither CT* nor CPY*, was stabilized in strains mutated individually for 
the cytosolic Hsp70 chaperone, Ssa1p (see below) (Hill and Cooper, 2000; Zhang et al., 2001). 
They also discovered that the cytoplasmic Hsp40 homologues Hlj1p, Cwc23, and Jid1p, and the 
Hsp104 chaperone modestly facilitate CTG* degradation. These data suggest that the GFP 
moiety in CTG*, which is properly folded, also influences ERAD, and one model to account for 
these data is that cytosolic chaperones help unfold GFP prior to proteasomal degradation. Overall 
the recent publications described indicate that ERAD substrates cannot simply be distinguished 
as being either lumenal or integral membrane proteins, and in Figure 4, I attempt to depict the 
requirements for the selection, targeting and degradation of model ERAD-C and ERAD-L 
substrates.   
 
 
 
 
1.3. MOLECULAR CHAPERONES IN THE CYTOPLASM 
 
 
Molecular chaperones, many of which were first identified as heat shock proteins (Hsps) are 
involved in a variety of cellular processes including protein folding and degradation, assembly 
and disassembly of protein oligomers, translocation of polypeptides across intracellular 
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 membranes, refolding of denatured proteins, solubilization of protein aggregates, and activation 
of enzyme-catalyzed reactions (Frydman, 2001). Members of one Hsp class with a molecular 
mass of 70 kD, the Hsp70s, are highly conserved and are among the most abundant molecular 
chaperone sub-types. Hsp70s are composed of a conserved, ~44 kD N-terminal nucleotide 
binding site, followed by a ~18 kD peptide-binding domain, and a ~10 kD relatively non-
conserved C-terminal lid region (Chappell et al., 1987; Milarski and Morimoto, 1989; Flaherty et 
al., 1990; Wang et al., 1993; Zhu et al., 1996). Hsp70s bind preferentially to substrate 
polypeptides containing stretches of amino acids with overall hydrophobic character (Flynn et 
al., 1991; Blond-Elguindi et al., 1993; Rudiger et al., 2001). Polypeptide binding is driven by a 
conformational change and is nucleotide-dependent: In the ADP-bound state, the substrate 
affinity for Hsp70 is high and the kinetics of release are relatively slow, whereas fast cycling 
between polypeptide binding and release is observed in the ATP-bound state (Schmid et al., 
1994; McCarty et al., 1995; Ziegelhoffer et al., 1995). 
 
The ATPase activity of Hsp70s, and thus their interaction with polypeptides, can be enhanced by 
Hsp40 molecular chaperones.  Hsp40 interaction with Hsp70s requires the J-domain, a conserved 
~70 amino acid domain that forms a four-helix bundle (Cyr et al., 1992; Wall et al., 1994; 
Cheetham and Caplan, 1998; Kelley, 1998; Qian et al., 2002). After ATP hydrolysis, nucleotide 
exchange factors (NEFs), another class of Hsp70 cofactors, release ADP from Hsp70 and thus 
facilitate substrate dissociation from the chaperone. Therefore, NEFs enable Hsp70-mediated 
substrate binding and release, although whether they facilitate or inhibit protein folding has been 
a matter of debate (Brehmer et al., 2001; Briknarova et al., 2001; Sondermann et al., 2001; 
Kabani et al., 2002a; Kabani et al., 2002b; Sondermann et al., 2002). 
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 Hsp110s comprise a subfamily of the Hsp70 family of chaperones with homology mostly in the 
N-terminal nucleotide-binding site (Easton et al., 2000). In the yeast cytoplasm there are two 
members of the Hsp110 family of molecular chaperones: Sse1p and Sse2p (Mukai et al., 1993; 
Shirayama et al., 1993). Sse1p retains proteins in a folding competent conformation, and 
interacts with and is required for the function of the Hsp90 complex (Oh et al., 1997; Brodsky et 
al., 1999; Liu et al., 1999; Goeckeler et al., 2002). In contrast to the Hsp70s, the substrate 
specificity of this class of chaperones has not been characterized.  
 
Hsp90 is one of the most abundant cytosolic proteins in the eukaryotic cell and is highly 
conserved (Caplan, 1999; Richter and Buchner, 2001). Unlike Hsp70, Hsp90 is able to bind ATP 
via an N-terminal domain as well as a C-terminal domain (though with lower affinity) (Grenert 
et al., 1997; Prodromou et al., 1997; Stebbins et al., 1997; Marcu et al., 2000; Garnier et al., 
2002; Soti et al., 2002). Binding of ATP to the N-terminal domain facilitates Hsp90 
dimerization, which then stimulates ATP hydrolysis (Prodromou et al., 2000) and substrate 
dissociation (Young and Hartl, 2000). Many Hsp90-dependent functions—for example steroid 
hormone receptor activation—require the formation of an Hsp90 complex that may include 
Hsp70, Hsp40, the Hsp90 organizing protein (Hop), p23, the cyclophilins, and other proteins 
(Pratt and Toft, 2003). 
 
Hsp70 and Hsp90 facilitate protein folding in mammalian cells but can “decide” to target 
substrates that are unable to fold for proteasome-mediated protein degradation. For example, 
mammalian Hsp70 and Hsp90 cooperate during the refolding of denatured firefly luciferase 
(FFLux), but addition of ansamycin antibiotics (geldanamycin, herbimycin A, radicicol) prevents 
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 substrate dissociation from Hsp90 and redirects FFLux to the degradation pathway (Schneider et 
al., 1996). In addition, the decision between folding and degradation can require Hsp70/Hs90 
cofactors: Together with the J-domain-containing proteins, Hdj1/2 and the NEF HspBP1, Hsp70 
facilitates the biosynthesis of the Cystic Fibrosis Transmembrane conductance Regulator 
(CFTR), the protein that when mutated gives rise to cystic fibrosis (CF) (see section 1.5. below); 
CFTR biogenesis is also facilitated by Hsp90 in mammalian cells (Strickland et al., 1997; 
Meacham et al., 1999; Choo-Kang and Zeitlin, 2001; Farinha et al., 2002; Alberti et al., 2004). 
However, when an Hsp70/Hsp90-interacting ubiquitin ligase, known as CHIP is recruited, there 
is a shift toward the degradation pathway (Connell et al., 2001; Meacham et al., 2001). The same 
is true during glucocorticoid receptor maturation and when the fate of heat-denatured FFLux was 
examined (Schneider et al., 1996; Connell et al., 2001). However, CHIP has also been reported 
to facilitate Hsp70-dependent folding when over-expressed (Kampinga et al., 2003). One 
potential problem with these studies, which can give rise to the noted controversial conclusions, 
is the difficulty of specifically and rapidly disabling molecular chaperone function in mammalian 
cells.  Particularly, administration of the ansamycin antibiotics can induce cell stress and 
chaperone or co-chaperone over-expression can initiate non-specific effects on cellular processes 
(Lawson et al., 1998). 
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 Table 2: Cytoplasmic chaperones and cofactors. 
 
 
Yeast Hsp Mammalian ortholog 
 
Description 
Sse1p Hsp110 heat shock protein, ~110 kD, 
ribosome associated, member 
of the hsp90 complex, 
prevents protein aggregation 
Hsp82 Hsp90 heat shock protein, ~90 kD, 
involved in protein 
maturation, prevents protein 
aggregation 
Ssa1p Hsp70 heat shock protein, 70 kD 
involved in protein translation, 
translocation, degradation, 
folding 
Ydj1p Hdj1/2 heat shock protein, 40 kD, 
Hsp70-cochaperone, 
involved in protein folding 
Sis1p Hsp40 ortholog heat shock protein, 40 kD, 
involved in translation 
initiation 
Hsp26 α-crystallin-like sHsp heat shock protein, 26 kD, 
prevents protein aggregation 
Hsp42 α-crystallin-like sHsp heat shock protein, 42 kD, 
prevents protein aggregation 
Fes1p HspBP1 Nucleotide exchange factor 
for Ssa1/Hsp70 
- CHIP Hsp70/Hsp90-interacting 
ubiquitin ligase 
Sba1p p23 Member of Hsp90 complex  
Sti1p Hop Hsp90 organizing protein 
Cprs Cyclophilins members of Hsp90 complex, 
prolyl-isomerases 
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 1.4. SMALL HSPS 
 
 
Small heat shock proteins (sHsps) constitute another, heterogeneous class of molecular 
chaperones that is so far rather ill-defined. sHsps share a conserved, ~80 amino acid “α-
crystallin” domain at their C-terminus that is found in the best characterized member of this 
family, a protein mainly expressed in the eye-lens, α-crystallin (Caspers et al., 1995; Horwitz, 
2003). Saccharomyces cerevisiae encodes 2 members of the sHsp family, Hsp26 and Hsp42 
(Geoffrey, 1997), while 10 human α-crystallin-related Hsps have been identified (Kappe et al., 
2003). All the proteins in this class examined so far oligomerize in vitro to form large complexes 
(de Jong et al., 1998; Narberhaus, 2002). The oligomers may form hollow spheres with openings 
or cylinders (Haley et al., 1998; Kim et al., 1998a; Haslbeck et al., 1999; Haley et al., 2000; Van 
Montfort et al., 2001a; van Montfort et al., 2001b; Haslbeck et al., 2004). For example, the 
crystal structure of Methanococcus jannaschii Hsp16.5 is shown in Figure 5. The spherical 
complex with octahedral symmetry consists of twenty four subunits and contains 14 openings. 
The monomers arrange into 10 β-strands, packed into 2 parallel sheets, and 2 short helices (Kim 
et al., 1998a). Most α-crystallin-like Hsps consist mainly of β-sheets (Merck et al., 1993; Leroux 
et al., 1997; Muchowski et al., 1997; Bova et al., 1999; Shearstone and Baneyx, 1999; van 
Montfort et al., 2001b; Narberhaus, 2002) as seen in the Methanococcus jannaschii (Mj) 
Hsp16.5, but the residues critical for monomer interaction may not be conserved. Also, the 
number of subunits within the oligomers seems to be exceptionally constant in Mj Hsp16.5 (Kim 
et al., 1998a), but this does not appear to be true in every sHsp oligomer examined  
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 Figure 5: Structure of Mj 16.5. 
A: A space filling model of Mj Hsp16.5 oligomer arranged in a hollow sphere. Each color 
depicts one Hsp16.5 tetramer. Top right: ovals representing the 24 subunits, symmetry axes 
indicated by arrows; top left: schematic illustration of octahedral symmetry. B: The front one-
third of the sphere is severed to expose the interior. View along the three-fold axis (left) and the 
four-fold axis (right). Each color depicts one Hsp16.5 tetramer. An octahedron in the same 
orientation as the corresponding sHsp is shown at the top.  
(Kim et al., 1998a).                     
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   Figure 5: Structure of Mj Hsp16.5. 
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 (Haley et al., 1998; Ehrnsperger et al., 1999; Haslbeck et al., 1999; Shearstone and Baneyx, 
1999; Haley et al., 2000; Lindner et al., 2000; Narberhaus, 2002).  For comparison, Figure 6 
represents a cryo-EM reconstruction of αB-crystallin and αB-crystallin with bound substrate, 
exhibiting a variable quaternary structure with a central cavity (Horwitz, 2003). 
 
The significance of the assembly into oligomers for chaperone function is still controversial. 
While some sHsps exhibit chaperone activity in a dimeric or tetrameric state, others seem to lose 
function upon disassembly of the oligomer (Narberhaus, 2002). For example, the activity of the 
yeast Hsp26 depends on heat-shock induced dissociation into dimers (Haslbeck et al., 1999). 
Overall, the predominance of β-sheets in the secondary structure and the tendency to oligomerize 
seems to be common among the family members of sHsp. In contrast, the subunit arrangement 
within the oligomers as well as the correlation between the chaperone activity and the state of the 
quaternary structure might differ between individual sHps.   
 
Regardless of their exact oligomeric properties, sHsps have been demonstrated to associate with 
unfolded proteins and to prevent their aggregation (Horwitz, 1992; Jakob et al., 1993; 
Ehrnsperger et al., 1997; Lee et al., 1997; Haslbeck et al., 1999; Biswas and Das, 2004; 
Haslbeck et al., 2004). In addition, α-crystallins have neuroprotective properties and confer 
resistance to apoptosis by negatively regulating tumor necrosis factor α and inhibiting caspase-3 
activation (Kamradt et al., 2001; Kamradt et al., 2002; Kamradt et al., 2005), as well as by 
preventing the translocation of Bax and Bcl-Xs into mitochondria (Mao et al., 2004). 
Interestingly, the ERK and the p38 MAPK pathways are responsible for αB-crystallin  
30 
 Figure 6:  Cryo-EM reconstructions and models of recombinant αB-crystallin and αB-crystallin 
associated with α-lactalbumin. 
A: A cryo-EM reconstruction of αB-crystallin illustrating the asymmetrical exterior of the αB-
crystallin oligomer. B: A cropped view of the αB-crystallin reconstruction displaying the 
interior. Red denotes the strongest density and green the weakest. Blue depicts the surface. C: A 
cryo-EM reconstruction of αB-crystallin associated with α-lactalbumin. D: A model of αB-
crystallin (magenta)/α- lactalbumin (red) complex. Scale bar = 100Å.  
(Horwitz, 2003).  
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Figure 6: Cryo-EM reconstructions and models of recombinant αB-crystallin and αB-crystallin associated with α-
lactalbumin. 
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phosphorylation on Ser-45 and Ser-59, respectively (Kato et al., 1998; Hoover et al., 2000; 
Eaton et al., 2001). Phosphorylation on Ser-59 seems to be necessary and sufficient for 
protection of cardiac myocytes from apoptosis via caspase-3 inhibition (Morrison et al., 2003).  
 
Moreover, it has been shown in human lens epithelial cells that αB-crystallin prevents UVA-
induced apoptosis by repressing UVA-induced activation of the RAF/MEK/ERK pathway, 
whereas αA-crystallin activates the PI3K/AKT pathway to promote survival  under the same 
conditions (Liu et al., 2004b). In addition, over-expression of αB-crystallin in vascular 
endothelial cells abrogates glucose-induced reactive oxygen species formation, activation of 
caspase-3, and therefore apoptosis (Liu et al., 2004a). α-crystallins, as well as Hsp27, interact 
with various intermediate filaments and modulate their assembly and their interactions (Nicholl 
and Quinlan, 1994; Quinlan et al., 1996; Perng et al., 1999; Perng et al., 2004). In addition, 
interactions between small Hsps and the actin cytoskeleton have been reported. (Miron et al., 
1991; Lavoie et al., 1993a; Lavoie et al., 1993b; Benndorf et al., 1994; Iwaki et al., 1994; 
Rahman et al., 1995; Wang and Spector, 1996; Gu et al., 1997; Piotrowicz and Levin, 1997; 
Wieske et al., 2001; Verschuure et al., 2002). In summary, sHsps seem to be able to regulate a 
plethora of signaling pathways to protect the cell under stress conditions. 
 
sHsp function has also been linked to the ubiquitin-proteasome system, and physical interactions 
between sHsps and the 20S proteasome have been detected (Boelens et al., 2001). While α-
crystallin decreases peptide hydrolyzing activities for some substrates, it protects the trypsin-like 
activity of the proteasome against oxidative inactivation (Wagner and Margolis, 1995; Conconi 
et al., 1998; Conconi et al., 1999; Boelens et al., 2001; Ito et al., 2002). Hsp27 binds to the 26S 
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 proteasome and to a polyubiquitinated substrate (Parcellier et al., 2003). In addition, αB-
crystallin may recruit the F-box protein, FBX4, an adaptor molecule for the ubiquitin ligase SCF, 
and promote substrate ubiquitination (den Engelsman et al., 2003; den Engelsman et al., 2004). 
Not surprisingly, then, specific diseases have been associated with mutations in α-crystallins 
(Litt et al., 1998; Vicart et al., 1998) and sHsps have been identified in glial inclusions in several 
tautopathies (Litt et al., 1998; Vicart et al., 1998; Dabir et al., 2004; Richter-Landsberg and 
Bauer, 2004). Together, these data suggest an important role for the family of small heat shock 
proteins in protein folding, degradation, and protection against stress.  
 
 
 
 
1.5. CFTR 
 
 
The Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene encodes a 1480 amino 
acid membrane glycoprotein (Riordan et al., 1989), and the protein belongs to the ATP-binding 
cassette (ABC) transporter superfamily (Higgins et al., 1988; Higgins, 1989). CFTR functions as 
a cAMP regulated chloride channel in the apical membrane of epithelial cells, including those of 
airways, pancreas, intestine, and kidney (Jilling and Kirk, 1997; Stanton, 1997; Kopito, 1999; 
Riordan, 1999; Bertrand and Frizzell, 2003). CFTR is composed of two membrane-spanning 
domains (MSD1 and MSD2), each comprising six transmembrane segments, two nucleotide 
binding domains (NBD1 and NBD2), and a central regulatory (R) domain (see Figures 7 and 8).  
34 
 Figure7:  Schematic of CFTR domain topology. 
N=N-terminus, C=C-terminus, MSD=Membrane spanning domain, NBD=Nucleotide binding 
domain, R=Regulatory domain 
(adapted from McCarty, 2000). 
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    Figure 7:  Schematic of CFTR domain topology. 
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 Figure 8:  Structural fold of mouse CFTR NBD1 with bound ATP. 
This figure depicts the tertiary structure of the NBD1 of mouse CFTR bound to ATP. α-helices 
are represented in purple, extended β-sheets in yellow, turns in cyan, and coils in white. The 
position of the residue deleted in most cases of CF, F508, is illustrated in dark blue, and the 
position of ATP in red.  
(Lewis et al., 2004; modified with VMD (Visual Molecular Dynamics), Humphrey et al., 1996). 
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                                      Figure 8:  Structural fold of mouse CFTR NBD1. 
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 CFTR channel gating depends on ATP binding to the NBDs   (see Figure 8) and hydrolysis 
(Carson et al., 1995; Gunderson and Kopito, 1995; Ikuma and Welsh, 2000; Vergani et al., 
2005). Mutations within the gene lead to cystic fibrosis (CF), one of the most frequent 
autosomal, recessive disorders in individuals of European descent. Although more than 1000 
mutations in the gene encoding CFTR have been discovered 
(http://www.genet.sickkids.on.ca/cftr/), the deletion of the phenylalanine at position 508 within 
NBD1, “∆F508-CFTR” (see Fig. 8) is the most common mutation associated with cystic fibrosis 
(Kerem et al., 1989; Riordan et al., 1989) and cells containing only this mutated variant lack the 
protein at the plasma membrane (Cheng et al., 1990). During CFTR biogenesis, NBD1 is folded 
co-translationally while NBD2 undergoes a post-translational folding mechanism that depends 
on the folded NBD1 (Du et al., 2005). After translocation into the ER, the folding of the core-
glycosylated, endoH-sensitive, 140-kD precursor (referred to as band “B” on SDS-PAGE gels) is 
assisted by cytoplasmic and lumenal chaperones and monitored by ERQC. In mammalian cells, 
interactions with the Hsp40s Hdj1 or Hdj2 and the NEF HspBP1 facilitate the Hsp70-dependent 
biosynthesis of CFTR; CFTR biogenesis is also impacted by Hsp90 and CHIP E3 ligase (see 
above) in mammals (Strickland et al., 1997; Meacham et al., 1999; Choo-Kang and Zeitlin, 
2001; Connell et al., 2001; Meacham et al., 2001; Farinha et al., 2002; Alberti et al., 2004). Yet 
another Hsp40, Csp1, stabilizes immature CFTR by binding to the N-terminus and regulatory 
domain of CFTR (Zhang et al., 2002a). Finally, the ER localized chaperone, calnexin, interacts 
with the immature form of CFTR and ∆F508-CFTR (Pind et al., 1994; Okiyoneda et al., 2004). 
Together, these data indicate that molecular chaperones play an essential role in the biogenesis of 
CFTR (also see Table 3 for complete list of CFTR-interacting chaperones). 
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Table 3: CFTR interacting chaperones and chaperone-cofactors. 
 
 
 Subcellular localization Interaction with CFTR 
Hsp70 Cytoplasm Regulates CFTR maturation 
and degradation 
Hdj1/2 (Hsp40) Cytoplasm Promotes CFTR maturation 
Csp1 (Hsp40) Cytoplasm Stabilizes immature CFTR 
CHIP (E3 ligase) Cytoplasm Promotes CFTR degradation 
HspBP1 (NEF) Cytoplasm Promotes CFTR maturation 
Hsp90 Cytoplasm promotes CFTR maturation 
Calnexin ER binds immature CFTR 
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 The ∆F508-CFTR mutant fails to reside at the apical plasma membrane because its folding is 
severely impaired (Qu and Thomas, 1996; Qu et al., 1997). This prevents ER export and leads to 
its degradation via ERAD (Cheng et al., 1990; Kartner et al., 1992; Yang et al., 1993; Lukacs et 
al., 1994; Ward and Kopito, 1994; Jensen et al., 1995; Ward et al., 1995; Kreda et al., 2005). 
The folding of the wild type protein is also inefficient, leading to the degradation of ~80 % of the 
protein (Cheng et al., 1990). However, it has been suggested that these values might be overly 
high and arise due to over-expression of CFTR in heterologous systems (Cheng et al., 1990; 
Kalin et al., 1999; Varga et al., 2004). But, even in cell lines that synthesize endogenously low 
levels of CFTR a similarly inefficient maturation has been observed (Lukacs et al., 1994; Ward 
and Kopito, 1994). Also, an effect of the immortalization of cell lines on maturation efficiency 
can’t be excluded (Kopito, 1999). By comparison, the assembly of the acetylcholine receptor 
proceeds with high efficiency in a primary muscle cell culture, but it is severely hampered in 
established cell lines (Merlie and Lindstrom, 1983; Ross et al., 1987), although, another member 
of the ABC transporter family, P-glycoprotein, matures with high efficiency in HEK293 cells 
(Loo and Clarke, 1997). Importantly, this issue may be finally settled because a very recent study 
on wild type CFTR and ∆F508-CFTR expression pattern in native tissues supports the 
hypothesis that defective protein processing is the major pathogenic mechanism in CF (Kreda et 
al., 2005).   
 
Regardless of the efficiency of wild type CFTR maturation, the ubiquitin-proteasome pathway 
has been identified as the degradative machinery responsible for proteolysis of wild type and 
∆F508-CFTR in mammals (Denning et al., 1992; Jensen et al., 1995; Ward et al., 1995; Xiong et 
al., 1999; Zhang et al., 2001; Gelman et al., 2002; Lenk et al., 2002; Younger et al., 2004). 
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 Export of properly folded CFTR from the ER and its transport to the Golgi in some cell lines 
may occur in a COPII-dependent fashion (Yoo et al., 2002; Wang et al., 2004), but only the wild 
type protein obtains the Golgi-specific modification of complex, endoH-resistant oligosaccharide 
chains, increasing its molecular weight to 160 kD (referred to as band “C” on SDS-PAGE gels, 
see Figure 9); however, ∆F508-CFTR never reaches this mature state under physiological 
conditions, indicating a block in ER exit (Lukacs et al., 1994; Ward and Kopito, 1994). This 
block in ER exit can be partially suppressed by treating CFTR-expressing cells with chemical 
chaperones or by growth at lower temperatures (Denning et al., 1992; Sato et al., 1996). These 
data indicate that the deletion of F508 leads to a temperature-sensitive defect in the folding 
pathway of CFTR. The rescued mutant CFTR, though, exhibits a much shorter half life in post-
Golgi compartments than the wild type protein due to increased susceptibility to ubiquitination 
and lysosomal degradation (Zhang et al., 1998; Benharouga et al., 2001; Sharma et al., 2001; 
Sharma et al., 2004). These results suggest that the misfolding and the complete absence of 
mutated CFTR from the plasma membrane in cystic fibrosis are major disease-causing defects. 
Therefore, facilitation of maturation and stabilization at the plasma membrane might be 
promising therapeutic targets.  
 
It is important to note that CFTR residence at the plasma membrane is not sufficient for channel 
activity: Phosphorylation of the R-domain by protein kinase A (PKA) seems to be a prerequisite 
for CFTR channel activity and it is thought to render the protein sensitive to stimulation via ATP 
(Gadsby and Nairn, 1999; Riordan, 2005).  CFTR chloride-conductance is also regulated by 
protein-protein interactions. At the apical plasma membrane, CFTR exists in a complex together 
with E3KARP or EBP50/NHERF1 and ezrin. This complex localizes PKA near the CFTR R- 
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 Figure 9:  Schematic of CFTR traversing the secretory pathway.  
CFTR is co-translationally translocated into the ER and inserted into the ER membrane. In the 
ER, CFTR is core-glycosylated and folded. ER quality control may detect misfolded CFTR and 
target it for degradation via the 26S proteasome. If folding succeeds, CFTR is transported to the 
Golgi, where it matures to the C-form. CFTR then traffics to the plasma membrane. Wild type 
CFTR can be internalized into endosomes and may recycle back to the plasma membrane. 
However, plasma membrane quality control mechanisms might recognize misfolded CFTR at the 
endosome and subject it to degradation via the lysosome (Riordan, 2005). 26S=26S proteasome, 
B-form=immature, core glycosylated (ER) from of CFTR, C-form=maturely glycosylated CFTR. 
Blue lines denote CFTR at different stages during the secretory pathway, gray line represents 
CFTR mRNA. Membrane bound organelles are shown in beige and are specifically labeled 
within the figure, transport vesicles are depicted as beige circles.   
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  Figure 9:  Schematic of CFTR traversing the secretory pathway. 
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 domain, and connects CFTR to the cytoskeleton. This, in turn, contributes to the regulation of the 
channel activity and may stabilize CFTR at the apical plasma membrane (Dransfield et al., 1997; 
Hall et al., 1998; Short et al., 1998; Wang et al., 1998; Sun et al., 2000a; Sun et al., 2000b). 
These data indicate that the regulation of CFTR channel activity is complex and further suggests 
that a multi-factorial therapeutic approach might be required to successfully treat CF patients. 
 
 
 
 
1.6. YEAST AS A MODEL SYSTEM 
 
 
One drawback of the mammalian cell culture system is the inability to specifically and rapidly 
disable molecular chaperones. Methods common to investigate the chaperone requirements for 
cellular processes include administration of drugs to impact Hsp activity and over-expression of 
chaperones or their cofactors. Treatment with Hsp90 inhibiting ansamycin antibiotics, for 
example, can induce cell stress and chaperone or co-chaperone over-expression might lead to 
non-specific effects on cellular processes (Lawson et al., 1998; Zou et al., 1998). These 
pleiotropic effects can lead to controversial results. For example, the recruitment of the ubiquitin 
ligase CHIP shifts protein biogenesis toward the degradation pathway (Schneider et al., 1996; 
Connell et al., 2001; Meacham et al., 2001); but CHIP has also been shown to promote Hsp70-
dependent folding when over-expressed (Kampinga et al., 2003). Also, inhibition of Hsp90 via 
administration of the ansamycin antibiotic geldanamycin leads to enhanced proteolysis of CFTR 
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 in mammalian cell lines (Loo et al., 1998), whereas the same drug caused stabilization of CFTR 
in an in vitro system (Fuller and Cuthbert, 2000). 
 
Many aspects of protein synthesis, trafficking, and degradation are conserved between yeast and 
mammals. In addition, the budding yeast Saccharomyces cerevisiae offers a variety of genetic 
and biochemical tools enabling us to investigate the impact of chaperones on these pathways 
more specifically. In fact, the Brodsky laboratory showed that CFTR is an ERAD substrate in 
yeast as it is in mammals, and that the degradation of CFTR in yeast requires Ssa1p, a cytosolic 
Hsp70, and the function of one of two redundant cytosolic Hsp40 homologs, Ydj1 or Hlj1 
(Zhang et al., 2001; Youker et al., 2004). Moreover, Youker et al. were able to address the 
conflicting reports on Hsp90 engagement in folding versus degradation by assessing CFTR 
stability in a yeast strain harboring a temperature sensitive mutation in a yeast Hsp90 ortholog 
upon shift to the non-permissive temperature. In agreement with Loo et al. (Loo et al., 1998), 
they found that Hsp90 facilitates CFTR biogenesis (Youker et al., 2004). Several other labs have 
also taken advantage of the yeast system and contributed to the further understanding of the 
mechanism of CFTR degradation (Kiser et al., 2001; Fu and Sztul, 2003; Gnann et al., 2004). 
Yeast have also been used to examine the biogenesis of other medically-relevant proteins 
(Coughlan and Brodsky, 2003). Together, these facts render yeast a useful model organism to 
study the conserved pathways of protein biogenesis, folding, and degradation. 
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 1.7. THESIS OVERVIEW 
 
 
Among other cellular processes, molecular chaperones are involved in protein biogenesis, 
folding, maturation, and degradation. Particularly, chaperone requirements for the folding and 
degradation of soluble, secretory proteins and integral membrane proteins have recently been 
compared and are distinct from each other (Strickland et al., 1997; Meacham et al., 1999; Hill 
and Cooper, 2000; Choo-Kang and Zeitlin, 2001; Meacham et al., 2001; Zhang et al., 2001; 
Farinha et al., 2002; Kabani et al., 2003; Taxis et al., 2003; Alberti et al., 2004; Huyer et al., 
2004; Youker et al., 2004). In comparison, relatively few reports have addressed the chaperone 
requirements concerning the biogenesis, folding, and degradation of distinct polypeptides that 
reside in the cytoplasm (Schneider et al., 1996; Brodsky et al., 1998; Kim et al., 1998b; 
Kampinga et al., 2003). 
  
In this work, I describe my characterization of the chaperone requirements for the biogenesis, 
maturation, and degradation of a cytosolic substrate, firefly luciferase, and of an integral 
membrane protein, the cystic fibrosis transmembrane conductance regulator, in yeast. I have also 
examined the role of one chaperone, αA-crystallin, on the biogenesis of CFTR in mammals.  
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 2. DISTINCT BUT OVERLAPPING FUNCTIONS OF HSP70, HSP90, AND AN 
HSP70 NUCLEOTIDE EXCHANGE FACTOR DURING PROTEIN BIOGENESIS IN 
YEAST 
 
 
 
 
2.1. INTRODUCTION 
 
 
 
In addition to their catalysis of post-translational events, several lines of evidence indicate that 
Hsp70 and Hsp40 molecular chaperones also play critical roles during protein translation. First, 
two Hsp70 classes in yeast, Ssb and Ssz, and an Hsp40, known as Zuotin, form a stable complex 
and interact with ribosomes and nascent polypeptide chains; consistent with their role in 
translation, each of the individual mutant strains are hyper-sensitive to translation poisons, and 
over-expression of a putative elongation factor suppresses ssb temperature sensitivity (Nelson et 
al., 1992; Pfund et al., 1998; Yan et al., 1998; Gautschi et al., 2002; Hundley et al., 2002). 
Second, another cytoplasmic Hsp40, Sis1p, associates with ribosomes, and deletion of the 
ribosomal proteins L35 and L39 rescues the temperature sensitivity of a sis1 mutant; sis1 
mutants also exhibit aberrant polysome profiles (Zhong and Arndt, 1993). Third, deletion of 
FES1, a yeast NEF for Hsp70 that is the HspBP1 homolog, confers temperature-sensitive 
growth, aberrant polysome profiles, and sensitivity to a translation poison (Kabani et al., 2002a). 
Fourth, the major Hsp70 in yeast, Ssa1p, associates with ribosomes and Sis1p (see above), and 
ssa1 mutants exhibit a general translational defect (Horton et al., 2001); consistent with these 
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 data, Brodsky et al. showed that Ydj1p, which is an Hsp40 partner for Ssa1p and a member of 
the Hsp90 complex, is required for efficient translation of green fluorescent protein (GFP) and 
firefly luciferase (FFLux) in yeast (Brodsky et al., 1998). And finally, it was also reported that 
Ssa1p associates with the poly(A)-binding protein (Pab1p), and that the association between 
Pab1p and the eIF4G translation initiation factor was reduced in the ssa1 mutant (Horton et al., 
2001). However, because the eIF4E-eIF4G-Pab1p complex has been proposed to stabilize 
mRNAs by blocking the activity of the yeast mRNA de-capping enzyme (Schwartz and Parker, 
2000; Vilela et al., 2000), and because mammalian Hsp70 has been shown to bind to mRNA 
stabilization motifs (Henics et al., 1999), the general ssa1-dependent translation defect might 
have arisen from a de-stabilization of untranslated messages.   
 
Given the profound roles of Hsp70, Hsp90, and HspBP1 on protein maturation in mammals, it is 
surprising that the impact of Ssa1p (Hsp70), Hsp90, and the NEF for Ssa1p, Fes1p, during the 
biogenesis and maturation of specific proteins has not been examined in parallel in yeast.  In this 
chapter, I show distinct but partially overlapping requirements for these factors during the 
biogenesis and degradation of FFLux.  These studies were aided by the availability of specific 
mutations in the genes encoding each factor, and my data indicate the complexity with which 
chaperones and chaperone-partners mediated protein biogenesis.   
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 2.2. MATERIALS AND METHODS 
  
 
2.2.1. Yeast strains, plasmids, and molecular methods 
 
 
The yeast strains used in this study were: JN516 (referred to as wild type or SSA1), MATα leu2-
3, 112 his3-1 ura3-52 trp1∆1 lys2 ssa2::LEU2 ssa3::TRP1 ssa4::LYS2; ssa1-45 (or Hsp70 
mutant), MATα leu2-3, 112 his3-1 ura3-52 trp1∆1 lys2 ssa1-45 ssa2::LEU2 ssa3::TRP1 
ssa4::LYS2 (Becker et al., 1996); RSY801 (referred to as wild type or FES1), MATa ura3-52 
leu2-3, 112 ade2-101; fes1∆ (or Fes1p mutant), MATa ura3-52 leu2-3, 112 ade2-101 
fes1::KanMX4 (Kabani et al., 2002a); HSP82 (Hsp90 wild type) MATa ade1-1 leu2-3,112 his3-
11, 15 trp1-1 ura3-1 can1-100 hsc82::LEU2 hsp82::LEU2 pTGDHSP82 (TRP); hsp82 (referred 
to as Hsp90 mutant) G313N MATa ade1-1 leu2-3, 112 his3-11, 15 trp1-1 ura3-1 can1-100 
hsc82::LEU2 hsp82::LEU2 pTGDHSP82 G313N (TRP) (Bohen and Yamamoto, 1993; Youker 
et al., 2004); W303 (referred to as SSE1 and SIS1), MATα ade2-1 his3-11 leu2-3,112 ura3-1 
trp1-1 can1-100; E0020 (referred to as ∆sse1), MATα his3 leu2 ura3 trp1 msi3::HIS3 
(Shirayama et al., 1993);  sis1-85 (Referred to as Sis1p mutant) MATα ade2-1 his3-11 leu2-
3,112 ura3-1 trp1-1 can1-100 sis1::HIS3 HA (C-term) sis1-85 (Leu/CEN) (Zhong and Arndt, 
1993). 
 
Cells were grown either in complete medium (YP), synthetic complete medium lacking uracil 
(Sc-ura) but containing raffinose, glucose, or galactose at a final concentration of 2% as the 
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 carbon sources at the indicated temperatures with vigorous shaking. The gene encoding firefly 
luciferase was in vitro transcribed from plasmid pGEM-luc (Promega). FFLux was expressed in 
yeast from a modified pRS316 CEN/ARS vector under the control of the GAL1-10 promoter 
(Brodsky et al., 1998). Plasmids were introduced into host strains using lithium acetate-mediated 
transformation, and transformants were selected by growth on Sc-ura medium (Rose, 1990). 
 
 
2.2.2. Preparation of cell extracts for luciferase assays and immunblot analysis, and of 
RNA for northern analysis, RT-PCR , and mRNA Decay assays 
 
 
A ~50 ml yeast culture was grown at 26°C for 12 –16 h to an optical density at 600nm (OD) of 
1-3 in Sc-ura supplemented with 2% raffinose. The cells were harvested, washed in double-
distilled sterile water, and then re-suspended in the same medium at an initial OD of ~0.3. Cells 
were then re-grown to an OD of 1-3, harvested, washed twice with double-distilled sterile water, 
re-suspended at an initial OD of ~ 0.8 in the same medium but instead containing 2% galactose 
to induce FFLux expression.  Finally, the yeast were grown in galactose at 30°C and processed at 
the indicated times.  
 
For immunoblot and northern blot analyses, 60 ODs of cells were harvested and washed once 
with DEPC (Diethyl Pyrocarbonate; Sigma)-treated water, and the pellets were re-suspended in 
200 µl of DEPC-treated water, split, and quick-frozen in liquid nitrogen.  
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 For mRNA decay assays, cells were harvested after growth for 16 h in Sc-ura containing 
galactose at a final concentration of 2%, and then resuspended to a final OD of 10/mL in Sc-ura 
supplemented with glucose at a final concentration of 2% to repress FFLux transcription from 
the GAL promoter (Parker et al., 1991). To ensure that transcription was inhibited, 1,10-
phenanthroline was also added to a final concentration of 100 µg/ml (Parker et al., 1991). At the 
indicated time points, duplicate 1ml aliquots of the culture were harvested and quick-frozen in 
liquid nitrogen.  Total RNA was prepared as described above. 
 
Protein extracts for immunoblot analysis were prepared as described previously (Brodsky et al., 
1998), and total RNA was isolated as published with minor modifications (Arndt et al., 1995). 
 
 
2.2.3. Luciferase activity assay 
 
 
A total of 0.75 ODs of cells were assayed for light production upon incubation with luciferin in 
an Analytical Luminescence Laboratory (Ann Arbor, MI) Monolight 2010 Luminometer as 
described previously (Brodsky et al., 1998). All assays were performed in triplicate. 
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 2.2.4.  Immunoblot analysis 
 
 
Samples were loaded onto 12.5% SDS-polyacrylamide gels, and after electrophoresis, the 
proteins were transferred to nitrocellulose membranes (Schleicher and Schuell, pore diameter of 
0.2µm).  The antibodies used were raised against FFLux (Cortex Biochem, Inc.) and Sec61p 
(Stirling et al., 1992). To detect the primary antibody either goat anti-rabbit horseradish 
peroxidase-conjugated secondary antibody (Amersham Life Sciences) was used, and the 
complex was visualized using the enhanced chemiluminescence detection kit (Pierce) or 125I-
labeled Protein A was added (Amersham Bioscience) and the complexes were detected by 
phosphorimager analysis. Data were quantified using Kodak 1D (v 3.6; Kodak) or Image Gauge 
(Fuji Film Science Lab) software. 
 
 
2.2.5. Northern blot analysis 
 
 
Total RNA was prepared from one aliquot of thawed cells (see above), and 40 µg were resolved 
on 0.8% agarose/formaldehyde gels, transferred to Gene Screen Plus membranes (NEN Life 
Science Products), and hybridized sequentially using 32P-labeled, randomly primed full-length 
probes produced from a BamH1-Sac1 fragment removed from the gene encoding FFLux, and 
then a BamH1-HindIII fragment obtained from the ACT1 gene that encodes yeast actin (obtained 
from K. Arndt, University of Pittsburgh). Filters were processed as previously described 
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 (Ausubel, 1988), except that the high temperature wash was performed at 55°C for 10 min. 
Membranes were re-hybridized after the bound probe was removed from the filters by incubation 
in 0.1xSSC (20xSSC stock solution: 175.3g NaCl, 88.2g CH3COONa·3H20/l, adjusted to pH 7.0 
with HCl), supplemented with an additional 15mM NaCl and containing 1% SDS for 20 min at 
100°C. P-values were calculated via the program at http://faculty.vassar.edu/lowry/t_ind_stats. 
html. 
 
 
2.2.6. RT-PCR 
 
 
Total RNA (prepared as described above) was DNaseI-treated (Ambion) according to the 
manufacturer’s specifications and the DNase and divalent cations were subsequently removed 
using DNA-free Kit (Ambion). First-strand cDNA synthesis was performed using 2.5 or 5 µg 
total RNA, M-MLV reverse transcriptase (GibcoBRL), and random primers (Roche) in a 10 µl 
reaction.  A 1 µl aliquot of a 10-fold diluted reverse transcription reaction was amplified (20 
cycles: 94oC for 1 min, 55oC for 1 min, 72oC for 1 min) with Taq-Polymerase (Promega) and 
trace-labeled with 32P labeled dCTP. The primers for firefly luciferase were: 5’- 
GCCATTCTATCCTCTAGAGG and 3’- TTCACTGCATACGACGATTC. The primers 
corresponding to the ACT1 gene were: 5’- GGATTCTGAGGTTGCTGCTT and 3’- 
CAGTTGGTGACAATACCGTG. 
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 2.2.7. Pulse-chase immuno-precipitation 
 
 
Pulse-chase immuno-precipitations from 35S-metabolically labeled yeast were performed as 
published previously (Zhang et al., 2001) using antibody raised against firefly luciferase (Cortex 
Biochem, Inc.) and Protein A Sepharose (Amersham). 
 
 
2.2.8.  In vitro transcription, mRNA capping, and decapping assay 
 
 
To prepare the poly(A)-tailed, capped FFLux substrate for the decapping assay, the plasmid 
pGem-luc was linearized with Sal1 and in vitro transcribed utilizing SP6 MEGAscriptTM  
(Ambion) according to the manufacturer’s instructions, and a poly(A)-tail was added (Poly(A) 
Tailing Kit, Ambion). The quality of the transcript was assessed by agarose gel electrophoresis. 
The mRNA substrate was then capped with purified vaccinia virus capping enzyme (see below) 
in the presence of [α-32P]GTP (NEN Life Science Products) and S-adenosylmethionine (Sigma) 
as described previously (Zhang et al., 1999b). Cap-labeled mRNA was then separated from free 
nucleotide by G50 RNA spin columns (Roche) and stored at –70°C. The quality of the purified 
[α-32P]m7GpppN-RNA was confirmed by thin-layer chromatography (TLC) to show that the 
substrate was free of nucleotide, and the expected size was confirmed by agarose gel 
electrophoresis followed by phosphorimager analysis of the transferred fragment in relation to 
RNA standards (Millennium MarkersTM –Formamide, Ambion). 
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 Recombinant His-tag vaccinia virus capping enzyme (His6- D1/D12) was purified from E.coli 
strain BL21 (DE3) provided by C. Wiluzs and S. Shuman (Luo et al., 1995) (UMDNJ-Robert 
Wood Johnson Medical School and the Sloan-Kettering Institute, respectively) by Ni2+-NTA 
chromatography and Heparin chromatography as described previously (Shuman, 1990; Zhang et 
al., 1999b). The activity and thus fractionation of the enzyme was assessed by GMP-enzyme 
complex formation according to Guo and Moss (Guo and Moss, 1990) after each purification 
step. 
 
To prepare extracts for the decapping assay, cells were grown in medium containing 2% 
raffinose as the sole carbon source to an OD600 of 0.7-1. The cultures were then switched to 
medium containing 2 % galactose, so that the growth conditions were identical to those used 
above, and grown to an OD600 of 0.7-1. Yeast cell extracts were prepared and the decapping 
reaction was performed as described previously (Zhang et al., 1999b).  In brief, 20 µg of yeast 
cell extract were incubated with [α-32P]7mGTP cap-labeled mRNA substrate for the indicated 
times at 37°C. The reaction products were analyzed by TLC and quantified by phosphorimager 
analysis using Image Gauge software (Fuji Film Science Lab). 
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 2.3. RESULTS  
 
 
2.3.1. Firefly luciferase enzymatic activity is compromised in ssa1, hsp82, and fes1 
mutant yeast 
 
 
It was shown previously that the galactose-inducible expression of FFLux was slowed in yeast 
encoding a mutated form of the cytoplasmic Hsp40, Ydj1p (Brodsky et al., 1998). Thus, I wished 
to determine whether two molecular chaperones known to interact with Ydj1p, Ssa1p (the 
primary yeast Hsp70), and Hsp82 (the yeast Hsp90), display a similar effect in FFLux expression 
after induction; I also examined whether the NEF for Ssa1p, Fes1p, impacted FFLux maturation 
(Cyr et al., 1992; Kimura et al., 1995; Becker et al., 1996; Kabani et al., 2002a). To this end, the 
gene encoding FFLux under the control of the same galactose-inducible yeast promoter was 
transformed into the temperature sensitive hsp82 G313N mutant strain, into the temperature 
sensitive ssa1-45 mutant strain, and into a strain deleted for FES1 (fes1∆), as well as into the 
respective isogenic wild type strains.  I chose to perform these assays at the semi-permissive 
temperature of 30°C because growth defects are not evident in the mutant strains relative to the 
isogenic wild types at this temperature (not shown). I first observed compromised luciferase 
activity in each mutant strain relative to wild type yeast after the carbon source had been 
switched from raffinose to galactose, and noted that the time-course of induction differed 
significantly in each set of wild type/mutant strains.  For example, in the ssa1-45 mutant, there 
was a more than 3-fold decrease in activity compared to the wild type 18h after galactose 
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 induction (Figure 10A), and a 4- and 3.5-fold difference in enzymatic activity between the 
isogenic wild type strains and the hsp82 G313N mutant (8 h after FFLux induction) and fes1∆ 
yeast (6 h after FFLux induction), respectively (Figures 10B and C). By comparison, FFLux 
induction in the ydj1 mutant previously used was reduced by 2-fold compared to the wild type 10 
h after induction (Brodsky et al., 1998). 
 
 
2.3.2. Firefly luciferase expression is delayed in the ssa1 mutant and more significantly 
in the hsp82 mutant strain  
 
 
I next wished to determine if the delayed increase and reduced levels of enzymatic activity in the 
chaperone mutant strains were caused by compromised translation, as observed in ydj1 mutant 
yeast (Brodsky et al., 1998), or by a defect in protein folding or another event.  To this end, 
FFLux expression was monitored in the wild type and chaperone mutants by immunoblot 
analysis after the carbon source had been switched from raffinose to galactose.  The levels of 
Sec61p, an integral ER membrane protein were examined in parallel and served as a loading 
control. I first monitored FFlux expression levels for 18 h after FFLux induction in the wild type 
and in the ssa1-45 mutant strain and observed a delayed increase in FFlux induction in the 
mutant (Figure 11). At 18 h more than twice as much FFLux was present in wild type yeast 
compared to the ssa1-45 mutant strain; the difference in FFLux enzymatic activity at this time 
point was approximately the same.  However, at later time points a higher percentage of the 
protein synthesized in the wild type versus ssa1-45 mutant strain was active (data not shown), 
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 Figure 10:  FFlux activity is delayed in the ssa1 and hsp82 mutant and in the fes1 deletion 
strains. A. FFLux activity is indicated in relative light units (RLU), and data represent the means 
from 2 independent sets of experiments and are plotted as a function of time (h): SSA1 wild type 
yeast, closed blue circles; ssa1 mutant strain, open purple circles. B. FFLux activity is shown in 
relative light units (RLU) and the means from 3 independent sets of experiments are plotted as a 
function of time (h): FES1 wild type yeast, closed blue circles; fes1 deletion, open purple circles. 
Vertical bars indicate the standard error. C.  FFLux activity is shown in relative light units (RLU) 
and the means from 3 independent sets of experiments are plotted as a function of time (h): 
HSP82 wild type yeast, closed blue circles; hsp82 mutant strain, open purple circles. Vertical 
bars indicate the standard error. 
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            Figure 10: FFLux activity is delayed in the ssa1 and hsp82 mutant and the fes1 deletion strain. 
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 Figure 11: FFlux protein induction is delayed in ssa1 mutant yeast. A. A western blot is shown 
depicting FFLux and Sec61p (as a control) protein levels in SSA1 wild type yeast and in the 
ssa1-45 mutant strain after growth in raffinose (repressing conditions, “R”), immediately after 
switch to galactose-containing medium (“G”), and at the indicated times (in h) after induction. B. 
The amounts of FFLux from 2 independent sets of experiments were plotted as a function of time 
(h). SSA1 wild type yeast, closed blue circles; ssa1-45 mutant strain, open purple circles. 
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                    Figure 11: FFlux protein induction is delayed in ssa1 mutant yeast. 
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 suggesting that Ssa1p is important for FFLux protein folding. Overall, I concluded that Ssa1p 
plays a previously uncharacterized role in FFLux biosynthesis, as well as a role in protein 
folding, as previously described (Kim et al., 1998b). In contrast, FFlux expression in the fes1∆ 
strain increased over time, even reaching a level somewhat higher than that in the wild type 
strain (Figure 12). This is in contrast to the decreased amount of FFLux activity observed in the 
fes1∆ strain (Figure 10B); therefore, these data indicate a role for the yeast Hsp70 NEF in protein 
folding, and are consistent with the finding that Ssa1p is required for maximal FFLux folding 
(see above). A recent report also indicates a role for Fes1p in protein folding in yeast (Shomura 
et al., 2005). Similarly, several lines of evidence also support a role for mammalian NEFs in 
protein folding (Kanelakis et al., 1999; Luders et al., 2000; Alberti et al., 2004). I also noted that 
a mild, general translation defect in fes1∆ yeast was observed in a previous study from the 
Brodsky laboratory (Kabani et al., 2002a); however, this effect was not evident when FFLux 
synthesis was examined, suggesting that the translation defect might be protein-specific, as 
reported for the Ydj1p-dependence on protein translation (Brodsky et al., 1998). The strongest 
defect in FFLux induction was observed in the hsp82 mutant yeast strain: Only ~25% of FFLux 
was present in the mutant compared to wild type cells 8 h after induction (Figure 13).  In this 
case, the difference in FFLux expression levels and in enzymatic activity between the hsp82 
mutant and the wild type strain are comparable, suggesting that yeast Hsp90 plays a significant 
role during FFLux synthesis, but a less profound role during the folding of newly translated 
FFLux. This second conclusion is consistent with observations in mammalian cells in which 
Hsp90 was shown to be involved in the refolding of denatured FFLux but not in the folding of 
newly synthesized FFLux (Schneider et al., 1996). 
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 Figure 12: FFlux protein induction is equally efficient in FES1 wild type and fes1 deletion 
strains. A. A western blot is shown that measures FFLux and Sec61p (as a control) protein levels 
in FES1 wild type yeast and in the fes1 deletion strain after the growth medium was switched to 
galactose. B. The amounts of FFLux from 3 independent sets of experiments were plotted as a 
function of time (h). FES1 wild type yeast, closed blue circles; fes1∆ strain, open purple circles. 
Vertical bars indicate the standard error. 
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               Figure 12: FFlux protein induction is equally efficient in FES1 wild type and fes1 deletion strains. 
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 Figure 13: FFlux protein induction is delayed in hsp82 mutant yeast. A. A western blot is shown 
that measures FFLux and Sec61p (as a control) protein levels in HSP82 wild type yeast and in 
the hsp82 G313N mutant strain. B. The amounts of FFLux from 3 independent sets of 
experiments were plotted as a function of time (h). HSP82 wild type yeast, closed blue circles; 
hsp82 mutant strain, open purple circles. Vertical bars indicate the standard error. 
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               Figure 13: FFlux protein induction is delayed in hsp82 mutant yeast. 
67 
 I also tested whether cells mutated for two other chaperones affect FFLux expression: Sis1p is an 
Hsp40 involved in translation initiation that interacts with Ssa1p on the translating ribosome 
(Zhong and Arndt, 1993; Horton et al., 2001), and Sse1p, a yeast Hsp110, interacts with Ydj1p 
and is a component of the Hsp90 complex (Kimura et al., 1995; Goeckeler et al., 2002). 
However, no effect was observed on FFLux enzymatic activity or induction in either the 
temperature sensitive sis1 mutant or in sse1∆  cells (data not shown).  These data suggest that the 
results described above were not due to global affects on chaperone function nor were they the 
result of incubating thermosensitive chaperone mutants at semi-permissive temperatures.  
 
 
2.3.3. Firefly luciferase degradation is significantly accelerated in the ssa1 mutant 
strain, but only modestly in hsp82 mutant yeast 
 
 
Hsp70s and Hsp90s have been implicated in the regulation of protein stability, and specifically, 
the rate of degradation of potentially mis-folded proteins changes in the ssa1-45 and hsp82 
G313N mutants (Schneider et al., 1996; Strickland et al., 1997; Imamura et al., 1998; Loo et al., 
1998; Verma et al., 2000; Connell et al., 2001; Gusarova et al., 2001; Meacham et al., 2001; 
Murata et al., 2001; Zhang et al., 2001; Farinha et al., 2002; Kampinga et al., 2003; Huyer et al., 
2004; Youker et al., 2004). Therefore, the decreased FFLux protein levels observed in these 
strains might have arisen in part from accelerated degradation.  To determine whether FFLux is 
less stable in ssa1-45 and hsp82 G313N yeast, the wild type and the mutant strains were 
transformed with the inducible FFLux gene and a pulse-chase analysis was performed at 30°C 16 
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 and 6 h, respectively, after the carbon source had been switched from raffinose to galactose.  As 
shown in Figure 14, FFLux is degraded significantly faster in the ssa1-45 mutant strain 
compared to the wild type strain, with only 20 % of the protein remaining after a 90 min chase 
compared to ~85 % in wild type yeast. In contrast, FFLux was largely stable in both wild type 
and fes1∆ yeast (Figure 15). Similarly, the hsp82 G313N mutant yeast exhibited a minor 
decrease in FFLux stability, with ~70% protein remaining after 90 min while FFLux levels 
remained relatively unaltered in the wild type strain (Figure 16). From these results we conclude 
that FFLux is destabilized significantly only in the ssa1-45 mutant, which further contributes to 
its decreased, steady-state expression (Figure 11). 
 
 
2.3.4. Firefly luciferase mRNA induction is compromised in the ssa1 mutant strain and 
in the hsp82 mutant strain 
 
 To determine if defects in FFlux expression in the ssa1-45 and hsp82 G313N mutant yeast result 
from lower levels of FFLux mRNA, I prepared total RNA from wild type yeast and the ssa1-45 
and hsp82 G313N mutants after galactose-mediated induction and performed northern blot and 
RT-PCR analyses to quantify FFLux mRNA levels over time (Figures 17 and 18). Whereas the 
wild type strains exhibited a pronounced increase in FFlux mRNA after galactose induction, 
whose time-courses were in-line with FFLux activity and protein levels, there was a 4-fold 
reduction in FFlux mRNA levels in the ssa1-45 mutant versus the wild type (Figure 17B). In 
comparison, the difference in the FFLux mRNA levels between the Hsp82 wild type and the  
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 Figure 14: FFLux protein degradation is enhanced in the ssa1-45 mutant strain. A. Rates of 
FFlux degradation were determined by pulse-chase immuno-precipitation in SSA1 wild type 
yeast and the ssa1-45 mutant strain after addition of cycloheximide. A. FFLux protein levels 
were quantified from 4 independent sets of experiments and averaged. All values were obtained 
after standardization to the levels detected directly after cycloheximide addition (0 min). Closed 
blue circles represent SSA1 wild type protein levels, open purple circles represent ssa1 mutant 
protein levels. Vertical bars indicate the standard error. 
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  Figure 14: FFLux protein degradation is enhanced in the ssa1-45 mutant strain. 
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 Figure 15: FFLux protein is stable in wild type and fes1∆ yeast. A. Rates of FFlux degradation 
were determined by pulse-chase immuno-precipitation in wild type and fes1∆ yeast after addition 
of cycloheximide. Prior to the pulse-chase, FFLux protein was induced for 4h. B. FFLux protein 
levels were quantified, and each value corresponds to the level after standardization to the 
amount of protein obtained at 0 min. Data represent means of two independent experiments and 
vertical bars indicate the range in values. Closed blue circles represent FES1 wild type protein 
levels, open purple circles represent fes1 mutant protein levels. 
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  Figure 15: FFLux protein is stable in wild type and fes1∆ yeast. 
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 Figure 16: FFLux protein degradation is enhanced in the hsp82 mutant strain. A. Rates of FFlux 
degradation were determined by pulse-chase immuno-precipitation in HSP82 wild type yeast and 
in the hsp82 G313N mutant strain after addition of cycloheximide. B. FFLux protein levels were 
quantified from 4 independent sets of experiments and averaged. All values were obtained after 
standardization to the levels detected directly after cycloheximide addition (0 min). Closed blue 
circles represent HSP82 wild type protein levels, open purple circles represent hsp82 G313N 
mutant protein levels. Vertical bars indicate the standard error. 
 
 
 
 
74 
  
 
 
   Figure 16: FFLux protein degradation is enhanced in the hsp82 mutant strain. 
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 Figure 17: Induction of FFlux mRNA is slowed in the ssa1 mutant. A. FFLux mRNA was 
detected both by reverse-transcriptase (RT)-PCR and northern blot analysis from wild type and 
ssa1-45 mutant yeast after the medium was switched from raffinose (“R”) to galactose. B. FFLux 
mRNA levels were quantified from 2 independent sets of experiments and averaged. All values 
were obtained after standardization to the levels detected 20 h after induction. Closed blue 
symbols represent SSA1 wild type mRNA levels, open purple symbols represent ssa1 mutant 
mRNA levels. Circles correspond to data obtained from northern blot analysis, and triangles 
correspond to results from RT-PCR.  
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      Figure 17: Induction of FFlux mRNA is slowed in the ssa1 mutant. 
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 Figure 18: Induction of FFlux mRNA is slowed in the hsp82 mutant. A. FFLux mRNA was 
detected by northern blot analysis from wild type and hsp82 mutant yeast after the medium was 
switched from raffinose to galactose. B. FFLux mRNA levels were quantified from 2 
independent sets of experiments and averaged. All values were obtained after standardization to 
the levels detected 8 h after induction. Closed blue circles represent HSP82 wild type mRNA 
levels, and open purple circles represent hsp82 mutant mRNA levels.  
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       Figure 18: Induction of FFlux mRNA is slowed in the hsp82 mutant. 
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 hsp82 mutant was less pronounced (~2-fold) (Figure 18B). As a control, I found only subtle 
differences in actin (ACT1) mRNA levels between the wild type and mutant strains (data not 
shown). Moreover, I found that FFLux mRNA levels were ~20% higher in fes1∆ yeast as 
compared to wild type cells two hours after induction (data not shown), indicating that deletion 
of FES1 does not slow FFLux-encoding mRNA accumulation. 
 
 
2.3.5.  Firefly luciferase mRNA degrades at a faster rate in the ssa1-45 mutant strain 
 
 
The decreased levels of FFlux mRNA in the ssa1-45 mutant strain could be the result of a defect 
in transcription efficiency or the result of enhanced mRNA degradation in the mutant.  Indeed, 
there is precedent that Hsp70 is involved in mRNA stability and decay.  Mammalian Hsp70 as 
well as Hsp110 bind to AU-rich elements (AREs) in the 3’-untranslated region (3’UTR) of 
mRNAs, a region that mediates mRNA stability (Henics et al., 1999). In contrast, the yeast 
Hsp70, Ssa1p, enhances ARE-regulated mRNA degradation (Duttagupta et al., 2003). Consistent 
with a protective effect of Hsp70 on mRNAs, induction of Hsp70, down-regulation of the 
ubiquitin-proteasome network, or inactivation of the ubiquitin enzyme E1 each block decay of 
AU-rich mRNAs (Laroia et al., 1999). Ssa1p was also proposed to be a regulatory factor of the 
decapping protein (Zhang et al., 1999a), and Hsp70 may regulate the stability of its own mRNA 
(Kaarniranta et al., 2000). Alternatively, a link between protein synthesis and mRNA stability 
has been established; SSA1 and SSA2-mRNA degradation is enhanced when translation initiation 
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 is limited (Barnes et al., 1993; Barnes et al., 1995; Barnes, 1998), and yeast strains defective in 
several translation initiation factors exhibit increased rates of mRNA decay, decapping, and 
deadenylation (Schwartz and Parker, 1999). 
 
To decipher whether the FFLux message is less stable in ssa1 mutant yeast compared to wild 
type cells, the strains containing the FFlux-inducible gene were grown in non-induction medium 
until mid-log phase and then switched to medium containing galactose and incubated at 30°C; 
these conditions were identical to those used to assess FFLux induction (see above). After 16 
hours, the cells were harvested, resuspended in selective medium containing glucose to repress 
FFLux transcription and 1,10-phenanthroline was added to ensure that transcription was blocked 
(Parker et al., 1991). Total RNA was prepared from cells removed from this reaction over time 
and FFlux and actin mRNA levels were measured. As shown in Figure 19, FFlux mRNA is 
degraded somewhat faster in the ssa1-45 mutant strain. These results indicate that the difference 
in FFlux expression may be caused by a difference in mRNA stability.  Because I was unable to 
detect the existence of AREs within the 3’UTR of the FFlux mRNA, I propose either that mRNA 
decapping activity is accelerated in the ssa1-45 strain, leading to enhanced FFLux degradation, 
and/or that the attenuation of translation initiation (Horton et al., 2001) de-protects the FFLux-
encoding message, resulting in enhanced turnover of the mRNA. 
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 Figure 19: FFlux mRNA decay rate is faster in ssa1 mutant cells than in SSA1 wild type yeast.  
mRNA degradation was measured using Northern blot analysis. Blotted mRNA levels represent 
relative amounts of Firefly Luciferase mRNA standardized to actin-1 mRNA levels. Closed blue 
circles represent SSA1 wild type yeast, open purple circles symbolize ssa1 mutant yeast. Vertical 
bars indicate the standard error. P-values are <  0.05, except were indicated: *< 0.1, ** < 0.15. 
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      Figure 19: FFlux mRNA decay rate is faster in ssa1 mutant cells than in SSA1 wild type yeast.  
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 2.3.6. Decapping of poly(A)-tailed firefly luciferase mRNA in the SSA1 wild type and in 
the ssa1-45 mutant strain occur at similar rates 
 
 
The removal of the 5’-terminal cap structure (m7G(5’)ppp(5’)N) is an important rate-limiting 
step in mRNA decay, and it had been shown previously that Ssa1p binds to the decapping 
enzyme (Dcp1p) and does so to a much higher level in strains mutated for genes encoding 
positive regulators of Dcp1p (Zhang et al., 1999a).  However, before examining whether 
decapping activity in ssa1-45 mutant yeast was enhanced with respect to wild type cells, I 
needed to determine if firefly luciferase mRNA receives a poly(A)-tail in yeast. Thus, poly(A)-
RNA was chromatographed from total RNA (see Materials and Methods) and the presence of 
poly-dT-bound FFLux mRNA was confirmed by Northern blot analysis.  Next, to measure the 
decapping activity in wild type and ssa1-45 mutant yeast, extracts were prepared and incubated 
with a poly(A)-tailed, capped FFLux-encoding mRNA. Aliquots were then removed over time 
and the amount of m7GDP liberated from the capped mRNA was measured after phosphorimager 
analysis of TLC plates as described (Zhang et al., 1999b). I first noted that decapping was 
magnesium-dependent, as anticipated (Zhang et al., 1999b), because EDTA efficiently abolished 
decapping activity (Figure 20A).  When I quantified the relative amounts of decapping activity in 
each extract I found no difference in the rates of decapping in the SSA1 wild type and ssa1-45 
mutant strains (Figures 20A and 20B). Thus, I suggest that mutation of the SSA1 gene might 
cause a defect in translation initiation that then leads to a shorter half-life of the firefly luciferase 
mRNA. 
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 Figure 20: Decapping activities in SSA1 wild type and ssa1 mutant extract are identical. 
A. The decapping products separated by thin-layer chromatography. B. Plotted decapping 
activity is shown as amount of m7GDP represented as percentage of the capped substrate added 
to the decapping reaction. Closed blue circles represent SSA1 wild type yeast, open purple circles 
symbolize ssa1 mutant yeast. Vertical bars indicate the standard error. 
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    Figure 20: Decapping activities in SSA1 wild type and ssa1 mutant extract are identical. 
86 
 2.4. DISCUSSION 
 
 
The data presented in this chapter demonstrate that the expression of FFLux, a widely-used 
model reporter in both prokaryotes and eukaryotes, depends on a specific set of chaperones and a 
recently identified chaperone cofactor. I also find that the chaperone requirements during FFLux 
biosynthesis are distinct but overlapping. While Fes1p, an NEF for Ssa1p, and Ssa1p likely 
collaborate to fold FFLux, Ssa1p was also required to maintain the stability of FFLux protein, 
and for efficient induction of FFLux mRNA. These functions are Fes1p-independent because 
FFLux synthesis was robust in the fes1 mutant.  Together, the results suggest that the NEF 
impacts only a subset of Ssa1p’s activities.  In contrast, Hsp90 did not appear to be required for 
folding nascent FFLux but was essential for FFLux expression: Hsp90’s contributions to protein 
stability and to FFLux mRNA induction were modest and can not explain the strong effect on 
FFLux protein expression noted in the hsp82 mutant. Therefore, these data indicate that yeast 
Hsp90 plays an uncharacterized role in FFLux translation, and future efforts will be necessary to  
establish the molecular basis of this observation. In agreement with my discovery of a role for 
Fes1p in promoting FFLux folding, I also noted a requirement for its partner, Ssa1p, in folding. 
Fes1p facilitates the dissociation of ADP from Ssa1p and is thus predicted to aid in peptide 
release (Kabani et al., 2002a). One can imagine that a defect in NEF function leads to prolonged 
Ssa1p-substrate binding, which would slow protein folding. Although the ssa1-45 mutant strain 
also exhibits a delay in FFLux expression, I suggest that this does not arise mainly from a defect 
in folding or translation: FFLux degradation is significantly accelerated (~4-fold) in the ssa1 
mutant and FFLux mRNA induction is compromised ~4-fold. The impact of both defects should 
account for reduced FFLux protein levels (2-fold difference between wild type and mutant). 
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 However, a general, mild translation defect was reported recently in ssa1-45 mutant yeast 
(Horton et al., 2001). In addition, it was observed that Ssa1p associates with ribosomes and with 
Sis1p (Zhong and Arndt, 1993; Horton et al., 2001). Nevertheless, I note that the reported 
translation defect in the ssa1 mutant was subtle and was examined at the restrictive temperature 
of 37°C, which arrests cell growth. In contrast, I examined the impact of Ssa1p in the mutant 
strain at the semi-permissive temperature of 30°C, at which no defect in cell growth is observed.  
Moreover, I note that neither FFLux induction nor enzymatic activity was compromised in a 
strain containing a temperature sensitive mutation in Sis1p, an Hsp40 that interacts with Ssa1p 
and functions in translation (not shown). I therefore conclude that Ssa1p has no major effect on 
FFLux translation per se and that it might rather impact FFLux translation efficiency indirectly 
by regulating the level of transcript.   
 
The decreased levels of firefly luciferase mRNA in the ssa1-45 mutant strain might have arisen 
at least in part from the relative instability of the FFLux-encoding mRNA in the ssa1-45 mutant.  
My findings are consistent with previous reports denoting a role of Hsp70 in mRNA stability, 
and I suggest three models by which a defect in Ssa1p function might have led to FFLux mRNA 
destabilization.  
 
First, mammalian Hsp70 binds to AREs in the 3’UTRs of mRNAs, elements which determine 
transcript decay rates by modulating the efficacy of poly(A)-tail-shortening (Wilson and 
Treisman, 1988; Greenberg et al., 1990; Chen and Shyu, 1995; Henics et al., 1999; Vasudevan 
and Peltz, 2001; Wilusz et al., 2001; Duttagupta et al., 2003).  However, I was unable to identify 
AREs in the 3’ UTR of FFLux (data not shown).  Moreover, because mammalian Hsp110 also 
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 binds to AREs (Henics et al., 1999), I examined FFLux expression in yeast deleted for the SSE1 
gene, which encodes the constitutive Hsp110 protein in yeast (Mukai et al., 1993; Shirayama et 
al., 1993), but found that FFLux expression was proficient in this mutant.  I suggest, therefore, 
that Ssa1p does not normally protect the FFLux message by binding to a putative ARE.  
 
Second, the primary mRNA decay pathway in yeast occurs via deadenylation of the 3’ poly(A) 
tail followed by removal of the 5’ cap structure (m7G(5’)ppp(5’)N) (Muhlrad et al., 1994; 
Beelman et al., 1996; LaGrandeur and Parker, 1998; Dunckley and Parker, 1999). The decapping 
enzyme competes with the eIF4F cap-binding translation initiation complex, which includes 
eIF4E, eIF4G (Schwartz and Parker, 1999, 2000; Vilela et al., 2000). Thus, removal of the cap 
can represent a critical determinant between cap-dependent translation initiation and mRNA 
decay.  This transition is proposed to occur after deadenylation through a rearrangement of a 
macromolecular complex associated with the cap, which includes Pab1p  (Vilela et al., 2000; 
Tharun and Parker, 2001; Ramirez et al., 2002). Because Ssa1p has been found to bind to the 
Dcp1p decapping enzyme, and this interaction is enhanced in yeast mutated for one of two genes 
encoding positive regulators of Dcp1p, it has been proposed that Ssa1p acts as a negative 
regulator of Dcp1p and protects transcripts (Zhang et al., 1999a). Alternatively, enhanced decay 
of FFLux mRNA in the ssa1-45 mutant strain might originate from the presence of codons that 
are rarely used in yeast and could cause the ribosome to stall, as suggested by Brodsky et al. 
(1998). The low efficiency of translation could facilitate decapping and therefore degradation of 
the message. However, it is important to note that there is a second major pathway of mRNA 
decay where the transcript is degraded by the exosome in 3’ to 5’ direction without the 
requirement of prior decapping via DCP1 (Muhlrad and Parker, 1994; Muhlrad et al., 1995; 
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 Jacobs et al., 1998; Butler, 2002). In accordance with these reports, I observed equal rates of 
decapping of the poly(A)-tailed firefly luciferase mRNA in the SSA1 wild type and ssa1-45 
mutant strain. Therefore, my data suggest that Ssa1p is not a negative regulator of Dcp1p, 
although it is a member of a multi-protein complex that includes the initiation complex and 
Pab1p.  
 
Third, the ssa1 translation defect has been proposed to arise from compromised interaction 
between Pab1p and eIF4G at the initiation complex (Horton et al., 2001).  Ssa1p interacts with 
Pab1p, one of whose functions during translation initiation is to bring the 5’- and 3’-ends of the 
mRNA together, which in turn is mediated through Pab1p-eIF4G binding (Jacobson and Peltz, 
1996; Tarun and Sachs, 1996; Gallie, 1998; Preiss and Hentze, 1998). Thus, Ssa1p might 
stabilize the translation initiation complex and prevent a nascent transcript from being degraded.  
Consistent with this view, Hsp70 appears to regulate the stability of its own message 
(Kaarniranta et al., 2000) and Upf1p and Upf2p, proteins that regulate nonsense-mediated 
mRNA decay in yeast, have been demonstrated to engineer SSA1- and SSA2-mRNA degradation 
when translation initiation is inhibited (Barnes, 1998). I therefore propose that destabilization of 
the translation initiation complex in the ssa1 mutant exposes FFLux mRNA, resulting in 
accelerated degradation. 
 
Although I found that wild type and ssa1 mutant extracts exhibited identical decapping activities 
for poly(A)-tailed FFlux message, I also found that the extent of decapping of FFLux mRNA 
lacking a poly(A)-tail was significantly higher in wild type extracts than in the ssa1 mutant 
extracts (data not shown). Thus, Ssa1p may also regulate decapping activity at least for some 
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 messages, as suggested (Zhang et al., 1999a). The difference in decapping activities observed for 
poly(A) versus non-poly(A)-tailed substrates could be explained by a scenario in which the 
protective role of Ssa1p on the initiation complex is more dependent on the poly(A)-tail than its 
function in decapping; consequently, increased decapping is observed in the absence of 
polyadenylation in the wild type extract. Alternatively, the absence of the poly(A)-tail might 
preclude the association of regulatory factors that promote either stabilization or decapping of 
the substrate.  Thus, it will be interesting to identify these modulators and to determine if Ssa1p’s 
function in the transition state between translation initiation and decapping is of a direct or an 
indirect nature, and if this function applies to other messages.   
 
In mammalian cells, the impact of Hsp90 and Hsp70 chaperones during protein biogenesis have 
been examined by treatment with ansamycin antibiotics, by over-expression of specific 
chaperones or co-chaperones, or by over-expression of a chaperone-associated E3 ubiquitin 
ligase that diverts proteins into the proteasome-mediated degradation pathway (Schneider et al., 
1996; Kanelakis et al., 1999; Luders et al., 2000; Connell et al., 2001; Meacham et al., 2001; 
Murata et al., 2001; Farinha et al., 2002). In my experiments, I employed specific mutant alleles 
of each gene that have been characterized for their effects on other cellular processes.  Although 
I did not observe defects in cell growth, it is possible that some of the effects might have arisen 
from allele-specificity.  However, the fes1 mutant employed is a complete deletion of the FES1 
gene.  Similarly, cellular levels of the hsp82 mutant gene are significantly reduced relative to 
wild type cells (Fliss et al., 2000). I therefore believe that it is unlikely that allele-specific effects 
account for my observations using the fes1 and hsp82 mutants. In contrast, the ssa1-45 mutation 
lies in the peptide binding domain (Becker et al., 1996) and could affect the binding kinetics 
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 between the chaperone and the substrate. For example, extended periods of binding could target 
the substrate for degradation. However a biochemical analysis of Ssa1-45p has not been 
undertaken, and to date there is a dearth of rapid-acting ssa1 mutants. I note that yeast lack a 
CHIP homologue, which in mammals interacts with the Hsp90 complex and regulates the 
decision between folding and degradation (Connell et al., 2001; Murata et al., 2001). CHIP also 
interacts with and regulates Hsp70-dependent decisions between the folding and degradation 
pathways (Meacham et al., 2001). So far, it is not known which yeast E3 ubiquitin ligase(s) 
is/are impacted by Hsp90 and Hsp70 function, but this is a topic of ongoing studies in the 
Brodsky laboratory. 
 
In summary, I have demonstrated in this chapter a high complexity of chaperone function in 
yeast. FFLux expression is facilitated by a specific set of chaperones and a chaperone cofactor, 
and the chaperone requirements are distinct but overlapping. While one chaperone can be 
involved in different steps of the biosynthesis of a substrate, its interacting factors might only 
collaborate for a subset of these functions. The choice of function may depend on the cofactor as 
well as on the polypeptide substrate. Characterization of the chaperone requirements for the 
biosynthesis of other substrates as well as an investigation of other chaperones and cofactors will 
hopefully reveal new features and interactions in the complex network of chaperone action. 
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 3. REGULATION OF CFTR MATURATION AND DEGRADATION 
 
 
 
 
3.1. INTRODUCTION 
 
   
As mentioned in Chapter 1.5., cells containing only the most common mutant associated with 
cystic fibrosis, the deletion of the phenylalanine at position 508, “∆F508-CFTR”, (see Figure 8) 
lack the protein at the plasma membrane because its folding is severely impaired (Kerem et al., 
1989; Riordan et al., 1989; Cheng et al., 1990; Kartner et al., 1992; Yang et al., 1993; Lukacs et 
al., 1994; Ward and Kopito, 1994; Jensen et al., 1995; Ward et al., 1995; Qu and Thomas, 1996; 
Qu et al., 1997). This prevents ER export and leads to its degradation via ERAD (Cheng et al., 
1990; Kartner et al., 1992; Yang et al., 1993; Lukacs et al., 1994; Ward and Kopito, 1994; 
Jensen et al., 1995; Ward et al., 1995). One very recent study on the wild type CFTR and ∆F508-
CFTR expression patterns in native tissue corroborates the proposition that defective protein 
processing is the major pathogenic mechanism in CF (Kreda et al., 2005). This translates into the 
necessity to characterize completely the molecular mechanism that enables the cell to distinguish 
∆F508-CFTR from the wild type protein. The importance of this approach is further underscored 
by the fact that recent studies have been performed to identify drugs that activate CFTR channel 
activity. Drugs that stimulate the gating of the ∆F508 mutant were identified that are distinct 
from those that enhance the conductivity of the wild type channel (Ma et al., 2002; Yang et al., 
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 2003). But more importantly, drug-induced activation of ∆F508-CFTR depended on conditions 
that allow ER exit and prevent degradation. This was accomplished by growing cells at 
decreased temperature (Ma et al., 2002; Yang et al., 2003). Therefore, a combinatorial therapy, 
correction of the processing defect as well as increasing channel gating, might prove vital.  
 
Because yeast expressing CFTR grow as well as cells lacking the CFTR-expression vector 
(Zhang et al., 2001), factors required for the ERAD of ∆F508-CFTR might be expressed at 
higher levels, which may counteract the accumulation of misfolded protein. Therefore, I utilized 
a genomic approach to identify components of the CFTR ERAD pathway that might have been 
up-regulated. In previous studies, two microarray analyses comparing gene expression levels in 
lung or in intestinal tissue between CFTR wild type mice and mice lacking CFTR detected an 
induction of the immune response (Xu et al., 2003; Norkina et al., 2004). The strong immune 
response elicited by CF in mammals might have masked the differential regulation of genes 
involved in recognition, trafficking, and degradation of CFTR. In contrast, because yeast lacks 
an immune response and because many aspects of CFTR degradation are conserved between 
yeast and mammals in general (see chapter 1.6.; Zhang et al., 2001; Youker et al., 2004), I used 
S. cerevisiae as a model system. Specifically, I identified genes that are differentially regulated 
in response to wild type CFTR expression in yeast by microarray analysis. I found that the 
protein product of one of the genes found to be up-regulated upon CFTR expression, HSP26, 
facilitates CFTR degradation in yeast, and that this sHsp and another sHsp, Hsp42, may be 
functionally redundant. In contrast, the turnover rates for a soluble and another integral 
membrane ERAD substrate were unaffected by deletion of the Hsp26 and Hsp42 encoding 
genes, suggesting client substrate specificity. I also found that a human ortholog of the sHsps, 
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 αA-crystallin, enhances ∆F508-CFTR proteolysis in mammalian cells when over-expressed. 
Finally, purified recombinant αA-crystallin suppressed the aggregation of CFTR-NBD1. 
Together, these results provide new evidence for an involvement of sHsps in CFTR degradation. 
 
 
 
 
3.2. MATERIAL AND METHODS 
 
 
3.2.1. Yeast strains, plasmids, and molecular methods 
 
 
The yeast strains used in this study were: JN516 (referred to as wild type or SSA1), MATα leu2-
3, 112 his3-1 ura3-52 trp1∆1 lys2 ssa2::LEU2 ssa3::TRP1 ssa4::LYS2; RSY368 (referred to as 
wild type or HSP26) Matα can1-100 leu2-3,112 his3-11, 15 trp1-1 ura3-1 ade2-1; hsp26∆ (or 
Hsp26 mutant) Matα can1-100 leu2-3,112 his3-11, 15 trp1-1 ura3-1 ade2-1 hsp26::KanMX4; 
SEY6211 (referred to as wild type or HSP26HSP42; kindly provided by J. Buchner, Technical 
University Munich) Mata ura3-52 leu2-3,112 his3-∆200 trp1-∆901 ade2-101 suc2-∆9 GAL10; 
hsp26∆  (or Hsp26 mutant; kindly provided by J. Buchner, Technical University Munich) Mata 
ura3-52 leu2-3,112 his3-∆200 trp1-∆901 ade2-101 suc2-∆9 GAL10 hsp26::HIS3; hsp42∆ (or 
Hsp42 mutant; kindly provided by J. Buchner, Technical University Munich) Mata ura3-52 
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 leu2-3,112 his3-∆200 trp1-∆901 ade2-101 suc2-∆9 GAL10 hsp42::LEU2; hsp26∆hsp42∆ (or 
Hsp26 Hsp42 double mutant; kindly provided by J. Buchner, Technical University Munich) 
Mata ura3-52 leu2-3,112 his3-∆200 trp1-∆901 ade2-101 suc2-∆9 GAL10 hsp26::HIS3 
hsp42::LEU2 (Robinson et al., 1988; Haslbeck et al., 2004); BY4742 (referred to as wild type or 
YBR075W) MATα his3∆1 leu2∆0 lys2∆0 ura∆0; ybr075w∆ (or Ybr075Wp mutant) MATα 
his3∆1 leu2∆0 lys2∆0 ura∆0 ybr075w∆C-term (http://www.openbiosystems.com). 
 
The hsp26∆ strain in the RSY368 background was created using PCR-based gene disruption as 
described previously (Brachmann et al., 1998). In brief, the RSY368 wild type strain was 
transformed with an hsp26::KanMX4 disruption cassette, generated by PCR from the template 
vector pRS400 (forward primer: GTGGTATTTCATAACAACGGTTCTTTTTC 
ACCCTTATTCCCTGTGCGGTATTTCACACCG; reverse primer: TGACATATGTTTCAA 
GCCATATGCAAGCAACAATGGTCCTAGATTGTACTGAGAGTGCAC). Transformants 
were selected by growth on complete medium supplemented with 2% glucose and G418 to a 
final concentration of 250 µl/ml (GibcoBRL). Correct insertion of the disruption cassette and the 
absence of the HSP26 gene were confirmed by PCR utilizing primers up- and down-stream of 
the HSP26 location in combination with primers within the sequence of the disruption cassette 
and HSP26 (KAN forward: ATTGATGTTGGACGAGTCGG; KAN reverse: 
ATCGCAGTGGTGAGTAACCA; HSP26 up-stream, forward: GGATCGGAATAGTA 
ACCGTC; HSP26 down-stream, reverse: GCCACATCCATAGAGATACC; HSP26 coding, 
forward: CACCAAGACGTCAGT TAGCA; HSP26 coding, reverse: TGTTGTCTGCATC 
CACACCT). 
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 Cells were grown at the indicated temperatures with vigorous shaking in complete medium (YP) 
or synthetic complete medium lacking uracil Sc-ura but containing glucose at a final 
concentration of 2% as the carbon source. HA-tagged CFTR, CPY*, and Ste6p* were expressed 
in yeast from a 2µ plasmid containing URA3 as the selectable marker under the control of the 
constitutive phosphoglycerate kinase promoter (Ng et al., 2000; Zhang et al., 2002b; Huyer et 
al., 2004); yeast transformed with the 2µ plasmid pRS426 (Christianson et al., 1992) without an 
insert served as controls, where indicated. Plasmids were introduced into host strains using 
lithium acetate-mediated transformation, and transformants were selected by growth on Sc-ura 
medium containing glucose (Rose, 1990). 
 
Protein extracts from yeast for immunoblot analysis were prepared as described previously 
(Brodsky et al., 1998). 
 
 
3.2.2. Mammalian cell culture, plasmids, and transient transfection 
 
 
HEK293 (human embryonic kidney) cells were cultured in Dulbecco’s modified Eagel’s medium 
(DMEM; Sigma) with 10% fetal bovine serum (Invitrogen), 4mM L-glutamine (Sigma), and 
penicillin-streptomycin (GibcoBRL) at 37°C in a humidified environment containing 5% CO2. 
  
To over-express chaperones, first, the αA-crystallin gene was removed from a pCIneo vector 
(kindly provided by U. Andley, Washington University) with SalI (3’), and XbaI (5’); the SalI 
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 end was blunted with Klenow before the XbaI cut, and the gene was sub-cloned into pcDNA3.1 
(kindly provided by R. Hughey, University of Pittsburgh) that had been cut with PmeI, blunted, 
and then cut with XbaI.  The Hsp110 encoding gene was removed from a pBacPAKHis-1 vector 
(kindly provided by J.R. Subjeck, Roswell Park Cancer Institute, Buffalo, New York) with AccI 
(5’), this end was blunted using Klenow, and the second cut was made with KpnI (3’). The gene 
was then sub-cloned into pcDNA.3.1, which had been cut with HinDIII, blunted, and then cut 
with KpnI. The gene encoding Hsp70 was cut out of the pMSHSP70 vector (kindly provided by 
R.I. Morimoto, Northwestern University, Chicago) by first cutting with HinDIII, blunting this 
end, and then cutting with KpnI (5’), before it was sub-cloned into pcDNA3.1 that had been cut 
with XbaI, blunted, and cut with KpnI. XL10 Gold supercompetent cells (Stratagene) were 
transformed with one tenth (= 1 µl) of a ligation reaction and transformants were selected based 
on resistance to Ampicillin. Correct insertion and the DNA sequence of the insert were 
confirmed by sequence analysis. HspBPI in pcDNA3.1 was kindly provided by V. Guerriero, 
University of Arizona, and the CFTR and ∆F508-CFTR genes in pcDNA3.1 were kindly 
provided by R.A. Frizzell, University of Pittsburgh. For all experiments, HEK293 cells were 
grown in 60-mm dishes and transiently transfected with the indicated pcDNA3.1 expression 
plasmids aided by Lipofectamine 2000 (Invitrogen). After 24h, cells were subjected to pulse 
chase analysis or cell lysis as described previously (Zhang et al., 2002a). 
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 3.2.3. Immunoblot analysis 
 
 
Samples were loaded onto 5% (CFTR detection in mammalian extracts), 10% (CFTR detection 
in yeast extracts), 15% (purified αA-crystallin), or 12.5% SDS-polyacrylamide gels. After 
electrophoresis, the proteins were transferred to PVDF (NEN) (to detect CFTR from mammalian 
cell extracts), or nitrocellulose (Schleicher and Schuell, pore diameter of 0.2µm). The antibodies 
used were raised against CFTR (M3A7, Upstate), αA-crystallin, Hsp90, Hsp70, Hsp110 
(Stressgen), HspBP1 (kindly provided by V. Guerriero, University of Arizona), Kar2p (Brodsky 
and Schekman, 1993), or Sec61p (Stirling et al., 1992). To detect the primary antibody, horse-
radish peroxidase-conjugated secondary antibodies (anti-rabbit, anti-mouse, anti-rat 
(Amersham); anti-sheep (Jackson Immuno Research)) were used. The complexes were 
visualized using the enhanced chemiluminescence detection kit (Pierce) and quantified using 
Kodak 1D software (v3.6; Kodak). 
 
 
3.2.4. Preparation of RNA for microarray and Northern blot analysis 
 
 
A single yeast colony was inoculated into 4 ml of Sc-ura supplemented with 2% glucose and 
incubated over night at 30°C with vigorous shaking. The culture was diluted into 250 ml of the 
same media and grown to an OD600 of 0.37 at 30°C. Cells were harvested by centrifugation at 
4000 rpm for 10 min in a Sorvall GSA rotor at 20°C. The pellet was resuspended in 25ml of 
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 double distilled sterile H2O and spun at 4000 rpm for 5 min at 20°C in a Sorvall SS 34 rotor. 
Pellets were snap frozen in liquid nitrogen and stored at -80°C. Yeast RNA was extracted with 
hot acid phenol (Sigma) as published in Current Protocols in Molecular Biology (Collart, 1993) 
with minor modifications. Specifically, the protocol was adjusted to isolate RNA from 250 ml of 
liquid yeast culture at a final OD600 of 0.37, and the RNA was extracted three times with acid 
phenol and twice with chloroform and subjected to RNeasy Midi Kit (Qiagen). RNA 
concentration and purity were determined spectrophotometrically by measuring the A260 and 
A280. Only samples with a ratio of A260/A280 higher than 1.8 were used. The integrity of total 
RNA was examined on a denaturing formaldehyde-agarose gel. Aliquots of all RNA samples 
were frozen and stored at -20°C. 
 
 
3.2.5. Microarray analysis 
 
 
Yeast 6.4K microarrays were obtained from the Ontario Cancer Institute Microarray Center 
(Toronto). Arrays were spotted with 6,240 yeast open reading frames plus control spots (6.4k 
total) in duplicate. cDNA probes were synthesized from 20 µg total yeast RNA (prepared as 
described above) and fluorescently labeled using the Atlas Glass Fluorescent Labeling Kit 
(Clontech) and Cy3 (CFTR expressing strain) and Cy5 (control strain) monofunctional reactive 
dyes (Amersham) according to the manufacturer’s instructions. Labeled cDNA was concentrated 
with microcon YM-30 filters (Amicon) to a final volume of 36 µl, and 2 µl of 10 mg/ml salmon 
sperm DNA and 10 mg/ml of polyadenylic acid were added. The labeled probe, including carrier 
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 DNA, was denatured at 90°C for 2 min and mixed with 40 µl pre-warmed (42°C) 2 x 
hybridization buffer  (50% formamide in 10x SSC, and 0.2% SDS). The hybridization mixture 
was added under the lifter coverslip (Erie Scientific Company) covering the array, and the 
hybridization reaction was set-up in a humidified hybridization chamber and incubated for 16 h 
at 42°C. Arrays were washed for 5 min in: 0.2x SSC/0.1% SDS; 0.2x SSC; and 0.1x SSC. They 
were then quickly rinsed in 0.01x SSC and dried by centrifugation in a S2096 rotor in a Beckman 
CS-15R centrifuge at 1200 rpm for 5 minutes. Microarrays were scanned with a GMS 418 Array 
Scanner (Genetic Microsystems) and Signal intensities were measured with GenePix Pro 4.1 
image analysis software (Axon Instruments). Data were normalized within an array by the ratio 
of total fluorescence. Statistical analysis was performed utilizing the program Significance 
Analysis of Microarrays (SAM). SAM employs a gene specific t-test and adds a small positive 
constant to the denominator to exclude genes with small differences between two examined 
conditions (Tusher et al., 2001).  
 
 
3.2.6. Northern blot analysis 
 
 
Total RNA was prepared from one aliquot of thawed yeast (see above), and 20 µg were resolved 
on 1% agarose/formaldehyde gels, transferred to Gene Screen Plus membranes (NEN Life 
Science Products), and hybridized sequentially using 32P-labeled, randomly primed probes 
produced from PCR fragments generated utilizing primers against HSP26 (forward: 
CACCAAGACGTCAGTTAGCA, reverse: TGTTGTCTGCATCCACACCT), FES1 (forward: 
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 CTACAGCAGTTATTCGGTGG, reverse: ACTCTCGTCAGACAAGCACT), YBR075W 
(forward: CTTGAGTATACCGATTATGC, reverse: CACTGGACTCCGATATGGTA), HSP82 
(forward: AGAGAGCACCATTCGACTTG, reverse: AATTGACCAGTTCTGATAGC), and 
SEC61 (forward: CCAACCGTGGTACTTTACTG, reverse: GTCCAGAAGAGCTTCGGATA). 
Filters were processed as previously described (Ausubel, 1988), except that the high temperature 
wash was performed at 55°C for 10 min. Membranes were re-hybridized after the bound probe 
was removed from the filters by incubation in 0.1x SSC, supplemented with an additional 15mM 
NaCl and containing 1% SDS for 20 min at 100°C.  
 
 
3.2.7. ERAD assays 
 
 
Yeast strains expressing HA-tagged CFTR were grown at 26°C over night in Sc-ura containing 
2% glucose. Cultures were diluted to an OD600 of 0.15 in the same medium and grown to an 
OD600 of 0.4-0.6. Protein synthesis was inhibited by the addition of cycloheximide (50 µg/ml 
final concentration) and cells were shifted to 30°C. A total of 2.5 ODs of cells were harvested at 
the indicated time points, and proteins were extracted as described previously (Zhang et al., 
2002b). Samples were loaded onto 10% SDS-polyacrylamide gels, and after electrophoresis, the 
proteins were transferred to nitrocellulose membranes (Schleicher and Schuell, pore diameter of 
0.2µm). Membranes were incubated with mouse monoclonal anti-HA antibody (12CA5, Roche 
Molecular Biochemicals) and rabbit polyclonal anti-Sec61p (Stirling et al., 1992). To detect the 
primary antibody, horseradish peroxidase-conjugated secondary antiserum was used, and the 
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 complex was visualized using the enhanced chemiluminescence detection kit (Pierce). Data were 
quantified using a Kodak 440CF Image Station and Kodak 1D (v 3.6; Kodak) software. The 
degradation of HA-tagged CPY* and HA-tagged Ste6p* were determined by pulse-chase 
immuno-precipitations from 35S-metabolically labeled yeast as published previously (Zhang et 
al., 2001) using mouse monoclonal anti-HA antibody (12CA5, Roche Molecular Biochemicals) 
and Protein A Sepharose (Amersham). 
 
Wild type CFTR/∆F508-CFTR degradation and maturation in HEK293 cells were assessed by 
pulse-chase immuno-precipitation as published previously (Zhang et al., 2002a) with minor 
modifications. In brief, transfected HEK293 cells were incubated at 37°C and cells were starved 
for 30 min in cysteine- and methionine-free DMEM (GibcoBRL). Metabolic labeling was 
initiated with 140 µCi/ml Redivue Pro-mix L35S (Amersham) for 30 min. The cells were then 
washed once with phosphate buffered saline (GibcoBRL),  and directly either lysed in RIPA 
buffer (1x phosphate buffered saline pH 7.4, 1 % Triton X-100, 1 % sodium deoxycholate, 0.1 % 
SDS) containing protease inhibitors (protease inhibitor cocktail tablets (Roche), 1 tablet/50 ml) 
or incubated for the indicated times in DMEM. DNA was sheared by repeated pipetting through 
a 1 ml syringe with an 18G needle. Cell lysates containing ~6 µCi were treated with M3A7 anti-
CFTR antibody (Upstate) or anti-αA-crystallin antibody (Stressgene) for 1 h at 4°C, and either 
Protein G- or Protein A-agarose (Invitrogen) was added, respectively. The mixture was incubated 
for 2 h at 4°C before the immuno-precipitates were isolated and washed three times with 1 ml 
RIPA buffer, resolved on 5 % SDS-PAGE, and analyzed by phosphorimager analysis using 
Image Gauge software (v3.45; Fuji Film Science Lab). P-values were calculated via the program 
at http://faculty.vassar.edu/lowry/t_ind_stats.html.
103 
 3.2.8. Purification of αA-crystallin and the NBD1 aggregation assay 
 
 
αA-crystallin was expressed in E.coli BL21 DE from the pAED4 vector (kindly provided by 
K.P. Das, Bose Institute, Kolkata, India). One colony of the transformed bacteria was inoculated 
into 40 ml LB medium supplemented with Ampicillin (50 µg/ml final concentration) and grown 
at 37°C over night. The culture was diluted 1:10 in fresh media and grown for ~1.5 h. αA-
crystallin expression was induced with isopropyl β-D-thiogalactoside (final concentration of 
0.5mM) for ~4 h until an OD600 of ~1 was reached. Cells were harvested and the protein was 
purified as described previously (Biswas and Das, 2004) with minor modifications. In brief, cells 
were resuspended in 15 ml of buffer A (20mM Tris, pH 7.2, 0.5mM EDTA, 0.5mM DDT) 
containing protease inhibitors (protease inhibitor cocktail tablets, 1 tablet/50 ml (Roche) and 
PMSF at a final concentration of 1mM (Diagnostic Chemicals Incoorporated)), and the cells 
were frozen at -80°C and thawed before they were treated with lysozyme and sonicated. The 
lysate was cleared by centrifugation at 10,000 rpm for 20 min at 4°C in a SS34 rotor (Sorvall). 
The clarified lysate was then dialyzed against buffer A over night and applied to a DEAE-anion 
exchange column (Amersham) and proteins were eluted with a linear 0-0.5M NaCl gradient. 
Peak fractions containing αA-crystallin (as assessed by SDS-PAGE and Coomassie Brilliant 
Blue staining) were concentrated with centricon YM-10 filters (Amicon) and loaded onto a 
Sephacryl S300-HR (Amersham) size exclusion column (1 x 50 cm) and proteins were eluted 
with buffer A supplemented with 0.1M NaCl. Peak fractions containing αA-crystallin, 
determined as above, were dialyzed against buffer A, and the protein concentration was assessed 
by Bradford assay (Biorad). Aliquots were snap frozen in liquid nitrogen and stored at -80°C. 
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 SDS-PAGE and Coomassie Brilliant Blue staining of the purified protein resulted in a band of 
~18 kD (that was 95% pure) that was recognized by anti-αA-crystallin antibody (Stressgen) by 
immunoblot analysis. Molar concentration is always expressed in the text assuming that the 
protein is a monomer. 
 
The ability of αA-crystallin to suppress the aggregation of NBD1 (kindly provided by R.T. 
Youker, University of Pittsburgh) was determined as described previously (Strickland et al., 
1997; Youker et al., 2004). 
 
 
 
 
3.3. RESULTS 
 
 
3.3.1. Identification of genes up-regulated in response to CFTR expression in yeast 
 
 
To identify genes up-regulated by the heterologous expression of CFTR in yeast, RNA was 
isolated from yeast strains transformed with either a plasmid synthesizing wild type CFTR under 
the control of a constitutive promoter or a vector control. Microarray analysis was performed 
with RNA from six pairs of independently transformed and grown yeast cultures. Exquisite care 
was taken to ensure that each yeast culture was grown and treated identically. Data from 6 Yeast 
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 6.4K Microarrays (Ontario Cancer Institute) were normalized and statistical analysis was 
performed utilizing the program Significance Analysis of Microarrays (SAM) (Tusher et al., 
2001).  
 
Allowing for a false discovery rate of 0.118 (the false discovery rate represents the median of the 
number of falsely identified genes divided by the number of genes termed significant), 359 genes 
were called significant, of these, 168 (~2.5% of the yeast genome) were up- and 191 (~2.9% of 
the yeast genome) were down-regulated (see Table 4 and 5). These changes in expression levels 
are most likely not due to Cl- conductance because wild type CFTR does not exhibit channel 
activity in yeast (J.L. Brodsky, personal communication). For the time being, I focused on the 
genes with elevated expression levels, because factors directly involved in CFTR degradation 
would be expected to be up-regulated rather than down-regulated in the presence of CFTR. In 
agreement with published reports (Zhang et al., 2001), genes typically up-regulated during cell 
stress responses or via the unfolded protein response (UPR) (e.g. KAR2, JEM1, UBC7, DER1, 
FKB2, PDI, ERO1; Chapman et al., 1998; Travers et al., 2000) did not exhibit an increase in 
mRNA levels as a result of CFTR expression in yeast. In fact, when I compared genes induced 
by CFTR expression in yeast with the genes listed as up-regulated during the UPR by Travers et 
al. (2000) and the UPR-induced genes screened by Palmer et al. (2003) there was no overlap. 
However, CFTR synthesis induced genes that might be involved in the proteolysis or maturation 
of the ion channel. These include the essential ubiquitin activating enzyme UBA1, a 26S 
proteasome subunit, RPT2 (probably a spurious effect, since the mRNA level of other 
proteasomal subunits did not change), a putative deubiquitinating enzyme UBP8, and a regulator 
of vacuolar protein sorting, VPS53.  Moreover, I detected amplification of the expression of three 
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 cytoplasmic molecular chaperones, HSP12, a polypeptide engaged in plasma membrane 
protection (Sales et al., 2000), HSP26, a member of the family of small Hsps or α-crystallin-like 
proteins (Narberhaus, 2002), and SIS1, an Hsp40 involved in translation initiation that acts in a 
complex with Ssa1p, Pab1p, and eIF4G (Zhong and Arndt, 1993; Horton et al.,2001). Although 
not every factor involved in translation initiation is up-regulated, different components of the 
complex might exhibit specific functions within this pathway so that the induction of one single 
factor might still modulate translation efficiency. In addition, HAA1, a transcriptional activator of 
the membrane stress response, was observed (Keller et al., 2001). However, HSP26 seems to be 
the most intriguing candidate of the three chaperones because members of the family of small 
Hsps have been implicated in a number of cellular processes, including the prevention of protein 
aggregation and of apoptosis, and the ubiquitin-proteasome pathway (see chapter 1.4, and 
Horwitz, 1992; Jakob et al., 1993; Wagner and Margolis, 1995; Ehrnsperger et al., 1997; Lee et 
al., 1997; Conconi et al., 1998; Conconi et al., 1999; Haslbeck et al., 1999; Boelens et al., 2001; 
Kamradt et al., 2001; Ito et al., 2002; Kamradt et al., 2002; Narberhaus, 2002; den Engelsman et 
al., 2003; Morrison et al., 2003; Parcellier et al., 2003; Biswas and Das, 2004; den Engelsman et 
al., 2004; Haslbeck et al., 2004; Liu et al., 2004a; Liu et al., 2004b; Kamradt et al., 2005). 
Several genes that are part of the trafficking machinery in the secretory pathway also exhibited 
elevated expression levels, including APL4, ERP5, and GYP7. In addition, 56 uncharacterized 
open reading frames (ORFs) were classified as significantly up-regulated, and computational 
analysis (http://www.incyte.com, http://www.ebi.ac.uk/InterProScan/, http://www.yeastgenome. 
org/) indicates that a subset of the corresponding polypeptides might impact CFTR degradation. 
For example, YDR049W encodes a protein associated with Cdc48p and Ufd2p, which, together 
with Npl4, catalyze ERAD substrate retro-translocation from the ER and delivery to the 
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 proteasome (Bays and Hampton, 2002); the product of YLR297W interacts with the Cul3p 
ubiqitin ligase; YBR062C contains a ring finger motif and exhibits similarity to several ring 
finger E3 ligases; YKL088W is an ER resident flavoprotein, which could indicate a role in protein 
folding, and YBL081W encodes an ER localized protein; YLL056C, exhibits enhanced expression 
during cell stress and encodes most likely an integral membrane protein; the gene product of 
YDR286C has similarity to glutaredoxin-like and thioredoxin-like folds, which is suggestive of 
an involvement in protein folding; the gene product of YAR028W, is a ubiquitin-modified ER 
membrane protein; YJL149W encodes a protein containing a cyclin-like F-box that interacts with 
the E3 Skp-Cdc53-Hrt1 ubiquitin-ligase. 
 
Accepting a false discovery rate of 0.218 (the false discovery rate represents the median of the 
number of falsely identified genes divided by the number of genes termed significant), 807 genes 
were called significant, of these, 324 (~4.9% of the yeast genome) were up- and 483 (~7.3% of 
the yeast genome) were down-regulated (see Table 6 and 7). From these induced candidates 3 are 
also up-regulated via the UPR (see above): CLB2, a G2-specific cyclin; HMX1, a heme-binding 
peroxidase; and YOR385W, which encodes a protein that interacts with the E3 ligase, Rsp5p 
(http://www.incyte.com, http://www.ebi.ac.uk/InterProScan/, http://www.yeastgenome.org/). 
Although the percentage of differentially regulated genes might seem high, it is important to note 
that, for example, the UPR induces ~5% of the yeast genome (Travers et al., 2000), and that 
treatment of cultured human airway epithelia with keratinocyte growth factor induced the 
expression of 12.9% of the genes examined two-fold or higher (Prince et al., 2001). Under these 
conditions, concurrent with published data, genes denoted as significantly up-regulated included 
FES1 (referred to as YBR101C in Table 6), HSP82, and NPL4. Fes1p and its human ortholog, 
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 HspBP1, serve as nucleotide exchange factors for the cytoplasmic Hsp70 (Kabani et al., 2002a; 
Kabani et al., 2002b). Moreover, HspBP1 facilitates the Hsp70-dependent biosynthesis of CFTR 
(Alberti et al., 2004). Hsp82, as well as its mammalian ortholog, Hsp90, facilitate CFTR 
biogenesis (Loo et al., 1998; Fuller and Cuthbert, 2000; Alberti et al., 2004; Youker et al., 2004). 
Npl4p complexes with Cdc48p and Ufd1p that together catalyze ERAD substrate retro-
translocation from the ER and delivery to the proteasome (Bays and Hampton, 2002), and this 
complex has been shown to facilitate CFTR degradation in yeast (Gnann et al., 2004). Additional 
genes with possible roles in CFTR degradation and maturation include CIC1, possibly involved 
in proteasome substrate specificity; UBP16, a potential ubiquitin-specific protease; RPN2, a 
proteasome subunit; VPS28, a component of the vacuolar protein sorting pathway; and CCT3, a 
component of the cytoplasmic chaperonin complex (http://www.yeastgenome.org/). Also, several 
genes implicated in protein trafficking, for example, SEC22, SFB3, and ERP5 were up-regulated. 
An additional ORF, YBR075W encoding a putative metalloprotease that was only induced 1.24-
fold will be discussed later (see Chapter 3.4).   
 
To confirm the results of the microarray analysis, the mRNA levels for several of the genes 
identified to be induced as a result of CFTR expression in yeast were measured by northern blot 
analysis. For this purpose, RNA isolated from an independently transformed and propagated 
culture was extracted and probed using PCR-fragments specific for the tested genes (see section 
3.2.6.). In agreement with the results presented in Table 4 and 6, HSP26, HSP82, FES1, and 
YBR075W exhibited elevated mRNA levels upon CFTR expression, whereas SEC61, which was 
chosen as a negative control, did not (see Figure 21). 
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 Table 4: List of genes up-regulated with a false discovery rate of 0.118. 
SAM analysis was performed using the one class response option. SAM score (di) is calculated 
as follows:    di= ri/si+s0;
 ri is the average base 2 logarithm of the median of pixel-by-pixel ratio, si is the standard 
deviation, s0 is a fixed value (Tusher et al., 2001).  
False discovery rate represents the median of the number of falsely identified genes divided by 
the number of genes termed significant. 
The cut-off was set at 0.51133.  
Candidates are represented in alphabetical order; genes that have not been assigned a name yet 
are positioned at the end ordered alphabetically according to their systematic gene name. 
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 Table 4: List of genes up-regulated with a false discovery rate of 0.118. 
 
 
Gene name Gene ID SAM score Gene name Gene ID SAM score 
ACE2 YLR131C 0.5354645 RVB1 YDR190C 0.6494475 
ACS1 YAL054C 0.8154645 RVS167 YDR388W 0.6981901 
AGE1 YDR524C 0.5252931 SAG1 YJR004C 0.7487353 
ALG11 YNL048W 1.1179425 SAS4 YDR181C 0.5229334 
ALG2 YGL065C 0.5721636 SHD7 YPL180W 0.6610702 
AME1 YBR211C 1.1423313 SHE2 YKL130C 0.7677449 
ANP1 YEL036C 0.7837898 SHS1 YDL225W 0.5385315 
APL4 YPR029C 0.7323618 SIS1 YNL007C 0.6081705 
ARD2 YOR253W 0.6415636 SKS1 YPL026C 0.6116995 
ARO80 YDR421W 0.6274118 SKY1 YMR216C 0.7658334 
BUD2 YKL092C 0.5996595 SLA1 YBL007C 0.8062825 
CBK1 YNL161W 0.5514176 SPO12 YHR152W 0.6978559 
CDC54 YPR019W 0.5814325 TBF1 YPL128C 0.7314996 
CET1 YPL228W 1.0211773 TDP1 YBR223C 0.6222723 
CIT2 YCR005C 0.6249329 TKL2 YBR117C 0.5700223 
COQ3 YOL096C 0.6207772 UBA1 YKL210W 0.784157 
DCP2 YNL118C 0.6408754 UBP8 YMR223W 0.8187045 
ECO1 YFR027W 0.8466539 URE2 YNL229C 0.6458571 
EMP70 YLR083C 0.5482601 VPS53 YJL029C 1.0312161 
ENA1 YDR040C 0.610744 YAK1 YJL141C 0.5659178 
ENP1 YBR247C 0.7467007 YAP1 YML007W 0.6273008 
ERP5 YHR110W 0.5140957 YAT2 YER024W 0.8762284 
FIT2 YOR382W 0.6383035 YHP1 YDR451C 0.6143564 
FLM1 YLR368W 0.6957145 YNG2 YHR090C 0.6465669 
FLO5 YHR211W 0.5217471 YSW1 YBR148W 0.7802424 
FRE6 YLL051C 0.556788 ZPR1 YGR211W 0.7056389 
FUN21 YAL031C 0.7113612 ZRT3 YKL175W 0.976345 
FYV9 YDR140W 0.5946895  YAR028W 0.5264223 
GAL2 YLR081W 0.5928116  YBL009W 1.1171276 
GAP1 YKR039W 0.5305734  YBL077W 1.1505036 
GDH3 YAL062W 1.8300928  YBL081W 0.5583936 
GLG2 YJL137C 0.5441961  YBR028C 0.7959197 
GPI1 YGR216C 0.7576396  YBR062C 0.584843 
GYP7 YDL234C 0.7388224  YBR063C 0.526655 
HAA1 YPR008W 0.7521704  YBR134W 0.8298711 
HAP4 YKL109W 0.5258314  YBR184W 0.718524 
HMG1 YML075C 0.6846509  YBR220C 0.5587535 
HOC1 YJR075W 0.9413915  YBR285W 0.6422557 
HSP12 YFL014W 0.650576  YCL003W 0.5255249 
HSP26 YBR072W 0.5148915  YCR023C 0.5113346 
HST1 YOL068C 0.5313157  YCR100C 0.5217153 
ISR1 YPR106W 0.5350464  YCRX01W 0.57279 
KEL3 YPL263C 0.609486  YDL233W 0.5877314 
LAG1 YHL003C 0.5536525  YDL238C 0.8471742 
LAG2 YOL025W 0.6741755  YDR049W 0.7098481 
LIN1 YHR156C 1.4123377  YDR109C 0.5260415 
LYS7 YMR038C 0.7775951  YDR286C 0.5326126 
MCM1 YMR043W 1.0563949  YDR357C 0.6599726 
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 (Table 4 continued) 
 
 
Gene name Gene ID SAM score Gene name Gene ID SAM score 
MDJ1 YFL016C 0.8767176  YDR396W 0.5475443 
MED2 YDL005C 0.8481425  YDR458C 0.5410779 
MEF1 YLR069C 0.5835699  YFL011W-A 0.713291 
MET1 YKR069W 1.0066376  YFL-TYA 0.5267725 
MMM2 YGL219C 0.5696961  YGL232W 0.650455 
MNT4 YNR059W 0.764895  YGR126W 0.6925856 
MOT1 YPL082C 0.8080344  YGR146C 0.6053002 
MOT3 YMR070W 0.8633962  YHR029C 0.7135 
MRPL3 YMR024W 0.6409642  YHR202W 0.7325546 
MRPL49 YJL096W 0.5153423  YIL105C 0.6368369 
MRS6 YOR370C 0.5719788  YJL010C 0.7446528 
NEJ1 YLR265C 0.5374652  YJL144W 0.5987485 
OKP1 YGR179C 0.5733336  YJL149W 0.5218521 
OSH7 YHR001W 0.8259891  YJR039W 0.5434616 
OXA1 YER154W 0.6362773  YKL088W 0.6878349 
PAN3 YKL025C 0.6046646  YKL121W 1.0225889 
PDR3 YBL005W 1.0103331  YKR023W 0.6001399 
PDX1 YGR193C 0.5239218  YKR064W 0.5756685 
PEX12 YMR026C 0.8941366  YLL056C 0.5821999 
PEX18 YHR160C 0.8099402  YLR077W 0.6787384 
PHO2 YDL106C 0.5846557  YLR101C 0.7894003 
PHO4 YFR034C 0.6298684  YLR254C 0.5953134 
POL32 YJR043C 0.8113145  YLR297W 0.5761218 
PZF1 YPR186C 0.8591886  YLR408C 0.5486848 
RAD27 YKL113C 0.7898438  YLR456W 0.6293983 
RAD7 YJR052W 0.9807294  YML040W 0.5194019 
REF2 YDR195W 0.9020187  YMR074C 0.6414522 
RFC1 YOR217W 0.8815917  YMR245W 0.7909302 
RPT2 YDL007W 0.5529343  YNL134C 0.5959392 
RRP3 YHR065C 0.5396577  YNL152W 0.7092224 
RRP4 YHR069C 0.5888745  YNL182C 0.5128074 
RRP9 YPR137W 0.5724691  YOL154W 0.5207258 
RSA3 YLR221C 0.6675734  YOR238W 0.6505084 
RSC9 YML127W 0.7431848  YOR243C 0.5551412 
RSM23 YGL129C 0.6523725  YOR315W 0.59822 
RTT106 YNL206C 0.8869165  YOR338W 0.5131982 
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 Table 5: List of genes down-regulated with a false discovery rate of 0.118. 
SAM analysis was performed using the one class response option. SAM score (di) is calculated 
as follows:    di= ri/si+s0; 
 ri is the average base 2 logarithm of the median of pixel-by-pixel ratio, si is the standard 
deviation, s0 is a fixed value (Tusher et al., 2001). 
False discovery rate represents the median of the number of falsely identified genes divided by 
the number of genes termed significant. 
The cut-off was set at -0.48842. 
 
Candidates are represented in alphabetical order; genes that have not been assigned a name yet 
are positioned at the end ordered alphabetically according to their systematic gene name. 
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 Table 5:  List of genes down-regulated with a false discovery rate of 0.118. 
 
 
Gene name Gene ID Sam score Gene name Gene ID Sam score 
ADE5,7 YGL234W -0.5638618 SIS2 YKR072C -0.8281534 
ANB1 YJR047C -0.8771838 SKI2 YLR398C -0.7773624 
APL3 YBL037W -0.5059574 SML1 YML058W -0.5947792 
ARP2 YDL029W -0.4893178 SOM1 YEL059C-A -1.0830485 
ASK10 YGR097W -0.5582381 SPC72 YAL047C -0.5990846 
ATM1 YMR301C -0.6166013 SPS2 YDR522C -0.8421081 
ATP16 YDL004W -0.5071484 SPT15 YER148W -0.5132295 
BCK2 YER167W -0.6621884 SSU1 YPL092W -0.5578112 
CAF20 YOR276W -0.489803 SSY5 YJL156C -0.7555033 
CAP2 YIL034C -0.5786572 SWI1 YPL016W -0.7993155 
CCW12 YLR110C -0.5080126 TFC3 YAL001C -1.2722991 
CDC123 YLR215C -0.5222616 THR1 YHR025W -0.51672 
CGR1 YGL029W -0.617686 TIF6 YPR016C -0.4912277 
CIN1 YOR349W -0.4919311 TLG2 YOL018C -0.5442128 
CMK1 YFR014C -0.8771254 TOS1 YBR162C -0.5127822 
CPR3 YML078W -0.5880611 TPI1 YDR050C -0.5763772 
CTP1 YBR291C -0.5741348 TPO4 YOR273C -0.6887964 
CUP5 YEL027W -0.5461762 TRM1 YDR120C -1.1159056 
CUS2 YNL286W -0.5565059 URA3 YEL021W -2.0327624 
CYR1 YJL005W -0.770266 URK1 YNR012W -0.8347968 
DDC1 YPL194W -0.4921074 VRG4 YGL225W -0.6518238 
DDI1 YER143W -1.0672786 VTI1 YMR197C -0.5099446 
ECM14 YHR132C -0.6296432 WSC2 YNL283C -0.5242826 
EDC1 YGL222C -0.6915139 YHB1 YGR234W -0.7115812 
ELP3 YPL086C -0.7761648 YHM1 YDL198C -0.5821653 
ERG24 YNL280C -0.6583339 YKT9 YKL199C -0.8987017 
ESS1 YJR017C -0.5154189 YPS1 YLR120C -0.667331 
EXG1 YLR300W -0.5039264 ZUO1 YGR285C -0.6367788 
EXG2 YDR261C -0.7857579  YAL061W -0.7721073 
GFD1 YMR255W -0.6508879  YBR096W -0.539775 
GSH1 YJL101C -0.6910685  YBR161W -0.5394987 
GTT2 YLL060C -0.5307255  YBR210W -0.5882846 
GUP2 YPL189W -0.6164146  YBR273C -0.555588 
GUT1 YHL032C -0.9843011  YCL049C -0.7209117 
HBS1 YKR084C -0.653613  YCR015C 0.6548429 
HDR1 YBR138C -0.7184401  YCR051W -0.8402798 
HIS1 YER055C -0.5840717  YCRX09C -0.7433812 
HIS3 YOR202W -0.9051203  YDL211C -0.5418984 
HKR1 YDR420W -0.6411346  YDR153C -0.7638346 
HMT1 YBR034C -0.5356794  YDR266C -0.595464 
HOM2 YDR158W -0.7588959  YDR267C -0.5616636 
HTA2 YBL003C -0.5267023  YDR417C -0.5829851 
HYP2 YEL034W -0.7604866  YDR474C -0.8745562 
ICY2 YPL250C -0.7400547  YFL065C -0.9317297 
IDP2 YLR174W -1.0389159  YFR017C -0.6100714 
KRE5 YOR336W -0.753278  YGL088W -0.7943729 
KRR1 YCL059C -0.7553605  YGL117W -0.5636607 
KTR7 YIL085C -1.5423158  YGL157W -0.7236745 
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 (Table 5 continued) 
 
 
Gene name Gene ID Sam score Gene name Gene ID Sam score 
YER146W LSM5 -0.6257448  YGL231C -0.5223212 
MCD1 YDL003W -0.8430706  YGR272C -0.6552175 
MDN1 YLR106C -0.5197688  YGR291C -0.5283463 
MET31 YPL038W -0.9244627  YHR048W -0.5585158 
MMP1 YLL061W -0.7514018  YIL083C -0.5263372 
MNN5 YJL186W -0.9352424  YJL120W -0.8680117 
MPM1 YJL066C -0.6837316  YJL162C -0.8677083 
MTR3 YGR158C -0.7688142  YJR141W -0.6508222 
MUS81 YDR386W -0.7542717  YKL206C -0.4993421 
NAF1 YNL124W -0.5031403  YKR015C -0.5973333 
NAT3 YPR131C -0.6452392  YKR100C -0.5733185 
NCE102 YPR149W -0.6372099  YLL023C -0.5178149 
NOC2 YOR206W -0.7384881  YLL047W -0.8169775 
NTF2 YER009W -0.5201889  YLL049W -0.6211896 
PAC2 YER007W -0.6327443  YLL067C -0.5901414 
PER1 YCR044C -0.4920325  YLR020C -0.556217 
PET111 YMR257C -0.542882  YLR023C -1.0143902 
PEX2 YJL210W -0.7291338  YLR047C -0.5013212 
PEX7 YDR142C -0.9158877  YLR050C -0.5232866 
PGK1 YCR012W -0.7175373  YLR162W -1.2259172 
PHM6 YDR281C -0.6125406  YLR331C -0.7910865 
PMP3 YDR276C -0.5436216  YLR346C -0.5909111 
PRS2 YER099C -0.7096873  YLR391W -0.5701325 
PSP2 YML017W -0.5065558  YLR407W -0.6437377 
PTA1 YAL043C -0.5121358  YLR454W -0.7141599 
PUT4 YOR348C -0.5628027  YML002W -0.5965356 
PXR1 YGR280C -0.8210194  YML108W -0.8036918 
REC102 YLR329W -0.9538199  YMR103C -0.7063822 
RER2 YBR002C -0.5960078  YMR124W -0.7289924 
RHR2 YIL053W -0.6780381  YMR157C -0.6056594 
RIB2 YOL066C -0.9407293  YMR252C -0.5955838 
RIC1 YLR039C -0.7041078  YMR313C -1.0197925 
RIM15 YFL033C -0.7190081  YMR321C -0.4905542 
RPB7 YDR404C -0.4981934  YNL035C -0.5544527 
RPL16B YNL069C -0.6626343  YNL058C -0.4910254 
RPL30 YGL030W -0.6581788  YNL338W -0.557514 
RPL38 YLR325C -0.5820594  YOL015W -0.764133 
RPL4A YBR031W -0.5264042  YOL073C -0.9509722 
RPL9A YGL147C -0.4916093  YOR051C -0.7200898 
RPL9B YNL067W -0.5893585  YOR073W -0.9731931 
RRB1 YMR131C -0.5777884  YOR155C -0.5105856 
SAH1 YER043C -0.6114601  YOR164C -0.8285988 
SAP190 YKR028W -0.4884243  YOR205C -0.5148132 
SCS2 YER120W -0.493586  YOR291W -0.6694206 
SED1 YDR077W -0.5088592  YOR322C -0.5010336 
SER3 YER081W -0.5556438  YPL276W -0.5134629 
SFL1 YOR140W -0.6625662  YPR012W -1.4859598 
SHC1 YER096W -0.6328324    
 
115 
 Table 6: List of genes up-regulated with a false discovery rate of 0.219. 
Candidates already represented in Table 4 are excluded. 
SAM analysis was performed using the one class response option. SAM score (di) is calculated 
as follows:    di= ri/si+s0; 
 ri is the average base 2 logarithm of the median of pixel-by-pixel ratio, si is the standard 
deviation, s0 is a fixed value (Tusher et al., 2001). 
False discovery rate represents the median of the number of falsely identified genes divided by 
the number of genes termed significant. 
The cut-off was set at 0.37478.  
 
Candidates are represented in alphabetical order; genes that have not been assigned a name yet 
are positioned at the end ordered alphabetically according to their systematic gene name. 
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 Table 6: List of genes up-regulated with a false discovery rate of 0.219. 
 
 
Gene name Gene ID Sam score Gene name Gene ID Sam score 
ADH4 YGL256W 0.493342 SHG1 YBR258C 0.4388417 
ALG8 YOR067C 0.4240654 SMD2 YLR275W 0.4354625 
ARN2 YHL047C 0.3837193 SNM1 YDR478W 0.3931462 
ASF1 YJL115W 0.4411638 SPP1 YPL138C 0.479571 
ASH1 YKL185W 0.4146571 SUR1 YPL057C 0.4417018 
BFR2 YDR299W 0.4938719 TAF12 YDR145W 0.4463338 
BNA4 YBL098W 0.49472 TFA1 YKL028W 0.3804029 
BRF1 YGR246C 0.4217324 TFB3 YDR460W 0.4405711 
CCT3 YJL014W 0.3787599 TFG2 YGR005C 0.4261854 
CDC50 YCR094W 0.5026724 TOS7 YOL019W 0.5041942 
CFT1 YDR301W 0.4775833 TPK2 YPL203W 0.4754099 
CHK1 YBR274W 0.4044078 UBP16 YPL072W 0.3747842 
CIC1 YHR052W 0.3857037 URA4 YLR420W 0.4791495 
CKI1 YLR133W 0.4340565 VPS28 YPL065W 0.3902836 
CLB2 YPR119W 0.4784397 XYL2 YLR070C 0.4965696 
CLF1 YLR117C 0.4255446 YAP1801 YHR161C 0.3779147 
COT1 YOR316C 0.468054 YAP6 YDR259C 0.4737717 
CRS5 YOR031W 0.4379941 YSC83 YHR017W 0.444902 
CUP1-1 YHR053C 0.4451074 YTA6 YPL074W 0.4415857 
CUP1-2 YHR055C 0.4257587 ZDS1 YMR273C 0.5027629 
CYC8 YBR112C 0.416638  YBL005W-B 0.376432 
DAT1 YML113W 0.4202432  YBL101W-A 0.5079474 
DEM1 YBR163W 0.4654022  YBL107C 0.4520141 
DOP1 YDR141C 0.452437  YBR101C 0.4538358 
DUO1 YGL061C 0.4662963  YBR168W 0.3758019 
ENB1 YOL158C 0.466643  YBR204C 0.407345 
ERG5 YMR015C 0.4108163  YBR235W 0.4125767 
FAT1 YBR041W 0.3808455  YBR259W 0.4039933 
FET3 YMR058W 0.3881147  YCL042W 0.4579868 
FHL1 YPR104C 0.4635475  YCRX15W 0.4940827 
FRE4 YNR060W 0.386091  YDR221W 0.4255089 
FUN26 YAL022C 0.4726588  YDR340W 0.4134746 
FUN31 YAL017W 0.3819605  YFL063W 0.4429495 
FYV1 YDR024W 0.3751428  YFR008W 0.4372755 
GDI1 YER136W 0.3888266  YGL042C 0.4946791 
GRE2 YOL151W 0.4536828  YGL168W 0.4158372 
HAM1 YJR069C 0.4436346  YGR111W 0.4546116 
HGH1 YGR187C 0.4903233  YGR125W 0.4332553 
HMX1 YLR205C 0.4340485  YHL010C 0.398237 
HSP82 YPL240C 0.3911802  YHL026C 0.4835794 
IMD1 YAR073W 0.3997759  YHR145C 0.3752084 
ISC1 YER019W 0.3959086  YHR149C 0.4488217 
IXR1 YKL032C 0.4673089  YIL121W 0.4180313 
LPD1 YFL018C 0.4855592  YIL127C 0.4767312 
LSM7 YNL147W 0.462476  YJL132W 0.4524199 
MAL33 YBR297W 0.4738088  YJL160C 0.4018974 
MDH3 YDL078C 0.4212906  YJR070C 0.3860262 
MRPL13 YKR006C 0.4755724  YJR088C 0.4143578 
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 (Table 6 continued) 
 
 
Gene name Gene ID Sam score Gene name Gene ID Sam score 
MTR2 YKL186C 0.4854254  YJR115W 0.4815571 
MUM2 YBR057C 0.4122139  YKL133C 0.456663 
NDD1 YOR372C 0.4155453  YKL137W 0.3857732 
NIT3 YLR351C 0.420616  YKR018C 0.4738795 
NPL4 YBR170C 0.4178502  YKR038C 0.4344144 
NUP57 YGR119C 0.4166915  YKR060W 0.37544 
OCA1 YNL099C 0.3795482  YKR089C 0.4004008 
PAN5 YHR063C 0.4844171  YLR137W 0.4527801 
PCD1 YLR151C 0.391998  YLR294C 0.4068739 
PCL9 YDL179W 0.411219  YLR412W 0.4862919 
PDR12 YPL058C 0.4022537  YLR440C 0.3999926 
PIN2 YOR104W 0.4431754  YMR046C 0.4332095 
POP5 YAL033W 0.4052184  YMR160W 0.4188163 
POS5 YPL188W 0.3863893  YMR192W 0.4010943 
PPE1 YHR075C 0.4666037  YMR215W 0.5003371 
PRD1 YCL057W 0.3780508  YMR304C-A 0.3919877 
PRP6 YBR055C 0.431794  YNL129W 0.4092399 
PUB1 YNL016W 0.4109086  YNL191W 0.4789758 
RDH54 YBR073W 0.5091566  YOL045W 0.4700731 
RGS2 YOR107W 0.4344168  YOL054W 0.3849798 
RHO5 YNL180C 0.4391915  YOR072W 0.3905673 
RPN2 YIL075C 0.4152061  YOR256C 0.3955263 
RRM3 YHR031C 0.425695  YOR292C 0.4235329 
RSC1 YGR056W 0.4634058  YOR320C 0.3773285 
RSM18 YER050C 0.3989076  YOR385W 0.3773067 
RSM22 YKL155C 0.3960271  YOR391C 0.459942 
RUB1 YDR139C 0.4684762  YPL103C 0.4416011 
SAE2 YGL175C 0.5091157  YPL146C 0.5055029 
SEC22 YLR268W 0.3783762  YPL184C 0.477432 
SFB3 YHR098C 0.4625626  YPR157W 0.399345 
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 Table 7: List of genes down-regulated with a false discovery rate of 0.219. 
Candidates already represented in Table 5 are excluded. 
SAM analysis was performed using the one class response option. SAM score (di) is calculated 
as follows:    di= ri/si+s0; 
 ri is the average base 2 logarithm of the median of pixel-by-pixel ratio, si is the standard 
deviation, s0 is a fixed value (Tusher et al., 2001). 
False discovery rate represents the median of the number of falsely identified genes divided by 
the number of genes termed significant. 
The cut-off was set at -0.31966. 
Candidates are represented in alphabetical order; genes that have not been assigned a name yet 
are positioned at the end ordered alphabetically according to their systematic gene name. 
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 Table 7: List of genes down-regulated with a false discovery rate of 0.219. 
 
 
Gene name Gene ID Sam score Gene name Gene ID Sam score 
ABF2 YMR072W -0.4035166 SES1 YDR023W -0.3600553 
ACC1 YNR016C -0.3420976 SFB2 YNL049C -0.4538388 
ADO1 YJR105W -0.3707425 SGT1 YOR057W -0.3761106 
AFG2 YLR397C -0.3329074 SHE9 YDR393W -0.4006388 
AMD2 YDR242W -0.4076542 SHM2 YLR058C -0.359617 
APS1 YLR170C -0.3764075 SHR3 YDL212W -0.3340474 
ARC18 YLR370C -0.4082286 SKI6 YGR195W -0.3644783 
ARG1 YOL058W -0.4850193 SLY1 YDR189W -0.3882459 
ARG3 YJL088W -0.4815167 SNQ2 YDR011W -0.3944842 
ARG8 YOL140W -0.3700517 SPT4 YGR063C -0.3951073 
ARO3 YDR035W -0.4793793 SRL3 YKR091W -0.3718807 
ARO4 YBR249C -0.3196622 SSE2 YBR169C -0.3791994 
AUT10 YFR021W -0.4339836 SSH1 YBR283C -0.3570308 
AUT4 YCL038C -0.3925144 STB5 YHR178W -0.3308338 
AUT7 YBL078C -0.4702483 STE11 YLR362W -0.4685999 
BUD23 YCR047C -0.3968652 STE4 YOR212W -0.3306096 
BUR6 YER159C -0.3416653 STM1 YLR150W -0.3555988 
CBF5 YLR175W -0.3959819 STP2 YHR006W -0.4209888 
CDC31 YOR257W -0.328109 STT4 YLR305C -0.4463394 
CHO2 YGR157W -0.3951097 SUB2 YDL084W -0.4008951 
CHS7 YHR142W -0.4781038 SUR4 YLR372W -0.3223841 
CLC1 YGR167W -0.3337671 SWD1 YAR003W -0.3924043 
CMD1 YBR109C -0.3692843 SWI6 YLR182W -0.4243125 
CNE1 YAL058W -0.4369845 SYS1 YJL004C -0.460956 
COS8 YHL048W -0.3936434 TAL1 YLR354C -0.4253518 
COX11 YPL132W -0.4546737 TCP1 YDR212W -0.3371377 
CRD1 YDL142C -0.3546696 TEF1 YPR080W -0.3272715 
CTR2 YHR175W -0.3914934 TIF2 YJL138C -0.4349815 
CWP1 YKL096W -0.4165249 TIF3 YPR163C -0.3229135 
CYB5 YNL111C -0.3535774 TOA2 YKL058W -0.3836746 
CYC3 YAL039C -0.3449293 TOM22 YNL131W -0.4323298 
DAK1 YML070W -0.342392 TRS33 YOR115C -0.3838477 
DBP2 YNL112W -0.4736917 TRX1 YLR043C -0.3708407 
DFR1 YOR236W -0.3230952 TUB2 YFL037W -0.4213864 
DIA2 YOR080W -0.3868678 TUP1 YCR084C -0.4541179 
DIT1 YDR403W -0.3911024 UGP1 YKL035W -0.3435169 
DRE3 YIL003W -0.3253628 UME1 YPL139C -0.4306439 
DYS1 YHR068W -0.4366676 UTP4 YDR324C -0.462796 
EAF3 YPR023C -0.4476286 VID24 YBR105C -0.4702607 
ECM1 YAL059W -0.4064597 VID31 YKL054C -0.4033984 
ECM17 YJR137C -0.3389033 VPS25 YJR102C -0.3335088 
ECM4 YKR076W -0.3227636 VPS5 YOR069W -0.4378908 
EDS1 YBR033W -0.339196 VPS73 YGL104C -0.4550529 
ELG1 YOR144C -0.3221461 YBT1 YLL048C -0.4126298 
ENA2 YDR039C -0.3642974 YCF1 YDR135C -0.4251066 
ERG10 YPL028W -0.3614997 YMD8 YML038C -0.4534763 
ERG13 YML126C -0.3832324 YNK1 YKL067W -0.3339919 
ERG28 YER044C -0.4361113 YPK2 YMR104C -0.3663585 
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 (Table 7 continued) 
 
 
Gene name Gene ID Sam score Gene name Gene ID Sam score 
ERG3 YLR056W -0.3638514 YRB1 YDR002W -0.4585467 
ERG9 YHR190W -0.3291244 YRF1-2 YER190W -0.4130435 
ERV1 YGR029W -0.4027255 YRF1-5 YLR467W -0.4021749 
FAP7 YDL166C -0.3776291 ZMS1 YJR127C -0.3693425 
FCY2 YER056C -0.3587603 ZRT2 YLR130C -0.3791246 
FKS1 YLR342W -0.452844  YAL011W -0.3294305 
FLO10 YKR102W -0.3920069  YAR066W -0.449276 
FPR1 YNL135C -0.4237143  YBL004W -0.4840155 
FUN19 YAL034C -0.3212891  YBL029W -0.4104987 
GFD2 YCL036W -0.4244291  YBL060W -0.3252889 
GOT1 YMR292W -0.3286361  YBR090C-A -0.3441699 
GPA1 YHR005C -0.3446049  YBR280C -0.3667338 
GSC2 YGR032W -0.3890059  YCR029C -0.3990985 
GSF2 YML048W -0.3807991  YDL193W -0.372173 
GTT1 YIR038C -0.4071764  YDL206W -0.3958075 
GUP1 YGL084C -0.3773532  YDR026C -0.3529741 
HAP3 YBL021C -0.3492004  YDR031W -0.4032447 
HEM1 YDR232W -0.3861053  YDR061W -0.3509296 
HEM15 YOR176W -0.376219  YDR112W -0.4508237 
HEM2 YGL040C -0.4616791  YDR133C -0.4015184 
HHF1 YBR009C -0.3834597  YDR134C -0.3656822 
HIF1 YLL022C -0.4138735  YDR185C -0.3779283 
HIS4 YCL030C -0.3359354  YDR233C -0.3961261 
HSP30 YCR021C -0.4314327  YDR445C -0.4780046 
HTB2 YBL002W -0.481522  YEL072W -0.340726 
HXT15 YDL245C -0.4569976  YER087C-A -0.3921715 
IDH2 YOR136W -0.4205422  YER160C -0.3224668 
IFM1 YOL023W -0.4194741  YFR035C -0.3601227 
ILV2 YMR108W -0.3684969  YFR039C -0.3580471 
ILV3 YJR016C -0.4218617  YFR041C -0.4061667 
IPP1 YBR011C -0.4496889  YFR042W -0.4286775 
IRA1 YBR140C -0.4615404  YGL020C -0.4025 
ISU2 YOR226C -0.430773  YGL039W -0.3362466 
ISY1 YJR050W -0.3472745  YGL057C -0.330754 
JNM1 YMR294W -0.3600522  YGL101W -0.4246622 
KIN2 YLR096W -0.3285851  YGL107C -0.4338464 
KRE2 YDR483W -0.419801  YGR093W -0.4369948 
KRE25 YNL296W -0.467667  YGR117C -0.3424121 
LOT6 YLR011W -0.4304672  YGR257C -0.3347576 
LRG1 YDL240W -0.41597  YGR273C -0.4209733 
LYS1 YIR034C -0.3282855  YHR209W -0.4612944 
LYS12 YIL094C -0.4510331  YIL039W -0.4699887 
LYS20 YDL182W -0.4232446  YIL088C -0.4183268 
MAK3 YPR051W -0.4197246  YIL165C -0.3762928 
MAK31 YCR020C-A -0.4274004  YIR043C -0.3542488 
MET10 YFR030W -0.4541879  YJL070C -0.4207034 
MET16 YPR167C -0.4223595  YJL131C -0.4707061 
MMF1 YIL051C -0.4551257  YJL163C -0.3985463 
MRPL35 YDR322W -0.3519177  YJL206C-A -0.3344618 
MRPS18 YNL306W -0.3211355  YKL036C -0.4372884 
MUB1 YMR100W -0.3270531  YKL083W -0.3848484 
MUP3 YHL036W -0.4547943  YKL084W -0.456032 
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 (Table 7 continued) 
 
 
Gene name Gene ID Sam score Gene name Gene ID Sam score 
NAP1 YKR048C -0.4645902  YKL097W-A -0.3776041 
NDE2 YDL085W -0.3846987  YKL224C -0.4424214 
NFI1 YOR156C -0.357053  YKR040C -0.3895782 
NFS1 YCL017C -0.4689462  YKR046C -0.3365784 
NGL1 YOL042W -0.4264941  YKR049C -0.3210018 
NOG1 YPL093W -0.3275348  YLL055W -0.3756343 
NOP13 YNL175C -0.3727326  YLL058W -0.3289342 
NOP58 YOR310C -0.3563652  YLR022C -0.3676946 
PAB1 YER165W -0.468184  YLR041W -0.4331768 
PAN6 YIL145C -0.4333445  YLR063W -0.428873 
PCL5 YHR071W -0.3940985  YLR072W -0.3555556 
PDA1 YER178W -0.4519567  YLR179C -0.3322725 
PEP3 YLR148W -0.3334164  YLR184W -0.3385824 
PET123 YOR158W -0.4424146  YLR326W -0.3826544 
PFK2 YMR205C -0.3931861  YLR392C -0.4856061 
POP6 YGR030C -0.4367696  YLR445W -0.4410903 
PRI1 YIR008C -0.4818085  YML005W -0.4287361 
PRP19 YLL036C -0.3493669  YML018C -0.3480285 
PRP22 YER013W -0.3380746  YML082W -0.4455778 
PRS5 YOL061W -0.4454714  YML089C -0.3282588 
PYC2 YBR218C -0.328169  YML117W-A -0.4611421 
RAD50 YNL250W -0.3503908  YMR086W -0.4689234 
RHO1 YPR165W -0.3917889  YMR196W -0.3671669 
RIF1 YBR275C -0.3502153  YMR291W -0.4341237 
RPG1 YBR079C -0.4307518  YMR315W -0.3596854 
RPL16A YIL133C -0.4616214  YNL047C -0.3834452 
RPL23A YBL087C -0.355134  YNL056W -0.3715618 
RPL7B YPL198W -0.3467297  YNL089C -0.3583673 
RPS27A YKL156W -0.4004054  YNL119W -0.4648008 
RPT5 YOR117W -0.4241453  YNL136W -0.4635686 
RRN3 YKL125W -0.3589719  YNL227C -0.4216299 
RRP12 YPL012W -0.4791035  YNL254C -0.3218216 
RRP5 YMR229C -0.4263711  YNR025C -0.3445592 
RRP8 YDR083W -0.3881478  YNR036C -0.3283297 
RSN1 YMR266W -0.372745  YNR063W -0.4398687 
RSR1 YGR152C -0.4058296  YOR108W -0.3519813 
SAC7 YDR389W -0.391687  YOR112W -0.3856989 
SAM1 YLR180W -0.349022  YOR282W -0.3346497 
SAM2 YDR502C -0.3503821  YOR296W -0.3203675 
SAM3 YPL274W -0.3710006  YOR304C-A -0.4436558 
SAR1 YPL218W -0.3747223  YOR352W -0.3688478 
SDC1 YDR469W -0.352773  YPL044C -0.4033875 
SEC11 YIR022W -0.4198859  YPL230W -0.3219021 
SEC9 YGR009C -0.3620644  YPR003C -0.3629078 
SEH1 YGL100W -0.45741  YPR099C -0.4398538 
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 Figure 21: HSP26, HSP82, FES1, and YBR075W mRNA levels are elevated in yeast expressing 
CFTR. 
HSP26, HSP82, FES1, YBR075W, and SEC61 mRNAs were detected by northern blot analysis 
from yeast transformed with a plasmid expressing CFTR under the control of a constitutive 
promoter (“+”) and yeast transformed with a vector control (“-“). The fold up-regulation upon 
CFTR expression as determined by northern blot analysis was: HSP26: 1.7; HSP82: 1.4; FES1: 
1.3; YBR075W: 1.24. 
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    Figure 21: HSP26, HSP82, FES1, and YBR075W mRNA levels are elevated in yeast expressing CFTR. 
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 Taken together, the microarray analysis of gene expression levels in response to heterologous 
synthesis of CFTR in yeast identified several genes already shown to impact CFTR biogenesis, 
but also revealed a number of putative factors that might regulate CFTR degradation and 
maturation in yeast, many of which are conserved in mammals.  
 
 
3.3.2. Small Hsps facilitate specifically the degradation of CFTR in yeast 
 
 
As mentioned above, one of the molecular chaperones exhibiting induced mRNA levels upon 
CFTR expression in yeast was HSP26, a member of the small Hsp family. Hsp26 and other 
sHsps have been shown to prevent proteins from aggregating.  Mammalian sHsps also inhibit 
apoptosis when up-regulated and two family members have been linked to the ubiquitin-
proteasome pathway (see Chapter 1.4, and Narberhaus, 2002). Therefore, I wanted to assess 
whether Hsp26 plays a role in CFTR degradation or maturation. To this end, I expressed an HA-
epitope-tagged form of wild type CFTR under the control of a constitutive promoter in a wild 
type yeast strain and in an hsp26 deletion strain that I generated via one-step gene-replacement. 
The rate of CFTR degradation was then determined by cycloheximide chase analysis at 30°C 
(see Materials and Methods). The levels of Sec61p, an integral ER membrane protein, were 
measured as well, and provided a loading control. I found that the proteolysis of CFTR was 
reduced in the hsp26∆ mutant compared to the wild type yeast: ~50% of the protein remained 90 
min after cycloheximide addition in the hsp26∆ strain and only ~25% of the CFTR remained in 
the wild type strain at this point (see Figure 22A and B).  
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 Figure 22: CFTR degradation is slowed in the hsp26 deletion mutant. 
A. Rates of CFTR degradation were determined by cycloheximide chase experiments in HSP26 
wild type yeast and in the hsp26∆ deletion mutant strain after addition of cycloheximide. Sec61p  
serves as a loading control. B. CFTR protein levels were quantified from 3 independent sets of 
experiments and averaged. All values were obtained after standardization to the levels detected 
directly after cycloheximide addition (0 min). Closed blue circles represent the CFTR protein 
levels in HSP26 wild type yeast, open purple circles represent the CFTR protein levels in the 
hsp26∆ mutant. Vertical bars indicate the standard errors of the mean. P-values for 40, 60, and 
90 minutes after cycloheximide addition are 0.0112, 0.0222, and 0.0625, respectively. 
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       Figure 22: CFTR degradation is slowed in the hsp26 deletion mutant. 
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 As mentioned in Chapter 1.3, different ERAD substrates require distinct factors for their 
degradation, depending on solubility, membrane association, and localization of the lesion 
(Plemper et al., 1997; Brodsky et al., 1999; Hill and Cooper, 2000; Fewell et al., 2001; 
Nishikawa et al., 2001; Vashist et al., 2001; Zhang et al., 2001; Kabani et al., 2003; Taxis et al., 
2003; Ahner and Brodsky, 2004; Huyer et al., 2004; Vashist and Ng, 2004). Hence, I wished to 
establish if Hsp26 contributes to the degradation of every ERAD substrate. If such an effect were 
observed it might arise from a general stress response in the deletion strain, and may simply be 
an artifact. To exclude this possibility I transformed the corresponding wild type and hsp26∆ 
strains with a vector expressing CPY*, a soluble ERAD substrate (Hiller et al., 1996), under the 
control of a constitutive promoter, and CPY* degradation was measured by pulse-chase 
immuno-precipitation at 30°C. In agreement with published results on the effects of other 
molecular chaperones on soluble ERAD substrates versus integral membrane proteins, I 
observed that the effects of deleting HSP26 on CFTR and CPY* were distinct: proteolysis of the 
soluble ERAD substrate was slightly enhanced in the hsp26∆ mutant (see Figure 23). 
 
Saccharomyces cerevisiae encodes 2 α-crystallin domain-containing members of the sHsp 
family, Hsp26 and Hsp42 (Geoffrey, 1997). Whereas Hsp42 seems to be a general sHsp, Hsp26 
can be induced by cell stress, even though, the two homologs share ~90% of their client proteins 
(Haslbeck et al., 2004). This suggested that Hsp42 may also impact CFTR degradation. To 
resolve this proposition, CFTR was expressed in strains containing a different genetic 
background (see Materials and Methods in subsection 3.2.1.), and that were deleted for HSP26, 
HSP42, or both genes. Cycloheximide chase experiments were performed at 30°C in these 
strains and in the isogenic wild type strain and the amount of CFTR remaining over time was  
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 Figure23: CPY* protein degradation is not attenuated in hsp26∆ yeast.  
A. The rates of CPY* degradation were determined by pulse-chase immuno-precipitation 
experiments in HSP26 wild type yeast and in the hsp26∆ mutant strain after addition of 
cycloheximide. B. CPY* protein levels were quantified from 3 independent sets of experiments 
and averaged. All values were obtained after standardization to the levels detected directly after 
cycloheximide addition (0 min). Closed blue circles represent the CPY* protein levels in HSP26 
wild type yeast, open purple circles represent the CPY* protein levels in the hsp26∆ mutant. 
Vertical bars indicate the standard errors of the means. 
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      Figure 23: CPY* protein degradation is not attenuated in the hsp26∆ yeast.  
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 measured. Sec61p served again as a loading control (data not shown). While neither the hsp26∆ 
mutant nor the hsp42∆ mutant showed a robust stabilization of CFTR, in this strain background,  
~90% of the protein remained stable after the 90 min chase period in the hsp26∆hsp42∆ double 
mutant compared to only 30% in the wild type strain (see Figure 24). These results indicate that 
Hsp26 and Hsp42 both facilitate CFTR degradation and suggest that they compensate for each 
other in the single deletion strains. This functional redundancy is consistent with the observation, 
noted above, that the two sHsps in yeast share ~90% of their substrates (Haslbeck et al., 2004). 
However, the degree of compensation appears to be dependent on the genetic background 
because CFTR was degraded at a faster rate in the isogenic wild type yeast compared to the 
hsp26∆ mutant in the first background utilized (see Fig.ure 22). Moreover, the stabilization 
observed in the single mutants shown in Figure 24 is less prominent than in the first experiment. 
Such background-specific chaperone-dependent effects are not without precedence (Caplan and 
Douglas, 1991; Atencio and Yaffe, 1992). 
 
To evaluate whether cells lacking both, Hsp26 and Hsp42 are able to degrade a soluble ERAD 
substrate, I transformed the isogenic wild type strain and the hsp26∆ hsp42∆ double mutant with 
the vector expressing CPY* and degradation was measured by pulse-chase immuno-precipitation 
at 30°C. In accordance with the ERAD substrate specificity of other chaperones (see above) 
there was no difference between the rate of CPY* proteolysis between the wild type yeast and 
the hsp26∆ hsp42∆ double mutant (see Figure 25). This indicates that neither of these sHsps in 
yeast assists in the ERAD of a misfolded, soluble ER protein, whereas they are required for the 
degradation of the integral membrane protein, CFTR. These data also preclude the possibility  
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 Figure 24: CFTR degradation is slowed in the hsp26∆hsp42∆ double mutant. 
A. Rates of CFTR degradation were determined by cycloheximide chase experiments in 
HSP26HSP42 wild type yeast, in the hsp26∆ deletion mutant and the hsp42∆ deletion mutant, 
and in the hsp26∆hsp42∆ double mutant strain after addition of cycloheximide. Sec61p levels 
served as a loading control (data not shown). B. CFTR protein levels were quantified from 4 
independent sets of experiments and averaged. All values were obtained after standardization to 
the levels detected directly after cycloheximide addition (0 min). Closed blue circles represent 
the levels of CFTR in HSP26HSP42 wild type cells, and open purple triangles represent CFTR 
levels in the hsp26∆ mutant. Closed red circles triangles CFTR remaining in the hsp42∆ mutant, 
and open yellow circles depict experiments in the hsp26∆hsp42∆ double mutant. Vertical bars 
indicate the standard errors of the means. Comparison of CFTR protein levels between the wild 
type yeast and the hsp26∆hsp42∆ double mutant strain at 60 and 90 minutes after cycloheximide 
addition yielded p-values < 0.03. 
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       Figure 24: CFTR degradation is slowed in the hsp26∆hsp42∆ double mutant. 
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 Figure 25: CPY* protein degradation is equally efficient in the HSP26HSP42 wild type and  
hsp26∆hsp42∆ double mutant strains. 
A. Rates of CPY* degradation were determined by pulse-chase immuno-precipitation 
experiments in HSP26HSP42 wild type yeast and in the hsp26∆hsp42∆ double mutant strain 
after addition of cycloheximide. B. CPY* protein levels were quantified from 2 independent sets 
of experiments and averaged. All values were obtained after standardization to the levels 
detected directly after cycloheximide addition (0 min). Closed blue circles represent CPY* 
protein levels in HSP26 wild type yeast, and open yellow circles represent CPY* protein levels 
in the hsp26∆hsp42∆ double mutant. Vertical bars indicate the range of the data. 
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 Figure 25: CPY* protein degradation is equally efficient in the HSP26HSP42 wild type and  hsp26∆hsp42∆          
double mutant strains. 
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 that the observed effect is due to a non-specific stress or growth response that arises from the 
deletion of the sHSPs.  
 
Kar2p is the ER resident Hsp70 that is up-regulated by the UPR, which arises from the 
accumulation of unfolded or misfolded proteins in the ER (Gething, 1999). To further confirm 
that the stress response was not induced in the hsp26∆ hsp42∆ double mutant, I assessed Kar2p 
levels in the wild type strain and the double mutant by immuno-precipitation. There was no 
elevation of Kar2p levels (see Figure 26) in the mutant relative to the wild type strain, suggesting 
again that the observed defects are due to deletion of the sHsps rather than to a nonspecific up-
regulation of stress inducible genes. 
 
To further determine the substrate specificity of the sHsps during ERAD we explored their effect 
on the degradation of another misfolded integral membrane protein in yeast. Ste6p is the yeast a-
mating factor pheromone transporter, an ABC transporter with structural similarity to CFTR, the 
sequence similarity between the two transporters is low and restricted to the NBDs (NBD1: 
~26% identical, NBD2 ~31% identical;  http://www.ncbi.nlm.nihgov/BLAST/Blast.cgi) 
(Kuchler et al., 1989). Deletion of the C-terminal 52 amino acids, instigates ER retention of the 
mutated protein, denoted Ste6p*, and prompts its degradation via ERAD (Loayza et al., 1998). 
Notably, a recent study reported identical requirements for the ERAD of CFTR and Ste6p* in 
yeast (Huyer et al., 2004). To examine if the sHsps are also involved in Ste6p* degradation, I 
transformed the hsp26∆ hsp42∆ double mutant and the isogenic wild type strain with a vector 
expressing Ste6p* under the control of a constitutive promoter and Ste6p* degradation was 
measured by pulse-chase immuno-precipitation experiments at 30°C. Surprisingly, the hsp26∆  
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 Figure 26: The UPR is not induced in the hsp26∆hsp42∆ mutant. 
Kar2p and Sec61p protein levels in the HSP26HSP42 wild type and hsp26∆hsp42∆ double 
mutant strains were determined by immuno-precipitation. Results of two independent 
experiments are displayed. The HSP26 wild type protein is denoted as “WT” in blue, 
hsp26∆hsp42∆ double mutant protein as “∆” in yellow. 
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                                   Figure 26: The UPR is not induced in the hsp26∆hsp42∆  deletion mutant. 
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 hsp42∆ double mutant proficiently degraded Ste6p* compared to the wild type strain (Figure 
27). This indicates that Hsp26 and Hsp42 are able to distinguish between two similar membrane 
proteins.  This could be attributable to differences between CFTR and Ste6p or to the difference 
in the nature of the defects that make each protein an ERAD substrate. Whereas wild type CFTR 
is an ERAD substrate in yeast, Ste6p* is distinguished from the wild type protein by a C-
terminal deletion. One can envision that the nature or degree of the misfolding between the two 
ERAD substrates might differ significantly, and so they might present distinct accessibility for 
interacting proteins. Also, one can not exclude the possibility that the sHsps might require the C-
terminus of the ABC transporters in order to impact their half life. 
 
 
3.3.3. Over-expression of the human sHsp, αA-crystallin, facilitates ∆F508-CFTR 
degradation in HEK293 cells 
 
 
I next wanted to establish if sHsp function in mammals is important for CFTR degradation. αA-
crystallin is one of 10 members of the small Hsps or α-crystallin-like proteins in humans (Kappe 
et al., 2003), and it has been demonstrated to associate with unfolded proteins and to prevent 
their aggregation (Horwitz, 1992; Jakob et al., 1993; Biswas and Das, 2004) and to prevent 
apoptosis when over-expressed (Liu et al., 2004b). Therefore, I transiently co-transfected 
HEK293 cells with vectors over-expressing wild type CFTR and either an empty vector or a 
vector expressing αA-crystallin. Also, I co-transfected the cells with CFTR and Csp1 (mHsp40), 
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 Figure 27: Ste6p* is degraded with equal efficiency in the HSP26HSP42 wild type and 
hsp26∆hsp42∆ mutant strains. 
A. Rates of Ste6p* degradation were determined by pulse-chase immuno-precipitation 
experiments in HSP26HSP42 wild type yeast and in the hsp26∆hsp42∆ double mutant strain 
after addition of cycloheximide. B. Ste6p* protein levels were quantified from 2 independent 
sets of experiments and averaged. All values were obtained after standardization to the levels 
detected directly after cycloheximide addition (0 min). Closed blue circles represent the levels of 
Ste6p* in HSP26 wild type cells, and open yellow circles represent Ste6p* levels in the 
hsp26∆hsp42∆ double mutant. Vertical bars indicate the range of the data. 
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Figure 27: Ste6p* is degraded with equal efficiency in the HSP26HSP42 wild type and hsp26∆hsp42∆ mutant 
strains. 
 
141 
 Hsp110, Hsp70, or HspBP1 (NEF for Hsp70) expression vectors, so that I could compare the 
effects of αA-crystallin to the impact of other chaperones and chaperone cofactors (see Materials 
and Methods). Initially, CFTR levels were assessed by western blot analysis (see Figure 28A). 
Hsp90 served as loading control and its expression levels remained essentially unchanged upon 
over-expression of CFTR in combination with different chaperones and chaperone cofactors (see  
Figure 28A). Successful over-expression of the chaperones, which varied considerably, was 
confirmed by western blot analysis (see Figure 28B). A lower molecular weight band of 
unknown identity was detected in addition to the expected signal at about 110 kD with the anti-
Hsp110 antibody. In accordance with previous reports, Csp1 prevented CFTR from maturating to 
the complex glycosylated form “band C” (Zhang et al., 2002a), and levels of CFTR were 
reduced about 3.5 fold (average of 2 independent experiments) upon Hsp70 over-expression, 
consistent with reports demonstrating an involvement of Hsp70 in CFTR degradation (Meacham 
et al., 2001; Zhang et al., 2001). The preliminary data also suggested that over-expression of 
Hsp110, HspBP1, and αA-crystallin did not lead to a robust change in wild type CFTR 
maturation (see Figure 28), although upon Hsp70 and αA-crystallin over-expression, the amount 
of immature CFTR (B-band) was reduced below detection level. This observation could be 
explained by an increase in the degradation of the immature form, but since the B-band signal 
was very low, no conclusions can be drawn with confidence.   
 
Since the deletion of HSP26 and HSP42 in yeast caused a stabilization of CFTR, I desired to 
investigate more carefully if the conserved human ortholog, αA-crystallin, plays a role in CFTR 
degradation. Two mammalian homologs of the family of small Hsps have been linked to the 
ubiquitin-preoteasome system (Wagner and Margolis, 1995; Conconi et al., 1998; Conconi et al., 
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 Figure 28: Steady-state expression levels of CFTR are decreased upon over-expression of 
Hsp70, and unchanged upon over-expression of Hsp110, αA-crystallin, and HspBP1. 
A. A western blot depicting CFTR and Hsp90 (as a loading control) protein levels in HEK293 
cells and HEK293 cells co-transfected with CFTR (1.5 µg) and a vector control or containing 
either CSP1, HSP110, HSP70, αA-crystallin, or HspBP1, (1.5 µg for each) is shown. B. Western 
blots are shown that measure Hsp110, Hsp70, αA-crystallin, and HspBP1 protein levels. 
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Figure 28: Steady-state expression levels of CFTR are decreased upon over-expression of Hsp70, and unchanged 
upon over-expression of Hsp110, αA-crystallin, and HspBP1. 
144 
 1999; Boelens et al., 2001; Ito et al., 2002; den Engelsman et al., 2003; Parcellier et al., 2003; 
den Engelsman et al., 2004). To this end, I co-transfected HEK293 cells with the CFTR 
expression vector and either the empty vector as a control or the αA-crystallin expression vector 
and performed pulse-chase immuno-precipitation experiments. Successful over-expression of 
αA-crystallin was confirmed by immuno-precipitation with anti-αA-crystallin antibodies (see 
Figure 29A). I also found that the maturation of CFTR from the immature, core-glycosylated 
form (CFTR B-band) to the mature, complex-glycosylated form (CFTR C-band) proceeded at 
equal rates in cultures transfected with the empty vector and those over-expressing αA-crystallin 
(see Figure 29A and B). Furthermore there is no difference in the disappearance of the B-band 
following over-expression of αA-crystallin (see Figure 29A and B). This suggests that the 
human sHsp αA-crystallin does not aid in the biogenesis of wild type CFTR, or that the levels of 
endogenous αA-crystallin or related chaperones are already saturating.  
 
Since wild type CFTR when heterologously expressed in yeast is quantitatively degraded like the 
∆F508-CFTR mutant is in mammalian cells (Zhang et al., 2001), sHsps might only impact the 
biosynthesis of the mutant in mammalian cells. To explore this possibility I repeated the pulse-
chase immuno-precipitation experiments in cells expressing the ∆F508-CFTR mutant. Consistent 
with the results on CFTR degradation obtained in the hsp26∆hsp42∆ mutant yeast, over-
expression of the human sHsp, αA-crystallin, enhanced the proteolysis of the ∆F508-CFTR 
mutant compared to the vector control (see Figure 30A and B). This result implies that αA-
crystallin impacts exclusively the ERAD of the ∆F508-CFTR mutant and, therefore, might be 
able to distinguish between the wild type and the mutant channel. 
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 Figure 29: αA-crystallin over-expression has no effect on the biogenesis of wild type CFTR. 
A. HEK293 cells were transfected with 1.5 µg of pcDNA3.1-CFTR and 0.5 µg of pcDNA3.1 or 
pcDNA3.1-αA-crystallin. Rates of CFTR maturation and CFTR B-band degradation as well as 
αA-crystallin expression levels were determined by pulse-chase immuno-precipitation in 
HEK293 cells co-transfected with CFTR, and in cells containing a vector control or the αA-
crystallin expressing vector. B. CFTR B-band degradation was determined from 3 independent 
sets of experiments and averaged. CFTR maturation was determined from 4 independent sets of 
experiments and averaged. All values were obtained after standardization to the levels detected at 
the beginning of the chase period (0 h). Closed blue circles represent immature/mature CFTR 
protein levels in HEK293 cells with the vector control, open purple circles represent 
immature/mature CFTR protein levels in HEK293 cells over-expressing αA-crystallin. Vertical 
bars indicate the standard errors of the mean.  
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      Figure 29: αA-crystallin over-expression has no effect on the biogenesis of wild type CFTR. 
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 Figure 30: αA-crystallin over-expression accelerates the degradation of ∆F508-CFTR. 
A. HEK293 cells were transfected with 1.5 µg of pcDNA3.1-∆F508-CFTR and 0.5 µg of 
pcDNA3.1 or pcDNA3.1-αA-crystallin. Rates of ∆F508-CFTR degradation as well as αA-
crystallin expression levels were determined by pulse-chase immuno-precipitation in each 
transfected HEK293 cell-type. B. ∆F508-CFTR degradation was determined from 4 independent 
sets of experiments and averaged. All values were obtained after standardization to the levels 
detected at the beginning of the chase period (0 h). Closed blue circles represent ∆F508-CFTR 
protein levels in HEK293 cells with the vector control, and open purple circles represent ∆F508-
CFTR protein levels in HEK293 cells over-expressing αA-crystallin. Vertical bars indicate the 
standard errors of the mean. P: * = 0.0768, ** = 0.0001, ***= 0.003 , **** = 0.5 
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     Figure 30: αA-crystallin over-expression accelerates the degradation of ∆F508-CFTR. 
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 3.3.4. αA-crystallin prevents aggregation of the NBD1 of CFTR 
 
 
Misfolding of a polypeptide can lead to its aggregation, and the NBD1 of CFTR is known to be 
aggregation prone (Qu and Thomas, 1996). During CFTR biogenesis, NBD1 is folded co-
translationally while the post-translational folding of NBD2 depends on pre-folded NBD1 (Du et 
al., 2005). It has previously been revealed that Hsp70 sustains NBD1 solubility but is also 
required for efficient degradation of CFTR (Strickland et al., 1997; Meacham et al., 1999; 
Meacham et al., 2001). One model to account for these data is that Hsp70 maintains NBD1 
solubility or unfolds the polypeptide to provide accessibility for proteasomal degradation. Since I 
found an involvement of sHsps in CFTR degradation, and sHsps have been demonstrated to 
associate with unfolded proteins and prevent their aggregation (Horwitz, 1992; Jakob et al., 
1993; Ehrnsperger et al., 1997; Lee et al., 1997; Haslbeck et al., 1999; Biswas and Das, 2004; 
Haslbeck et al., 2004), I wished to uncover if αA-crystallin inhibits NBD1 aggregation.  
 
Toward this goal, I purified αA-crystallin from E. coli engineered to over-express the protein 
utilizing DEAE- and size-exclusion column chromatography (see Figure 31). The recombinant 
αA-crystallin was ~95% pure and its identity was confirmed by immunoblot analysis (see Figure 
32A and B). At a molar ratio of 1:1, αA-crystallin suppressed the aggregation of CFTR NBD1 
by ~80% (see Figure 33). The efficiency of αA-crystallin to abolish NBD1 aggregation was 
ATP-independent, and it should be noted that the ATP-dependence of sHsps action is still 
controversial. While some groups report no enhancement of activity upon addition of ATP 
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 Figure 31: Purification of αA-crystallin. 
A. Lysate from E. coli expressing αA-crystallin was loaded onto a DEAE column and proteins 
were separated with a linear 0-0.5M NaCl gradient and protein profiles of the fractions were 
assessed by SDS-PAGE and Coomassie Brilliant Blue staining. The indicated fractions (13-16) 
were pooled and concentrated. B. Concentrated eluate was further purified by size exclusion 
column chromatography. Indicated fractions (24-27; 28-30; 31-34) were pooled and dialyzed. 
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     Figure 31: Purification of αA-crystallin. 
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 Figure 32: αA-crystallin is 95 % pure. 
A. Silver stained 15% SDS-PAGE of purified αA-crystallin.  The pooled fractions 24-27 are 
95% pure and were used for the in vitro aggregation experiments. B. Identity of the purified 
protein was verified by western blot analysis. αA-crystallin runs at a molecular weight of 18 kD. 
The higher molecular weight bands visible in the western blot might be αA-crystallin dimers and 
higher oligomers, which are known to exist (Narberhaus, 2002; Horwitz, 2003). 
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             Figure 32: αA-crystallin is 95% pure. 
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 Figure 33: αA-crystallin prevents NBD1 aggregation. 
NBD1 aggregation was measured as a change in absorbance at 400 nm after its dilution out of 
denaturant and was determined in the presence and absence of αA-crystallin at a monomeric 
molar ratio of 1:1. The effect of 3.5mM ATP on the aggregation of NBD1 and the efficiency of 
αA-crystallin were also measured. Assays were performed at 37°C. Dark blue diamonds 
represent NBD1 aggregation alone, pink triangles represent NBD1 aggregation in the presence of 
αA-crystallin. Light blue circles depict NBD1 aggregation in the presence of ATP and purple 
squares depict NBD1 aggregation in the presence of αA-crystallin and ATP. NBD1=nucleotide 
binding domain 1, Apha-A=αA-crystallin. 
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  Figure 33: αA-crystallin prevents NBD1 aggregation. 
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 (Lee et al., 1995; Chang et al., 1996; Ehrnsperger et al., 1997; Veinger et al., 1998), others claim 
an increase in efficiency in the presence of ATP, but not in the presence of nonhydrolyzable ATP 
analogs (Muchowski and Clark, 1998; Smykal et al., 2000). A reduction of chaperone activity in 
the presence of ATP has also been described (Muchowski and Clark, 1998; Smykal et al., 2000), 
and a recent study observed  improved sHsp function even in the presence of nonhydrolyzable 
analogs (Biswas and Das, 2004). In any event, the results presented in Figure 37 could offer a 
putative explanation for the mechanism of sHsp action during ERAD. 
 
 
 
 
3.4. DISCUSSION 
 
 
In this Chapter, I describe the utilization of yeast to detect changes in transcript levels in 
response to the heterologous expression of CFTR via microarray analysis. The validation of this 
approach was provided by the identification of several genes known to play a role in CFTR 
maturation and degradation, such as FES1, HSP82, and NPL4. In addition, CFTR synthesis 
induced genes that are generally involved in protein biogenesis, trafficking, and degradation, as 
well as a number of uncharacterized ORFs. I was able to prove that for one of these candidates, 
Hsp26, the elevated mRNA level was significant: The deletion of the corresponding gene slows 
CFTR degradation, and the mammalian ortholog, αA-crystallin, also plays a role in the ERAD of 
∆F508-CFTR. 
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 The fold up-regulation of gene messages in response to CFTR expression in yeast was generally 
modest. Particularly, genes that may be involved in the control of CFTR biogenesis and 
degradation displayed a fold increase in mRNA levels ranging from ~1.4 to 1.8. Nevertheless, 
the results presented were based on 6 independent experiments and the up-regulation of several 
candidates was verified by northern blot analysis in which RNA from another set of 
independently transformed and grown cells was tested. Moreover, several of the induced 
transcripts correspond to proteins already known to affect CFTR biogenesis. Fes1p and its 
human ortholog, HspBP1, serve as nucleotide exchange factors for the cytoplasmic Hsp70 
(Kabani et al., 2002a; Kabani et al., 2002b), and HspBP1 facilitates the Hsp70-dependent 
biosynthesis of CFTR (Alberti et al., 2004). Hsp82, as well as its mammalian ortholog, Hsp90, 
facilitate CFTR biogenesis (Loo et al., 1998; Youker et al., 2004). Npl4p, which resides in a 
complex with Cdc48p and Ufd1p, catalyzes ERAD substrate retro-translocation from the ER and 
transfer to the proteasome (Bays and Hampton, 2002), and this complex facilitates CFTR 
degradation in yeast (Gnann et al., 2004). Finally, it is important to note that we purposely chose 
to express CFTR from a moderate, constitutive promoter, rather than from a strong promoter, 
which might have given stronger induction of target genes. The reason for this choice is that we 
feared that strong induction of CFTR might lead to non-specific stresses. 
 
Further characterization of one message identified in the microarray analysis, HSP26, revealed 
that deletion of this gene led to a modest stabilization of CFTR in yeast, but not of other tested 
ERAD substrates. This effect was even stronger in a yeast strain doubly mutated for HSP26 and 
its homologue, HSP42. This finding is consistent with a recent study reporting a 90% overlap in 
substrate specificity for Hsp26 and Hsp42 (Haslbeck et al., 2004). I was then able to confirm my 
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 discovery by using mammalian cell culture systems, where ∆F508-CFTR, but not wild type 
CFTR degradation was enhanced upon over-expression of the mammalian ortholog, αA-
crystallin. These results suggest that sHsps impact the ERAD of specific substrates, and αA-
crystallin seems even to be able to distinguish between the wild type and ∆F508 mutant form of 
CFTR.  
 
One mechanism to explain the sHsp control over proteolysis might be the prevention of substrate 
aggregation which may be required to preserve accessibility for ubiquitination and proteasome-
mediated degradation. Indeed, αA-crystallin was able to suppress NBD1 aggregation in vitro at a 
molar (monomeric) ratio of 1:1 by 80%. This effect is stronger than the recently reported 5:1 
molar ratio required for Hsp90 to decrease NBD1 aggregation by 60% (Youker et al., 2004), but 
it is in line with other studies reporting a 1:1 molar ratio of sHsps to other substrates as being 
sufficient to nearly completely prevent aggregation (Horwitz, 1992; Jakob et al., 1993; Chang et 
al., 1996; Ehrnsperger et al., 1997; Haslbeck et al., 1999; Studer and Narberhaus, 2000). While 
suppression of aggregation may aid in efficiency of ERAD, there is also evidence that sHsps 
might regulate degradation more directly. For example, the interaction of sHsps with the 
ubiquitin-proteasome machinery provides an additional hypothesis to explain the enhanced 
degradation of ∆F508-CFTR in response to α-crystallin over-expression. Misfolded CFTR is 
targeted for ER-associated degradation via the ubiquitin-proteasome machinery (Jensen et al., 
1995; Ward et al., 1995; Hohfeld et al., 2001; Meacham et al., 2001; Zhang et al., 2001), and 
mutant CFTR that is artificially driven to the plasma membrane is ubiquitinated and thus 
rerouted for lysosomal degradation (Sharma et al., 2004). Functional and physical interaction 
between sHsps and the 20S proteasome have been detected. While α-crystallin decreases peptide 
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 hydrolyzing activities for some substrates, it protects the trypsin-like activity of the proteasome 
(Wagner and Margolis, 1995; Conconi et al., 1998; Conconi et al., 1999; Boelens et al., 2001; 
Ito et al., 2002). Hsp27 binds to the 26S proteasome and to a polyubiquitinated substrate 
(Parcellier et al., 2003) and, αB-crystallin has been proposed to recruit the F-box protein, FBX4, 
an adaptor molecule for the ubiquitin ligase SCF, and to promote substrate ubiquitination (den 
Engelsman et al., 2003; den Engelsman et al., 2004). Intriguingly, one of the uncharacterized 
ORFs identified in my screen, YJL149W, encodes a cyclin-like F-box that interacts with the E3 
ubiquitin-ligase, Skp-Cdc53-Hrt1. Together with my finding that the yeast sHsps, Hsp26 and 
Hsp42, and one of their mammalian orthologs, αA-crystallin, promote CFTR or ∆F508-CFTR 
degradation, respectively, and αA-crystallin keeps CFTR in a soluble state, the data suggest 
putative roles for sHsps in detecting misfolding of CFTR. I propose further that this provides 
maximal accessibility of CFTR for ubiquitination and/or degradation.  
 
To further determine the mechanism by which sHsps regulate protein degradation I would first 
determine if the yeast Hsp26 and Hsp42 are also able to prevent aggregation of NBD1. In 
addition, a mutation of the conserved R116 to C in αA-crystallin causes cataracts in humans and 
diminishes its chaperone activity (Litt et al., 1998; Andley et al., 2002). An alignment of several 
sHsps identifies R159 in Hsp26 and R309 in Hsp42 as the corresponding, conserved residue (see 
Figure 34). Figure 35 represents the crystal structure of the wheat Hsp16.9, which presents the 
closest αA-crystallin ortholog with a solved crystal structure. R116 is shown in red and engages 
in an intermolecular salt bridge with E100 (depicted in blue) in Hsp16.9 to support dimerization.  
 
 
160 
 Figure 34: Sequence alignment of 5 sHsps.  
Sequence alignment of Saccharomyces cerevisiae Hsp26 and Hsp42, Homo sapiens αA-
crystallin, Triticum aestivum Hsp16.9, Methanococcus jannaschii Hsp16.5. The red arrow 
indicates the conserved arginine in the α-crystallin domain. 
Alignmet was created via the programs at: 
http://searchlauncher.bcm.tmc.edu/multi-align/multi-align.html 
http://www.ch.embnet.org/software/BOX_form.html. 
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Figure 34: Sequence alignment of 5 sHsps. 
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 Figure 35: Crystal structure of wheat Hsp16.9 dimer. 
This figure depicts the tertiary structure of an Hsp16.9 dimer of the wheat Triticum aestivum. α-
helices are represented in purple, extended β-sheets in yellow, turns in cyan, and coils in white. 
The position of the conserved R108 in the α-crystallin domain is illustrated in red, and the 
position of E100 in blue. The 42 N-terminal residues are depicted only for one of the monomers. 
(Van Monfort, et al., 2001, Nat Struct Biol 1025; modified with VMD (Visual Molecular 
Dynamics): Humphrey et al., 1996). 
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                        Figure 35: Crystal structure of wheat Hsp16.9 dimer. 
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 Although E100 is not conserved in αA-crystallin, R116 is still predicted to face the dimer 
interface and it might make possible variations in assembly modes (van Montfort et al., 2001b; 
Guruprasad and Kumari, 2003). Particularly, since dimerization and oligomerization seem to 
play an important, but still largely ill-defined role in the regulation of sHsp activity (see Chapter 
1.4), this residue should be mutated and its effects characterized. If the R to C mutants of αA-
crystallin, Hsp26, and Hsp42 loose their ability to prevent NBD1 aggregation, it would then be 
important to test the impact of this mutation in vivo (e.g. effects on CFTR degradation and on 
other substrates). An alternative or parallel mechanism that sHsps might use to regulate ERAD 
that should be investigated is substrate poly-ubiquitination. If an impact on the level of CFTR 
ubiquitination is observed when αA-crystallin, Hsp26, and/or Hsp42 levels are altered, it will be 
important to examine effects on E3 ligase recruitment and activation. 
 
The question also rises whether the observations described in this work are the result of a direct 
physical interaction between CFTR and the sHsps. Particularly, the observation that sHsps had 
no impact on Ste6p* degradation, despite the fact that CFTR and Ste6p are related members of 
the family of ABC transporters, raises the question if certain structural features might be required 
for association.  If sHsps bind to the C-terminal part of CFTR, and maybe other ABC 
transporters, it would explain why Ste6p*, a C-terminal truncation mutant, might escape a sHsp 
quality control mechanism. Investigations of different Ste6p* and CFTR mutants might answer 
this question, and it might be worthwhile to map possible interaction sites. 
 
A more indirect mechanism that might explain the results presented in this chapter might be 
provided by a role of the sHsps as mediators between CFTR and the cytoskeleton.  
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 First, since intermediate filaments have been shown to play a role in CFTR biogenesis as well as 
to interact with small Hsps, the coordination of the intermediate filament-CFTR interaction could 
be an alternate mechanism by which α-crystallin effects CFTR maturation/degradation. In a 
recent study, Davezac et al. detected keratin 8 and keratin18 to be up-regulated in response to 
∆F508-CFTR expression in HeLa cells. Moreover, knock-down of K18 by siRNA led to some 
∆F508-CFTR maturation and its transport to the plasma membrane (Davezac et al., 2004). Of 
interest, α-crystallins, as well as Hsp27, interact with various intermediate filaments and 
modulate their assembly and their interactions (Nicholl and Quinlan, 1994; Perng et al., 1999; 
Perng et al., 2004). The beaded filament of the eye lens is comprised of CP49 and filensin, two 
intermediate filament proteins, associated with α-crystallin. Most notably, CP49 and filensin 
show greatest sequence homology to type I and type II keratins, respectively, and CP49 is 39% 
identical to keratin 18 (Quinlan et al., 1996). Also, Hsp27 has been shown to colocalize with 
keratin (Perng et al., 1999).  Finally, during apoptosis, K18 is cleaved at its C-terminus by 
caspase-9 and the caspase-9-activated caspases-3 and -7 (Schutte et al., 2004). Caspase-3 
activation in turn, can be inhibited by α-crystallin (Kamradt et al., 2001; Kamradt et al., 2002; 
Liu et al., 2004a; Kamradt et al., 2005). This evidence raises the question of a possible 
interaction between K18 and/or K8 and α-crystallin. Since we observed enhanced degradation of 
∆F508-CFTR upon α-crystallin over-expression (see Figure 30), α-crystallin might interact with 
keratin/keratin filaments or induce rearrangement of intermediate filaments, and thus prevent 
their association with ∆F508-CFTR. This could abolish the stabilization of mutant CFTR by 
keratin and enhance its proteolysis. On the other hand, the fact that we did not observe an effect 
on wild type CFTR upon α-crystallin over-expression could be explained by a dual role of α-
crystallin in CFTR biogenesis: In the case of wild type CFTR, α-crystallin might promote the 
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 degradation of misfolded CFTR as well as the trafficking of properly folded CFTR out of the ER 
by coordinating CFTR interactions with keratins. Over-expression of α-crystallin would then 
enhance maturation as well as degradation, so that the net outcome might not yield an observable 
phenotype. Another explanation for the different effects of α-crystallin over-expression on wild 
type CFTR and ∆F508-CFTR would be that different keratins exert unique effects upon CFTR 
that might lead to its stabilization or destabilization. α-crystallin could be involved in the 
decision-making process that determines which keratin interacts with mutant and wild type 
CFTR.  
 
Another cytoskeletal element linked to both α-crystallin and CFTR is actin. CFTR has been 
shown to exist in a multi-protein complex that includes E3KARP or EBP50/NHERF1, and ezrin 
at the apical plasma membrane. In addition to its function in regulating channel activity, this 
complex also connects CFTR to the cytoskeleton. This, in turn, could stabilize CFTR at the 
apical plasma membrane (Dransfield et al., 1997; Hall et al., 1998; Short et al., 1998; Wang et 
al., 1998; Sun et al., 2000a; Sun et al., 2000b). Interactions between small Hsps and the actin 
cytoskeleton have also been reported. The unphosphorylated, monomeric form of αB-crystallin, 
Hsp27, and yeast Hsp26 inhibit actin polymerization in vitro (Miron et al., 1991; Benndorf et al., 
1994; Rahman et al., 1995; Wieske et al., 2001), over-expression of sHsps stabilized the actin 
cytoskeleton and organized cortical actin (Lavoie et al., 1993a; Lavoie et al., 1993b; Gu et al., 
1997; Piotrowicz and Levin, 1997). In addition, disorganization of the microfilament network 
was observed when αB-crystallin expression was reduced (Iwaki et al., 1994), and a complex of 
αA-crystallin and αB-crystallin exhibited a stabilizing effect on actin filaments in vitro (Wang 
and Spector, 1996). The interactions between actin and sHsps seem to be dynamic and adjustable 
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 to the needs of the cell, as inhibition of the proteasome causes the redistribution of sHsps to the 
actin cytoskeleton (Verschuure et al., 2002). Hence, sHsps may help provide a network for 
CFTR interactions with actin and other proteins, which is vital for stability, activation, and 
mobility. Or, sHsps might even mediate interactions between the cytoskeleton and the CFTR 
regulatory complex. As suggested by some authors, actin-interaction might stabilize CFTR at the 
apical membrane (Sun et al., 2000b) so that manipulation of the effects of sHsps on the actin 
cytoskeleton might even stabilize rescued ∆F508-CFTR at the apical plasma membrane. 
 
Keratin and actin do not only interact with both CFTR and sHsps, but they also interact with 
each other. This offers additional complexity for a putative α-crystallin regulatory mechanism of 
CFTR. Intermediate filaments engage in various kinds of movements to coordinate assembly, 
disassembly, and subcellular organization, and although some of these activities are intrinsic to 
intermediate filaments, others are mediated via interactions with microtubules or actin-filaments, 
depending on the type of intermediate filament (Helfand et al., 2004). In the case of keratins, the 
motile activities are mainly attributable to their interaction with actin-containing microfilaments, 
and possibly with actin-based motors like myosin (Helfand et al., 2004). Interestingly, myosin 
VI seems to be involved in CFTR endocytosis (Swiatecka-Urban et al., 2004). Since sHsps 
interact with intermediate filaments as well as with actin, they might help further to provide the 
crosstalk and organization of the cytoskeletal components required for CFTR transport to the 
plasma membrane, as well as for its endocytosis. Alternatively, they might mediate cytoskeleton-
CFTR interaction directly.  
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 In addition to HSP26, one uncharacterized ORF, YBR075W, that displayed only minimally 
elevated transcript levels in the microarray analysis has caught our interest. Computational 
analysis revealed that the gene product is a putative member of the M28 family of 
metalloproteases, and the closest human homolog is the uncharacterized KIAA1815 
(http://hitsisb-sib.ch/cgi-bin/PFSCAN_pareser). The 976 amino acid protein may have 8 
transmembrane segments that are predicted to span the ER membrane, and a ~36 kD soluble 
segment comprising the putative protease domain is calculated to reside within the ER lumen 
(http://psort.nibb.ac.jp/cgi-bin/runpsort.pl). An alignment of the putative protease domain of 
Ybr075Wp with those of S. griseus aminopeptidase and human Glutamate Carboxypeptidase II, 
both M28 metalloproteases, reveals conserved divalent cation (zinc)-coordinating residues in 
Ybr075Wp: H156, D168, E201, E/D226, H319 (see Figure 36) that in other proteases are known 
to impact protease activity (Speno et al., 1999; Fundoiano-Hershcovitz et al., 2004). Information 
about YBR075W from genome/proteome-wide screens is limited.  On average, only 1 copy of 
YBR075W messanger RNA has been detected (http://web.wi.mit.edu/young/expression/ 
transcriptome2.html), and Ybr075wp has been identified as ubiquitin-modified gene by mass 
spectrometry (Peng et al., 2003).  
 
To determine a potential involvement of this candidate in CFTR biogenesis I transformed yeast 
harboring a C-terminal truncation of YBR075Wp and the isogenic wild type strain with a 
plasmid expressing CFTR under the control of a constitutive promoter. Cycloheximide chase 
analysis uncovered compromised CFTR degradation in the ybr075w mutant yeast (see Figure 
37). In contrast, CPY* degradation proceeded with equal efficiency in wild type and mutant 
yeast (see Figure 38). In addition, a general stress response was not induced in the truncation  
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 Figure 36:  Sequence alignment of the protease domains of 3 M28 metalloproteases. 
Sequence alignment of Saccharomyces cerevisiae Ybr075Wp, Streptomyces griseus 
aminopeptidase and Homo sapiens Glutamate Carboxypeptidase II. The conserved divalent 
cation binding residues are denoted in red, and the red arrows indicate the identical positions in 
Ybr075Wp.  
Alignmet was created via the programs at: 
http://searchlauncher.bcm.tmc.edu/multi-align/multi-align.html 
http://www.ch.embnet.org/software/BOX_form.html. 
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 Figure 36: Sequence alignment of the protease domains of 3 M28 metalloproteases. 
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 Figure 37: CFTR degradation is slowed in the ybr075w truncation mutant. 
A. Rates of CFTR degradation were determined by cycloheximide chase experiments in 
YBR075W wild type yeast and in the ybr075w∆ C-terminal truncation mutant strain after addition 
of cycloheximide. Sec61p levels served as loading control. B. CFTR protein levels were 
quantified from 5 independent sets of experiments and averaged. All values were obtained after 
standardization to the levels detected directly after cycloheximide addition (0 min). Closed blue 
circles represent CFTR protein levels in YBR075W wild type cells, and open purple circles 
represent CFTR protein levels in ybr075∆ mutants. Vertical bars indicate the standard errors of 
the means. P: * = 0.0299, ** = 0.0464, ***= 0.0003, **** = 0.0005. 
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  Figure 37: CFTR degradation is slowed in the ybr075w truncation mutant. 
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 Figure 38: CPY* protein degradation is equally efficient in YBR075W wild type and ybr075w 
truncation strains.  
A. Rates of CPY* degradation were determined by pulse-chase immuno-precipitation 
experiments in YBR075W wild type yeast and in the ybr075w∆ C-terminal truncation mutant 
strain after addition of cycloheximide. B. CPY* protein levels were quantified from 2 
independent sets of experiments and averaged. All values were obtained after standardization to 
the levels detected directly after cycloheximide addition (0 min). Closed blue circles represent 
CPY* protein levels in YBR075W wild type cells, and open purple circles represent CPY* 
protein levels in ybr075∆ mutant yeast. Vertical bars indicate the range in the data. 
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      Figure 38: CPY* protein degradation is equally efficient in YBR075W wild type and ybr075w truncation strains.  
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 mutant because levels of Kar2p were not elevated (see Figure 39). Therefore, Ybr075wp seems 
to impact ERAD directly and might degrade transmembrane and ER luminal segments left 
behind by the proteasome, similar to a sequential action of proteases described for the 
mitochondria (Kambacheld et al., 2005), or it might provide a parallel or alternate pathway for 
quality control of membrane proteins.   
 
To confirm the role of YBR075Wp in protein degradation, the putative protease activity should 
be verified through in vitro protease assays and functional investigation of mutations in active 
site residues (see above) might confirm Ybr075Wp as member of the M28 protease family. 
Determination of Ybr075W’s subcellular localization and substrate specificity would then be 
essential to corroborate the computational prediction of this protein as a new ER resident 
protease that plays a role in ERAD.   
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 Figure 39: The Stress response is not induced in the ybr075w truncation mutant. 
Kar2p and Sec61p protein levels in the YBR075W wild type and ybr075w truncation mutant 
strain were determined by immuno-precipitation. Results of two independent experiments are 
displayed. The proteins in the YBR075W wild type strain are denoted as “WT” in blue, and the 
proteins in the  ybr075w truncation mutant are denoted as “∆” in purple.  
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                                Figure 39: The Stress response is not induced in the ybr075w truncation mutant. 
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 In summary, the microarray analysis of the transcriptional response of yeast to heterologous 
expression of CFTR has provided me with at least 2 genes that affect CFTR degradation in yeast. 
Prior to this study the impact of these proteins on CFTR biogenesis or ERAD was unknown. I 
also began to characterize the gene products and was able to show that sHsp function in ERAD is 
conserved. In addition, there are a large number of interesting up-regulated genes that will 
provide an avenue of future research. Together, my results validate the use of a genomic 
approach in yeast to investigate proteins related to human diseases, and I suggest that this attack 
might be of great value to examine the cause of other protein quality control diseases. 
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 4. CONCLUSION 
 
 
 
 
Chaperone requirements for the folding and degradation of soluble, sectretory proteins and 
integral membrane proteins have been studied in detail and are distinct from each other (see 
above) (Plemper et al., 1997; Strickland et al., 1997; Brodsky et al., 1999; Meacham et al., 1999; 
Hill and Cooper, 2000; Choo-Kang and Zeitlin, 2001; Meacham et al., 2001; Nishikawa et al., 
2001; Zhang et al., 2001; Farinha et al., 2002; Kabani et al., 2003; Taxis et al., 2003; Alberti et 
al., 2004; Huyer et al., 2004; Youker et al., 2004). However, the chaperone requirements for the 
biogenesis, folding, and degradation of distinct cytoplasmic polypeptides is still rather poorly 
defined (Schneider et al., 1996; Brodsky et al., 1998; Kim et al., 1998b; Kampinga et al., 2003). 
My results on the biogenesis on FFLux in yeast (see Chapter 2) and CFTR (see Chapter 3) 
suggest some overlap in the chaperone requirements between cytoplasmic substrates and integral 
membrane protein substrates with prominent cytosolic domains (see Table 8). For example, I 
found that the yeast Hsp70, Ssa1p, and its NEF, Fes1p, facilitate FFLux folding in yeast (Chapter 
2), consistent with the involvement of their mammalian orthologs, Hsp70 and HspBP1, in the 
maturation of CFTR (Strickland et al., 1997; Meacham et al., 1999; Farinha et al., 2002; Alberti 
et al., 2004). In addition, I found that αA-crystallin prevents the aggregation of the first NBD of 
CFTR, one of its cytoplasmic domains, and αA-crystallin and other sHsps are known to keep 
numerous cytoplasmic polypeptides soluble (Narberhaus, 2002). Further evidence in the 
literature indicates that Hsp70 and Hsp90 can solubilize  cytoplasmic client proteins and CFTR  
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 Table 8:  Chaperone action on cytoplasmic and integral membrane substrate proteins. 
 
 
Hsp 
 
Yeast 
 
mammalian 
Function Cytoplasmic soluble 
substrate 
Integral membrane 
substrate 
Prevention of 
aggregation 
Goeckeler et al., 2002 
Oh et al., 1999 - Sse1p Hsp110 
Protein maturation 
 - 
Appendix, this study 
Translation 
 
Ahner et al.,2005; 
Chapter 2, this study - 
Folding/maturation 
 
Schneider et al., 1996 
Wegele et al., 2004 
Youker et al., 2004 
Loo et al., 1998 
Prevention of 
aggregation 
Wiech et al., 1992 
Wegele et al., 2004 
Youker et al., 2004 
 
 
Hsp82 Hsp90 
Protein degradation 
 
Immamura et al., 1998 
Murata et al., 2001 
Connell et al., 2001 
Fuller et al., 2000 
RNA 
stability/degradation 
 
Ahner et al., 2005 
Chapter 2, this study 
Barnes, 1998 
Duttagupta et al., 2003 
- 
Translation 
 
General effect, specific substrates not examined 
Folding/maturation 
 
Ahner et al., 2005 
Chapter 2, this study 
Kim et al., 1998 
Luders et al.,, 2000 
Wegele et al., 2004 
Farinha et al., 2002 
Meacham et al., 1999 
Strickland et al., 1997 
Prevention of 
aggregation 
Kim et al., 1998 
Luders et al.,, 2000 
Wegele et al., 2004 
Meacham et al., 1999 
Strickland et al., 1997 
Ssa1p Hsp70 
Protein degradation 
 
Murata et al., 2001 Zhang et al., 2001 
Meacham et al., 2001 
Prevention of 
aggregation 
Narberhaus, 2002 Chapter 3, this study Hsp26/ 
Hsp42 
αA-
crystallin 
Protein degradation 
 - 
Chapter 3, this study 
Translation 
 
General effect, specific substrates not examined Fes1p HspBP1 
Folding/Maturation 
 
Ahner et al., 2005 
Chapter 2, this study 
Alberti et al., 2004 
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 NBD1 (Wiech et al., 1992; Strickland et al., 1997; Kim et al., 1998b; Meacham et al., 1999; 
Luders et al., 2000; Youker et al., 2004), that Hsp70 and Hsp90 are involved in the degradation 
of cytoplasmic and transmembrane proteins (Imamura et al., 1998; Fuller and Cuthbert, 2000; 
Connell et al., 2001; Meacham et al., 2001; Murata et al., 2001; Zhang et al., 2001; Huyer et al., 
2004), and that Hsp90 aids in the folding of diverse cytoplasmic proteins as well as in the folding 
of CFTR (Loo et al., 1998; Wegele et al., 2004; Youker et al., 2004). Finally, Hsp110 has been 
reported to prevent denatured FFLux from aggregating, and the slight increase in wild type 
CFTR maturation upon Hsp110 over-expression that I report in the Appendix might have arisen 
from a similar phenomenon (Oh et al., 1999; Goeckeler et al., 2002). To this end, it will be 
interesting to reveal if sHsps are involved in the degradation of FFLux or other cytoplasmic 
proteins, consistent with their role in CFTR degradation (see also Table 8). 
 
 Despite the observed similarity in chaperone requirements between cytoplasmic and 
transmembrane proteins, my findings also emphasize specificity in Hsp function. A chaperone 
does not only recognize its substrates but it also needs to “decide” which function to exert on a 
client protein. This decision depends on the substrate polypeptide and on the interaction with co-
chaperones. For example, although Ssa1p and Fes1p have been implicated in protein translation, 
neither of them affects FFLux translation: instead, both likely collaborate to help FFLux folding 
(see Table 8; Horton et al., 2001; Kabani et al., 2002a). In addition, while Ssa1p also impacts 
FFLux biogenesis at several other levels, Fes1p does not (see Capter 2.3.). The fact that I 
uncovered multiple, functionally distinct involvements of Ssa1p during the biosynthesis of one 
substrate but the Ssa1p cofactor Fes1p was only required for one of these functions, leads to 
several questions: Does Ssa1p interact with a different cofactor or different cofactors to support 
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 each function? Is there a default function of Ssa1p when it acts on its own and does association 
with a distinct cofactor induce a specific change in function?  For example, Ssa1p might keep a 
polypeptide soluble and hence accessible for cofactor-mediated functions, such as ubiquitination, 
degradation, folding, and maturation. How do different cofactors compete for chaperone 
interaction? And, what is the mechanism utilized by the co-chaperones that alters chaperone 
function?  
 
For example, two mammalian co-chaperones, the E3 ubiquitin ligase CHIP, and the NEF Bag-1, 
associate simultaneously with Hsc70, and this protein complex promotes substrate ubiquitination 
and degradation; however, the nucleotide release factor for Hsc70, HspBP1, competes with Bag-
1 for Hsc70 binding and inhibits CHIP-mediated ubiquitination of CFTR by the chaperone 
complex, but does not impact the CHIP-regulated half-life of the glucocorticoid receptor (Alberti 
et al., 2004). Therefore, Hsc70 function is dependent on Hsc70-co-chaperone interaction, co-
chaperone-combinations, and the substrate.  
 
In fact, yeast contain two known nucleotide exchange factors for the cytoplasmic Hsp70, Ssa1p, 
the Bag-1 ortholog, Snl1 (Sondermann et al., 2002), and the HspBP1 ortholog, Fes1p (Kabani et 
al., 2002b), which I found to be involved in Ssa1p-catalyzed FFLux folding (see Chapter 2.3.). 
Hence, it should be worthwhile to investigate a putative involvement of Snl1p in FFLux 
biogenesis and a possible cooperation between this Bag-1 ortholog and Ssa1p in FFLux 
biosynthesis and maturation. It should be mentioned though that a yeast ortholog of CHIP has 
not been identified to date, so that an Hsp70-Snl1p interaction in yeast might lead to different 
effects than the action of their mammalian counterparts. Also, because different cofactors might 
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 bind to different domains of a chaperone, an investigation of mutated chaperones might only 
reveal allele specific effects. 
 
 Additional evidence for the specificity of Hsp action originates from the observation that the 
presence of a mutation within a protein might change the impact of the chaperone: whereas the 
biogenesis of wild type CFTR was unaffected by αA-crystallin over-expression, ∆F508-CFTR 
degradation was enhanced (see Chapter 3.3.). Moreover, two structurally related transmembrane 
ERAD substrates, CFTR and Ste6p*, with homology limited to their NBDs (see Chapter 3.3.; 
and Kuchler et al., 1989), are degraded by the same proteolytic machinery in yeast, and efficient 
proteolysis of both requires the yeast Hsp70, Ssa1p (Huyer et al., 2004). In contrast, I found that 
sHsps impact only the degradation of CFTR but not the proteolysis of Ste6p* (see Chapter 3.3.). 
Hence, sHsps either differentiate between these integral membrane substrates whereas Ssa1p 
does not, or sHsps might recognize the C-terminus of Ste6p, which is deleted in mutant Ste6p*, 
to associate with this substrate (see Chapter 3.3.). These data suggest that the Ssa1p interaction 
site resides in a different segment of the protein.  
 
Together, these results indicate a high complexity of the chaperone network. To gain a better 
understanding of the decision processes it will be necessary to determine the chaperone and co-
chaperone requirements for numerous protein substrates and different mutant variants of each 
substrate.  
 
 
184 
  
 
APPENDIX A 
 
 
 
 
 
 
 
 
THE ROLE OF HSP110 IN CFTR MATURATION AND DEGRADATION 
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Introduction 
 
 
Hsp110s comprise a subfamily of the Hsp70 family of chaperones, and homology between the 
two groups resides mostly in the N-terminal nucleotide-binding site (Easton et al., 2000). 
Mammalian Hsp110 and the yeast Hsp110 ortholog, Sse1p, retain denatured proteins in a folding 
competent conformation, but are unable to catalyze the refolding process, and they interact with 
and are required for the function of the Hsp90 complex (Oh et al., 1997; Brodsky et al., 1999; 
Liu et al., 1999; Oh et al., 1999; Goeckeler et al., 2002). In contrast to the Hsp70s, the substrate 
specificity of this class of chaperones has not been characterized.  
 
It was previously shown that the deletion of the yeast HSP110 did not affect CFTR biogenesis or 
degradation (Youker et al., 2004). But, this result could not rule out that redundancy in 
chaperone function might have compensated for the loss of Hsp110. Also, the functions of the 
yeast and mammalian Hsp110 might not be entirely conserved. In addition, a previous report on 
a microarray analysis on the transcriptional response of IB3-1 cells (a bronchial epithelial cell 
line that expresses ∆F508-CFTR) to 4-phenylbutyrate (PBA) reported an up-regulation of 
HSP110 (Wright et al., 2004). PBA has been demonstrated to impact the expression levels of 
many molecular chaperones, and it induces ∆F508-CFTR maturation and restores ion 
conductance of the mutant channel (Rubenstein et al., 1997; Rubenstein and Zeitlin, 1998, 2000; 
Zeitlin et al., 2002). These data raised the question whether the effect of PBA is at least in part 
mediated through Hsp110 up-regulation. Therefore, I tested the effect of Hsp110 over-expression 
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 on the biogenesis of wild type CFTR and on ∆F508-CFTR in HEK293 cells. My preliminary 
data suggest that elevated Hsp110 levels are insufficient to induce maturation of ∆F508-CFTR 
maturation. 
 
 
Materials and Methods 
 
 
Mammalian cell culture, plasmids, and transient transfection 
 
 
HEK293 (human embryonic kidney) cells were cultured in Dulbecco’s modified Eagel’s medium 
(DMEM; Sigma) with 10% fetal bovine serum (Invitrogen), 4mM L-gutamine (Sigma), and 
penicillin-streptomycin (GibcoBRL) at 37°C in a humidified environment containing 5% CO2. 
The Hsp110 encoding gene in the pBacPAKHis-1 vector (kindly provided by J.R. Subjeck, 
Roswell Park Cancer Institute, Buffalo, New York) was sub-cloned into pcDNA3.1 (kindly 
provided by R. Hughey, University of Pittsburgh) as described in chapter 3.2.2., and the CFTR 
and ∆F508-CFTR genes in pcDNA3.1 were kindly provided by R.A. Frizzell, University of 
Pittsburgh. 
 
 For all experiments, HEK293 cells were grown in 60-mm dishes and transiently transfected with 
the indicated pcDNA3.1 expression plasmids aided by Lipofectamine 2000 (Invitrogen). After 
24h, cells were subjected to pulse-chase analysis as described previously (Zhang et al., 2002a) 
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 with minor modifications (described in Chapter 3.2.7.). P-values were calculated via the program 
at http://faculty.vassar.edu/lowry/t_ind_stats.html.
 
 
Immunoblot analysis 
 
 
Protein extracts were prepared as described (Zhang et al., 2002a) with minor modifications 
(described in Chapter 3.2.7.) and were concentrated ~4-fold with microcon YM-30 filters 
(Amicon). Samples were loaded onto 12.5% SDS-polyacrylamide gels, and after electrophoresis, 
the proteins were transferred to nitrocellulose (Schleicher and Schuell, pore diameter of 0.2µm). 
The primary antibodies used were raised against Hsp90 and Hsp110 (Stressgen). To detect the 
primary antibody, horse-radish peroxidase-conjugated secondary antibodies (anti-rabbit and anti-
rat (Amersham)) were used. The complexes were visualized using the enhanced 
chemiluminescence detection kit (Pierce) and quantified using Kodak 1D software (v3.6; 
Kodak). 
 
 
Results 
 
 
To assess the impact of Hsp110 on CFTR biogenesis, I co-transfected HEK293 cells with the 
CFTR expression vector and either the empty vector as a control or the Hsp110 expression 
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 vector and performed pulse-chase immuno-precipitation experiments. Successful over-
expression of Hsp110 was confirmed by western blot analysis (see Figure 40A). I found that the 
efficiency of CFTR maturation from the immature, core-glycosylated form (CFTR B-band) to 
the mature, complex-glycosylated form (CFTR C-band) was slightly increased in cultures 
transfected with the Hsp110 over-expression vector (see Figure 40A and B). There was no 
difference in the disappearance of the B-band following over-expression of Hsp110 (see Figure 
40A and B). These preliminary data suggest that the human Hsp110 might aid in the maturation 
of wild type CFTR. To explore the possibility that Hsp110 might similarly affect the biogenesis 
of ∆F508-CFTR I repeated the pulse-chase immuno-precipitation experiments in cells expressing 
the ∆F508-CFTR mutant. Successful over-expression of Hsp110 was confirmed by western blot 
analysis, and Hsp90 served as a loading control (see Figure 41A). In preliminary experiments, I 
did not observe an increase in ∆F508-CFTR maturation upon Hsp110 over-expression (no C-
band could be detected), and the degradation of the B-band proceeded with equal efficiency in 
HEK293 cells, independent of Hsp110 protein levels (see Figure 41A and B).   
 
 
Discussion 
 
 
I observed that the over-expression of Hsp110 caused a small increase in the efficiency of wild 
type CFTR maturation, but processing of the ∆F508-CFTR mutant protein was unaffected. 
Although these results are preliminary, they suggest a role for Hsp110 in at least wild type CFTR 
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  Figure 40: Hsp110 over-expression slightly increases the efficiency of wild type CFTR 
maturation. A. HEK293 cells were transfected with 1.5 µg of pcDNA3.1-CFTR and 1.5 µg of 
pcDNA3.1 or pcDNA3.1-Hsp110. Rates of CFTR maturation and CFTR B-band degradation 
were determined by pulse-chase immuno-precipitation in HEK293 cells co-transfected with 
CFTR, and in cells containing a vector control or the Hsp110 expressing vector.  Hsp110 
expression levels were assessed by western blot analysis. B. CFTR B-band degradation and 
CFTR maturation were determined from 3 independent sets of experiments and averaged. All 
values were obtained after standardization to the levels detected at the beginning of the chase 
period (0 h). Closed blue circles represent immature/mature CFTR protein levels in HEK293 
cells with the vector control, and open purple circles represent immature/mature CFTR protein 
levels in HEK293 cells over-expressing Hsp110. Vertical bars indicate the standard errors of the 
mean. P: * = 0.024, ** = 0.0228. 
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   Figure 40: Hsp110 over-expression slightly increases the efficiency of wild type CFTR maturation. 
  
 
 
 
 
 
 
 
 
191 
 Figure 41: Hsp110 over-expression has no effect on the degradation of ∆F508-CFTR. 
A. HEK293 cells were transfected with 1.5 µg of pcDNA3.1-∆F508-CFTR and 1.5 µg of 
pcDNA3.1 or pcDNA3.1-HSP110. Rates of ∆F508-CFTR degradation were determined by 
pulse-chase immuno-precipitation in each transfected HEK293 cell-type. Hsp110 and Hsp90 (as 
a loading control) expression levels were assessed by western blot analysis B. ∆F508-CFTR 
degradation was determined from 3 independent sets of experiments and averaged. All values 
were obtained after standardization to the levels detected at the beginning of the chase period (0 
h). Closed blue circles represent ∆F508-CFTR protein levels in HEK293 cells with the vector 
control, and open purple circles represent ∆F508-CFTR protein levels in HEK293 cells over-
expressing Hsp110. Vertical bars indicate the standard errors of the mean. 
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   Figure 41: Hsp110 over-expression has no effect on the degradation of ∆F508-CFTR. 
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maturation. The fact that I did not detect any maturation of the ∆F508-CFTR mutant protein 
might tell us that Hsp110 alone does not mediate the PBA-induced restoration of ∆F508-CFTR 
trafficking and function, or Hsp110 might be necessary but not sufficient for this mechanism 
(Rubenstein et al., 1997; Rubenstein and Zeitlin, 1998, 2000; Zeitlin et al., 2002). Also, the 
heterologous over-expression of ∆F508-CFTR and the cell line chosen might interfere with a 
putative impact of Hsp110 on ∆F508-CFTR biogenesis. Careful repetition of the experiments, 
the use of a physiological relevant system, and simultaneous manipulation of other 
chaperones/factors might aid in solving this question. 
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